











Title of Document: USING “SMALL” MOLECULES AS 
TRANSMEMBRANE ANION TRANSPORTERS.   
  
 Oluyomi Adeola Okunola, Doctor of Philosophy, 2009 
  
Directed By: Professor Jeffery T. Davis,  
Department of Chemistry and Biochemistry 
 
 
Functional, “small” molecule anion transporters have been identified and 
developed from natural products and synthetic organic compounds. The major 
discoveries include the design of a transmembrane Cl- transporter whose activity is pH-
tunable, a NO3- transporter that displays unique selectivity for NO3- over Cl- anions, and a 
series of small molecules that efficiently transport HCO3- across liposomal membranes 
via a HCO3-/Cl- exchange mechanism. An assay for detecting transmembrane HCO3- 
transport using paramagnetic Mn2+ and 13C NMR is also described. 
 Modulated Cl- transport was achieved by lipophilic calix[4]arene amides 2.2–2.4, 
all in the cone conformation.  Modulation was achieved through functional group 
modification to one of the four side-chains. The cone conformation was confirmed by 
both 1H NMR and X-ray crystallography. Significantly, Cl- transport was gated by pH in 
the presence of triamido calixarene TAC-OH 2.3, which possesses a phenolic hydroxyl 
group. Using fluorescence assays, the rate of Cl- transport by TAC-OH 2.3 across 
  
liposomal membranes decreased with increasing pH, while transport rate by cone-H 2.2a, 
lacking an OH group, was not affected by pH.  
 Nitrate was selectively transported over Cl- in the presence of nitro tripod 3.1, a 
small molecule receptor for both anions.  The selective transport of NO3- by 3.1 is a 
significant discovery as most known synthetic Cl- transporters also transport NO3- ions 
and vice versa. Nitrate transport across liposomal membranes was confirmed by enzyme-
coupled and fluorescence assays. Tripod 3.1 induced an increase in the intravesicular pH 
of liposomes that were not experiencing a pH gradient, while no pH changes occurred in 
the presence of calixarene 2.1 a known Cl- and NO3- transporter.  This result suggests that 
3.1 is an H+/NO3- symporter. 
 Transmembrane HCO3- transport was achieved using the natural product, 
prodigiosin, 4.1, and synthetic isophthalamides 4.2–4.4. The Cl-/HCO3- exchange 
mechanism by which compounds 4.1–4.4 transport HCO3- was elucidated by ISE and 
NMR assays. The 13C NMR assay provided direct evidence for HCO3- transport in the 
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Chapter 1: Transmembrane Anion Transport 
1.1 Introduction. 
 The exchange of materials between a cell and its environments – a crucial process 
for survival and well-being – is achieved through the transport of solutes across the 
plasma membrane.  The plasma membrane serves as an external boundary for the cell, as 
well as a selective barrier for the passage of solutes in and out of the cell. Sub-cellular 
components such as the nucleus, mitochondria, Golgi complex, lysosomes, and the 
endoplasmic reticulum, are also bound by membranes, which also function as effective 
and highly selective barriers.1  The structure of the membrane, which is the basis for its 
selectivity, is that of a bilayer that is assembled from amphiphilic phospholipids that have 
polar headgroups and hydrophobic tails.  Thus, in the aqueous environment of the cell, 
the hydrophobic tails align to form a compact but fluid core, while the polar headgroups 
point away from this core into the aqueous environment in the interior and exterior of the 
cell (Figure 1.1).  Due to the flexibility and semi-permeability of biological membranes, 
some small uncharged molecules such as water or carbon dioxide can diffuse across the 
membrane unaided.  However, for polar solutes such as anions, passage through the 
membrane must be assisted.  This assisted process is facilitated by proteins which 
function as carriers or membrane-bound channels (Figure 1.1).  The transmembrane 
transport of anions is of great biological importance since defective anion transport has 
been linked to the patho-physiology of numerous diseases.2-4  Synthetic compounds that 
mimic natural anion receptors and transporters will therefore aid in understanding natural 
ion transport processes, and could be potential therapeutics in diseases associated with 
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ion transport.  This thesis, “Using Small Molecules as Transmembrane Anion 
Transporters” describes the design and identification of various small organic molecules 
for the transmembrane transport of the biologically relevant chloride (Cl-), nitrate (NO3-), 
and bicarbonate (HCO3-) anions.   
 









Figure 1.1. Structure of the phospholipid bilayer showing the component parts: the polar 
headgroups and hydrophobic interior.  The mechanisms of transmembrane transport – 
carriers and channels – are also depicted.  Carriers are mobile and diffuse through the 
membrane, while channels are ‘stationary’ and span the membrane.  Anions are depicted 
as red spheres, while the transport pathway is outlined by blue arrows. 
 
1.2 Thesis Organization. 
 This thesis is organized into six chapters.  The initial goal of this research was to 
identify and develop small organic molecules capable of the transmembrane transport of 
the biologically relevant Cl- and HCO3- anions, by mimicking natural anion receptors and 
transporters (Figure 1.1).  This goal was accomplished as will be discussed in the 
following chapters. Additionally, the efforts also led to the serendipitous discovery of a 
synthetic transporter that selectively transports NO3- ions over Cl-.   
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 The discussion in Chapter 1 focuses on the general concepts of facilitated 
transmembrane anion transport, such as types of transporters, and classes (stoichiometry) 
of transport.  A detailed discussion on the types of interactions between transporter and 
anion is presented with examples of crystal structures of natural proteins bound to the 
anionic substrate.  Liposome-based techniques for detecting anion transport across 
bilayer membranes are presented, followed by selected representative examples of 
synthetic anion transporters that have been reported in the literature.  Chapter 2 focuses 
on the transmembrane transport of chloride by some lipophilic calix[4]arene amides.  The 
influence of calixarene conformation and substitution on Cl- transport, especially by 
triamido calixarene TAC-OH 2.3 (Chart 1.1), is discussed.  Previous studies in the Davis 
group had suggested that arene scaffolds substituted with three amide side chains gave 
highly efficient transmembrane Cl- transporters.5, 6  The phenolic hydroxyl group of 
calixarene 2.3 afforded a robust Cl- transporter whose transporting activity can be ‘gated’ 
by pH.  Examples of synthetic Cl- transporters with gated activities are, therefore, 
presented at the beginning of Chapter 2.  In Chapter 3, I discuss the studies on nitro 
tripod 3.1 (Chart 1.1), which was designed as a rigid analog of TAC-OH 2.3.  The 
success of triamido calixarene 2.3, along with incentive from previous group data,5, 6 led 
us to investigate the influence of a more rigid tripodal scaffold on transmembrane Cl- 
transport.  The studies revealed that tripod 3.1, rather than function as a Cl- transporter, 
turned out instead to be selective for the transmembrane transport of NO3- anion.  Thus 
anion transport selectivity was changed due to modification of the transporter scaffold.  
Tripod 3.1 turns out to be the only nitrate transporter reported to date, to the best of the 
author’s knowledge that displays a marked selectivity for NO3- over Cl- anions.  Chapter 
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4 focuses on the identification of small molecule transmembrane transporters of 
bicarbonate anion.  Despite the importance of transmembrane bicarbonate transport, no 
published studies have examined the use of ‘small’ molecules to promote the efficient 
transport of bicarbonate anions across lipid membranes.7  The studies described in 
Chapter 4 show that the natural product, prodigiosin 4.1 and synthetic isophthalamides 
4.2-4.4 (Chart 1.1) transported HCO3- via an anion exchange mechanism, with Cl- as the 
exchange anion.  Chapter 5 describes future directions, especially as applied to the 
transmembrane bicarbonate transport, while the experimental protocols used for the 
research described in Chapters 2-4 are outlined in Chapter 6.  
 







































TAC-OH 2.3 Isophthalamides 4.2-4.4  
 
1.3 Anions in Nature and Human Health.  
 Anions abound in Nature and play important roles in chemical and biological 
processes.  Environmentally, the presence of anions such as nitrate and phosphate in 
bodies of water leads to eutrophication, while radioactive anions such as pertechnetate 
are known to be anthropogenic.  In biological systems, anions are critical to the 
maintenance of life, as they are involved in fundamental cellular functions such as 
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regulating pH, maintaining cell volume and osmotic balance, and serve as cellular 
signals.  Anions also carry genetic information (DNA and RNA are polyanions), and act 
as substrates and cofactors for a number of enzymes.1  As previously stated, the 
misregulation of function in natural anion transporters have been associated with certain 
diseases in humans.2, 8, 9  For example, misregulation of function in Cl– ion channels has 
been associated with the pathology of diseases such as Bartter’s syndrome, Dent’s 
disease, osteopetrosis (bone disease), and cystic fibrosis (CF).10, 11  Similarly, with HCO3- 
which is involved in the most basic of cellular processes – respiration, defects in 
bicarbonate transport proteins has been linked to diseases of most organ systems 
including the brain, heart and bones, as well as CF.12-16  The metabolites of NO3- ions 
have also been implicated in carcinogenesis.17 
 
1.4 Transport of Anions across Biological Membranes.  
 This section provides a short introduction to the biochemistry of membrane 
transport, with specific focus on anion transport; the reader is referred to any standard 
biochemistry text for an in-depth discussion of the subject.  The general concepts 
described in the section apply to all membrane transport processes, irrespective of 
whether the transported entity is a charged or non-polar species.   
 The transport of anions across biological membranes is an assisted process 
facilitated by proteins that act either as carriers or channels (Figure 1.1).  Channels are 
usually membrane-bound proteins, while carriers may or may not be membrane-
associated.  The fact that carriers shuttle their guests from one side of the membrane to 
the other implies that they are lipophilic enough to diffuse through the hydrophobic 
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portion of the membrane.  Channels, on the other hand, are embedded within and 
transverse the membrane.  Channels, therefore, have to induce a ‘defect’ in the membrane 
to effect transmembrane transport.  This ‘defect’ is usually in the form of a pore through 
which their substrate can pass.  A list of some of the fundamental differences between 
carriers and channels are shown in Table 1.1.  A very unique property of channel-type 
transporters is that their transport activity is often gated or regulated in response to certain 
cellular events, such as ligand binding, changes in cellular volume or membrane potential 
(i.e., voltage gating).  The carrier/channel classification is very broad-based and further 
subdivisions exist within each category based on protein primary sequence and/or 
secondary structure.  Transmembrane anion transport, as with transmembrane transport in 
general, can either be a passive or active process.  Passive transport involves the simple 
diffusion of anions down an electrochemical gradient.  On the other hand, active transport 
involves anion transport against an electrochemical gradient, therefore requiring energy, 
usually derived from adenosine triphosphate (ATP) hydrolysis. 
  
Table 1.1 Some differences between carrier- and channel-type transport proteins. 
Carriers Channels 
Binds substrate with high 
stereoselectivity 
 
Usually less stereoselective in substrate 
binding 
 
Transport rate below limits of free 
diffusion 
 
Transport rate approaches limit of 
unhindered diffusion (107–108 ion/s) 
 
Usually composed of monomeric proteins 
 
 
Usually oligomeric complexes of 
multiple identical subunits 
 
Transport activity not gated 
 
Transport activity is gated in response to 




 Transport proteins are also classified based on the stoichiometry (i.e., the number 
of solutes being transported) and direction of transport as uniport, symport or antiport 
transport systems (Figure 1.2).  Uniport occurs when a transporter carries only one 
substrate at a time, for example, members of the ClC chloride channels family, which are 
specific to small monovalent anions, such as Cl-, Br-, I-, NO3- and SCN-, of which Cl- is 
the most biologically abundant.18, 19  Transporters that carry two different types of solutes 
across the membrane are known as co-transporters.  Co-transporters achieve solute 
transport by simultaneously moving the two solutes either in the same direction – 
symport, or in opposite directions – antiport.  The term ‘co-transport’ is also often used to 
refer to symport, even though both symport and antiport involve the co-transport of 
solutes.  Similar to the carrier/channel classification of transport proteins, the uniport/co-
transport classification is also generic, and does not indicate whether transport is an 
energy-independent (passive) or energy-driven (active) process.  A biological example of 
an anion antiporter is the chloride/bicarbonate exchanger, also known as the anion 
exchange (AE) protein.4  The AE protein is very crucial to the process of respiration in 
cells as it allows the transport of CO2, in the form of HCO3-, from respiring tissues to the 
lungs (see details in Chapter 4). The synthetic transporters studied in this thesis also fall 
into the symporter/antiporter categories: nitro tripod 3.1 is a H+/NO3- symporter (see 
discussion in Chapter 3), while prodigiosin 4.1 and isophthalamides 4.2-4.4 function as 
Cl-/HCO3- exchangers (discussion in Chapter 4). 
 Finally, another phenomenon to be considered in the transport of charged species 
across biological membrane is the separation of charges such that transport is either 
electrogenic or electroneutral.  Electrogenic transport results in the build-up of charges 
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because negative or positive charges are transported with symport of an uneven number 
of counter ions or antiport of an uneven number of like charges.  On the other hand, in 
electroneutral transport there is no net charge transfer due to the symport/antiport of an 






Figure 1.2 Classification of transport systems based on the stoichiometry and direction of 
transport. In uniport, one solute only is transported. Co-transport systems can either be 
classified as symport – the transport of two different solutes in the same direction, or as 
antiport – transport of two different solutes in opposite directions.  
 
1.4.1 Receptor-Anion Interactions.  
 Since anion transport proteins are not enzymes, anionic substrates are not 
chemically altered during the transport process.  However, most of these proteins are 
highly selective, and like enzymes, they often bind their anionic substrates with 
geometrical specificity.  The specific binding is usually achieved through the use of 
multiple, weak non-covalent interactions such as hydrogen bonding, and electrostatic 
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interactions which include charge-charge, charge-dipole, and dipole-dipole interactions.  
Chemists seeking to develop synthetic anion transporters also employ these types of 
interactions in their synthetic designs.  Following is a short description of electrostatic 
and hydrogen bond interactions, followed by examples of these interactions as shown in 
the crystal structures of proteins that bind Cl-, NO3-, and HCO3- anions. 
 
1.4.1.1 Electrostatic Interactions.  The term “electrostatic interactions” is often used to 
refer to charge-charge (A−•••D+), charge-dipole (A−•••Dδ+), and dipole-dipole (Aδ-•••Dδ+) 
(Figure 1.3) interactions in proteins.20  The strengths of these interactions vary depending 
on the environment in which they exist; with stronger interactions in non-polar 
environments and weaker ones in polar environments due to competition from the 
environment.  However, notwithstanding the environment, dipole-dipole interactions are 
usually the weakest (0–50 kJ mol-1), charge-charge interactions the strongest (100–350 kJ 
mol-1), and charge-dipole interactions intermediate (50–200 kJ mol-1) in strength.21  
These interactions are ubiquitous in protein structures, and influence a lot of important 
processes such as selective ion transport in anion channel proteins.22, 23  Examples of 




























Figure 1.3. Examples of electrostatic interactions: a) charge-charge, b) charge-dipole, 
and c) dipole-dipole interactions. 
 
1.4.1.2 Hydrogen Bond Interactions.  These are a type of electrostatic interactions that 
occur between a weak acid donor group (Dδ-–Hδ+; D is an electronegative atom, usually 
O or N), and the negative dipole of an acceptor atom (Aδ-/A-) possessing at least one lone 
pair of electron.  Typical functional groups employed as hydrogen bond donors in 
proteins are amide, hydroxyl, amino, and guanidinium.  Hydrogen bonds are highly 
directional with the D–H bond preferably pointing along the lone pair axis of the 
acceptor.24  They can either be intramolecular (occurring between different parts of a 
single molecule) or intermolecular (occurring between two or more different molecules).  
Although they are generally weaker than covalent or ionic bonds, hydrogen bonds can 
vary in length and strength from strong, mainly covalent to weak, electrostatic 
interactions (Table 1.2).25  Hydrogen bonds also take on different geometries in which 
bifurcated (or “three-centered”) connections are made between one donor and two 
acceptors (a bifurcated donor), or between one acceptor and two donors (bifurcated 
acceptor; Figure 1.4).  The secondary structures of proteins (α-helices and β-sheets), the 
double helix structure of DNA, and the high substrate recognition property of enzymes 
are all due to, and stabilized by hydrogen bonds.  In particular, high substrate specificity 
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by enzymes (or molecular recognition) is usually achieved through cooperativity among 
multiple, weak hydrogen bond interactions.  Hydrogen bonds have also been extensively 
utilized in the design of synthetic anion receptors and transporters.12, 26-29  The small 
molecules described in this thesis also employ hydrogen bond interactions for binding 










Bifurcated donor Bifurcated acceptor
b)a)
 
Figure 1.4.  Geometries of hydrogen bonds: a) a bifurcated donor, and b) a bifurcated 
acceptor.  
 
Table 1.2. Properties of hydrogen bond interactions.†  
 Strong Moderate Weak 











Bond lengths (Å)    
H•••A 1.2–1.5 1.5–2.2 2.2–3.2 
D•••A 2.2–2.5 2.5–3.2 3.2–4.0 
Bond angles (º) 175 – 180 130 – 180 90 – 150 
Examples Gas phase dimers with 
strong acids/bases 
Alcohols C–H hydrogen 
bonds 








1.4.1.3 Examples of Non-covalent Interactions in Anion Transport Proteins.   
NO3- and HCO3- Transport Proteins. Smith and coworkers recently resolved the crystal 
structures of the anion binding component of ATP-binding cassette (ABC)-type nitrate 
(NrtABCD) and bicarbonate (CmpABCD) transporters of cyanobacteria.22, 23  The crystal 
structures of the anion binding sites of the nitrate-binding NrtA, and bicarbonate-binding 
CmpA proteins are shown in Figure 1.5.  The two proteins are highly homologous, being 
48% identical and 61% similar in amino acid sequence; however, each is highly selective 
for its specific substrate.  The anion selectivity has been attributed to the substitution of a 
single amino acid from a hydrogen bond donor in NrtA to a hydrogen bond acceptor in 
CmpA.22, 23  As shown in Figure 1.5a, NO3- is bound using both electrostatic and 
hydrogen bonds within the cleft.  One of nitrate’s oxygen atoms (O1) is involved in three 
non-covalent interactions: two electrostatic interactions with charged lysine (K269) and 
histidine (H196) residues (2.8 and 3.0 Å, respectively), and one hydrogen bond 
interaction with a neutral glutamine (Q155; 2.9 Å) residue.  The other two oxygen atoms 
(O2 and O3) are each involved in only one type of interaction: O2 in an electrostatic 
interaction with H196 (3.0 Å), and O3 in a hydrogen bond interaction with a tryptophan 
(W102; 2.8 Å) residue.  Similarly, bicarbonate ion is bound in CmpA by electrostatic and 
hydrogen bond interactions (Figure 1.5b), albeit the electrostatic interaction in CmpA is 





Figure 1.5. Depiction of the anion binding sites of: a) nitrate-binding protein NrtA, and 
b) bicarbonate-binding protein CmpA showing the electrostatic interactions between 
protein amino acid residues and anionic substrates NO3- and HCO3- respectively. In the 
case of CmpA, a Ca2+ ion is also present in the binding site.  Potential hydrogen bonds 
and electrostatic interactions are depicted as dashed lines. Copyright © 2007, by the 
American Society for Biochemistry and Molecular Biology.22, 23  
 
 Bicarbonate is involved in three hydrogen bonding, and one electrostatic 
interactions.  The O3 atom of bicarbonate is within hydrogen bonding distances of the 
NH group of W99 (O3•••H−N = 2.8 Å) and the carboxyl oxygen of a glutamate (E271; 
O3•••O- = 2.5 Å) residue, suggesting that O3 is protonated.  The carbonyl oxygen of 
bicarbonate was assigned as O2, which is in hydrogen bond contact (2.7 Å) with the 
hydroxyl group of a threonine (T192) residue.  Lastly, O1 was labeled the carboxyl 
oxygen atom of bicarbonate, since it is involved in the strongest type of interaction – 
electrostatic interaction with the Ca2+ ion, and Smith’s calculations showed that it is the 
most polarized of the bicarbonate anion’s oxygen atoms.  The Ca2+ ion adopts a six-





atoms of five amino acid residues (E70, E270, E271, Q198, and asparagine, N152) and 
bicarbonate’s carboxyl oxygen atom (O1; Figure 1.5b).  
 The similarities between the binding sites of NrtA and CmpA are striking and one 
can envisage the Ca2+ ion in CmpA partially occupying the volume/space occupied by the 
O1 oxygen atom of NO3- in NrtA.  The most significant difference between NrtA and 
CmpA is the substitution of K269 in NrtA with E271 in CmpA.  The K269 residue in 
NrtA complements nitrate’s negative charge (Figure 1.5a).  Substitution to glutamate 
would nullify anion binding due to charge repulsion between nitrate and the carboxylate 
group.  Conversely, the E271 residue provides a hydrogen bond acceptor for the hydroxyl 
hydrogen of HCO3- in CmpA.  Smith proposed that the determining factor for anion 
selectivity is the charge at residue 269/271. 
 
Cl- Transport Protein.  The crystal structure of a ClC chloride channel from Salmonella 
enterica serovar typhimurium (StClC) recently resolved by McKinnon and workers 
reveals that Cl- ion is bound within the selectivity filter of the protein with only hydrogen 
bond interactions.30, 31  The crystal structure of the StClC is shown in Figure 1.6.  The 
channel is a dimer made up of two identical subunits (Figure 1.6a) each of which 
contains a selectivity filter.  The amide (NH) and hydroxyl (OH) protons of serine 
(S107), tyrosine (Y445), and isoleucine (I356) residues participate in hydrogen bonding 
with Cl– ions in the selectivity filter.  The ‘opening’ of the selectivity filter on the 
extracellular side is lined by residues with positive dipoles, but not full positive charges.  
A glutamate (E148) residue occupies this opening and blocks the selectivity filter in the 
resting state of the channel.  A conformational change arising from the protonation or 
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deprotonation of this E148 residue results in the opening and closing, and subsequent 
conduction of Cl– ions through the channel (Figure 1.6b).31  The ClC family of Cl- 
transporters are anion selective and completely exclude cations.19  This anion selectivity 
is achieved through partial positive charges (as observed in the selectivity filter), and not 
through full positive charges.  Rather than answer all the questions about how Cl- ions are 
conducted through the pore of the ClC protein, the resolved crystal structure has 
uncovered more questions about the gating mechanism.  For example, there is evidence 
that the gating mechanism is closely associated with Cl- concentration in the protein 
surrounding.32, 33  Thus the question remains: Is Cl- serving as a signal for its own 
transport through the channel pore?  Diligent efforts are being made by biologists and 










 a) b) 
 
Figure 1.6.  a) Ribbon representation of a StClC chloride channel dimer.  The two 
subunits are red and blue ribbons while the Cl- ion is a green sphere. Reprinted by 
permission from Macmillan Publishers Ltd: Nature 2002, 415, 287-294, copyright 
2002.30  b) Depiction of the selectivity filter of the Cl- channel showing the closed and 
opened conformations. Cl- ions are shown as red spheres, the Glu148 side chain is 
colored red, and hydrogen bonds are drawn as dashed lines. Reprinted from Science 
2003, 300, 108-112 with permission from AAAS.31 
 
1.5 Techniques for Detecting and Quantifying Anion Transport. 
 Since ion transporters (both natural and synthetic) change the concentration of 
solutes, and oftentimes the potential across a membrane, it is therefore crucial to 
accurately detect and quantify their activity. Numerous analytical and biophysical 
techniques have been developed for detecting and quantifying transmembrane anion 
transport across cellular and synthetic membranes.  The two most prominent techniques 
include patch-clamp studies in planar bilayer membranes and liposome-based assays.  
Patch-clamp assays measure voltage directly and distinguish ion channel mechanism 
from carrier mechanism. Interested readers are directed to the book by Hille: “Ionic 
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Channels of Excitable Membranes” for a more detailed description of patch-clamp 
techniques.34  Chemists often use synthetic vesicles (or liposomes) to mimic the cell.  The 
synthetic vesicles are prepared from the same types of phospholipid molecules that make 
up cellular membranes.  The transport studies described in this thesis (Chapters 2-4) are 
all liposome-based and were carried out in liposomes made from egg-yolk derived 










Egg Yolk Phosphatidylcholine (EYPC)  
 
 Liposomes are spherical vesicles with membranes that can consist of one 
(unilamellar) or more (multilamellar) bilayer of phospholipids encapsulating an internal 
aqueous compartment (Figure 1.7).35, 36  Unilamellar liposomes are classified as small (< 
50 nm), large (50-1000 nm), or giant (> 1000 nm) unilamellar vesicles (SUVs, LUVs, or 
GUVs).  The terms ‘liposome’ and ‘vesicle’ are often used interchangeably in the 
literature, however, in this thesis, ‘liposome’ will be the preferred term.  Numerous 
techniques have been described for the preparation of liposomes of specific sizes.36  The 
liposomes used for the studies described in this thesis are predominantly LUVs (unless 
stated otherwise) prepared using high pressure extrusion through a polycarbonate 
membrane of defined pore size; a detailed description of the preparation is given in 
Chapter 6.  The aqueous interior of liposomes makes the encapsulation of water-soluble 
components, such as ions and fluorescent dyes possible.  The components encapsulated in 
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the liposomes can be varied and tailored to specific experiments.  Similarly, the content 
of the external solution in which the liposomes are suspended can be varied.  The 
variability of the contents of both the liposome’s interior and exterior environments 
makes it possible to generate gradients (concentration and/or pH) across the membrane.  





Figure 1.7. a) Depiction of unilamellar and multilamellar liposomes. Blue spheres 
represent water molecules filling the aqueous interior of the unilamellar liposome, and 
separating the individual layers in the multilamellar vesicles.  b) A two-dimensional 
rendition of liposomes that will be used throughout this thesis. 
 
1.5.1 Fluorescence Detection of Anion Transport. 
 This is the most common method used for detecting transmembrane ion transport. 
It involves the use of fluorescent dyes whose fluorescence is sensitive to a change in the 
concentration of specific anions.  For example, in the ‘base-pulse’ assay, the pH-sensitive 
fluorescent dye 8-hydroxy-1,3,6-pyrene-trisulfonate (HPTS) is quenched in response to a 
change in pH.37  HPTS, also known as pyranine, exists as an acid/conjugate base pair 
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(Figure 1.8a).  The excitation wavelengths for the acid and base forms are 403 and 460 
nm respectively, while emission wavelength is 510 nm for both.  As the ratio of the 
acid/base pair changes, the fluorescence ratio also changes.  The magnitude of the change 
in pH can then be correlated to the change in fluorescence ratio.  In a typical assay, HPTS 
is encapsulated in liposomes in a dilute buffer, and excess external dye is removed by gel 
filtration (size-exclusion chromatography).  A solution of the transporter is added to the 
liposome suspension after which a pH gradient is induced by the addition of base to the 
external solution.  An active transporter would relieve the pH gradient by transporting 
ions, which in turn leads to a change in the fluorescence of HPTS due to a change in the 
ratio of its acid and conjugate base forms.  Maximal possible changes in dye emission are 
then obtained at the end of the experiment by liposomal lysis with a detergent.  The 
limitation of the base pulse assay is that it does not differentiate between anion and cation 
transport as change in pH can either be due to an anion exchange (OH-/X-) or a cation 
symport (H+/X-) (Figure 1.8b).  Some of the transport experiments described in Chapter 
2 and the majority of those in Chapter 3 use the base-pulse assay to monitor 
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Figure 1.8. a) The acid and conjugate base forms of HPTS along with the excitation and 
emission maxima for each state. b) A depiction of transport events occurring in the 
liposome in a base pulse assay. The pH gradient generated at the addition of base is 
relieved either as an OH-/X- exchange (curved arrows pointing in opposite directions) or 
an H+/X- symport (arrows pointing in the same direction). The transporter is depicted as a 
cylinder.  
 
 Ion-selective dyes are often used to differentiate between a cation and an anion 
transport process.  The most widely used anion-selective dye for this purpose is lucigenin 
(Figure 1.9), a fluorescent dye whose fluorescence is quenched by polarizable anions 
such as the halides (Cl-, Br-, or I-), through the formation of a charge-transfer complex 
between excited singlet-state lucigenin and anion.38, 39  The fluorescence of lucigenin is 
unaffected by oxoanions such as NO3-, SO42-, phosphates, and HCO3-, thus it is suitable 
for monitoring the exchange of Cl- with such anions. A typical experiment is similar to 
that described for the base-pulse assay, except that the liposome-encapsulated dye is 
lucigenin instead of HTPS, and a concentration gradient is generated.  One of the 
challenges of studying transmembrane anion transport by fluorescence techniques is that 
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the majority of known ion-selective dyes are sensitive for Cl- (or the halides) and not 
other anions (especially the oxoanions).  Therefore, transport assays have to be designed 
to incorporate Cl- or the other halides, in order to obtain indirect evidence for the 
transport of anions other than halides.  However, compared to assays based on the ion-
selective electrode technique discussed below, one of the advantages fluorescence-based 
assays is that the transporter can be pre-incorporated into the liposomes if necessary.  
Fluorescence experiments are also suitable for the measurement of kinetic parameters 
such as rate constants.  The Cl- transport experiments described in Chapter 2 are 
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Figure 1.9. a) The Cl--sensitive dye, lucigenin and its excitation and emission maxima. 
b) A depiction of transport events occurring in the liposome in a lucigenin assay. The 
concentration gradient generated at the addition of external anion is relieved either as an 
X-/Y- exchange (curved arrows pointing in opposite directions) or an M+/Y- symport 
(arrows pointing in the same direction).  X- is usually an oxoanion, particularly NO3-, 




1.5.2 Ion-Selective Electrodes. 
 Ion-selective electrodes for specific ions such as Cl- offer the advantage of 
sensitivity and specificity, so that direct measurement of concentration can be achieved.  
Again, the most widely used ion-selective electrode is the chloride selective electrode.  In 
a typical experiment, Cl- ions are encapsulated in liposomes, and excess Cl- ions on the 
exterior of the liposomes are replaced with another anion by dialysis.  The liposome-
encapsulated Cl- ions are then invisible to the chloride-selective electrode until an active 
Cl- transporter is added to the extravesicular solution (Figure 1.10).  The amount of Cl- 
released from the liposome can then be determined from the measured potential 
difference between the reference and sensing electrode (Figure 1.10).  Another 
advantage of this technique is that it is direct and easy to perform.  However, it is limited 
in terms of kinetic measurements due to the slow response time of the electrode.  As 
stated above, the limitation of this technique is that transporters cannot be pre-
incorporated, as the pre-incorporation of transporter will lead to Cl- leakage during 
liposome preparation thereby compromising the integrity of the data collected.  This 
technique is used in Chapter 4 to obtain initial evidence that transmembrane bicarbonate 





























Figure 1.10. A cartoon depiction of the chloride ion-selective electrode assay.  Chloride 
ions encapsulated inside liposomes (open purple spheres) are invisible to the sensing 
electrode, and both the reference and sensing electrodes are at a resting potential (left 
panel).  A detectable current can be measured upon the addition of an active Cl- 
transporter indicative of Cl- efflux from the liposomes (right panel).  An influx of the 
exchange anion A-, to which the electrode is insensitive, allows electroneutrality for the 
overall process.   
 
1.5.3 NMR Spectroscopy. 
 Finally, NMR spectroscopy can also be used to monitor the translocation of 
anions across membranes.40 Anions inside and outside liposomes can be differentiated 
based on different chemical environments that leads to a difference in chemical shift for 
the internal and external anion populations.  In the event that the chemical shift difference 
is too small to be detected, a suitable paramagnetic shift or relaxation agent may be 
encapsulated in the liposome, or added to the external solution.  The method is used 
widely for cation transport, particularly sodium-23 (23Na+) NMR.41-43  NMR detection for 
anion transport holds promise for a host of anions and can be the method of choice when 
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ion-selective fluorescent dyes or electrodes are not available.  As such NMR detection 
would be suitable for monitoring the transport of anions such as NO3- (by 15N NMR) or 
HCO3- (by 13C NMR).  Cobalt II (Co2+) and manganese II (Mn2+) are two paramagnetic 
metals that have been used extensively for monitoring anion transport in liposomal 
membranes.44, 45  Paramagnetic Co2+ shifts the 35Cl resonance, while Mn2+ relaxes the 
signal to the baseline.46  Lanthanide metals such as samarium III (Sm3+) may also hold 
promise as it has been used to resolve chiral amino acid mixtures.47  A limitation of the 
NMR technique is its low sensitivity, which becomes magnified when the nuclei under 
study has a low natural abundance.  The low abundance problem can however be 
overcome by the use of enriched nuclei samples.  Also, lengthy acquisition times are 
required to observe the inherently weak signal, and the technique becomes unsuitable for 
rate constant calculations when a very fast transport process is under study.  The method 
however provides direct evidence for transport and can be useful for differentiating 
between a symport and antiport mechanism as will be described in Chapter 4.  The use 
of 13C NMR provided direct evidence for bicarbonate transport across the membrane and 
established the mechanism of transport as a HCO3-/Cl- exchange mechanism. 
 
1.6 Selected Examples of Synthetic Anion Carriers and Channels.  
 There are not as many known synthetic transmembrane anion transporters as there 
are anion receptors.12, 26, 27, 48-52  However, the field is continually expanding with new 
examples steadily appearing in the literature.  Synthetic transporters that function as 
carriers as well as channels have been described.  A number of reviews have recently 
been written by Gale,26 Smith,53 Matile,49 and Gokel50 on the topic of synthetic anion 
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transporters.  The synthetic transporters described incorporate the same anion recognition 
motifs and non-covalent interactions used by proteins.  Some effective synthetic 
transporters have also been reported that make use of non-natural recognition motifs and 
electrostatic interactions such as urea and anion-π interactions.49, 54  A majority of the 
compounds that have been reported in the literature are Cl- transporters, probably due to 
the implication of a myriad of natural Cl- transport proteins in diseases.3  Also, according 
to the Hofmeister series, Cl- is the most hydrophobic physiological anion.12, 27  Thus, 
most simple, synthetic organic anion transporters tend to be Cl- transporters.26, 53  A few 
selected examples of these synthetic anion (Cl-) transporters that have been reported from 
2008 to date are presented in the following sections.  The examples are separated into the 
broad carrier and channel categories, and were selected for a number of reasons, such as 
detailed characterization, and unique transport properties and mechanisms.   
 
1.6.1 Transporters that Function as Anion Carriers. 
1.6.1.1 Steroidal Anion Shuttles.  One of the definitions of the word ‘shuttle’ is “a going 
back and forth regularly over an often short route by a vehicle.”55  A synthetic transporter 
that functions as a shuttle can therefore be envisaged as a discrete entity that diffuses 
back and forth within the membrane without having a localized position.  Shuttles also 
operate as unimolecular entities, that is, one carrier per anion.  Anion carriers are required 
to bind their substrate with very high affinity, that is, to essentially extract the anion from 
its aqueous environment, separate it from its counter ion, and form a stable, but reversible 
complex.  The carrier must, therefore, be amphiphilic in nature to facilitate both 
membrane passage and anion complexation.  A.P. Davis and coworkers have described a 
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class of such amphiphilic, steroid-based anion carriers with exceptionally high anion 
binding affinity and Cl- transport activity.54  Davis and coworkers used urea-
functionalized cholic acid derivatives (also known as ‘cholapods’) as the anion carriers. 
Cholic acid confers lipophilicity, for partition into membranes, to the receptor, while the 
urea groups serve as hydrogen bond donors for anion binding.   The di-ureido cholapods 
1.1 and 1.2 (Chart 1.2), containing four and five hydrogen bond donors respectively, 
were identified as the first set of potent Cl- receptors (Ka for 1.1 and 1.2 in water-
saturated chloroform is 5.2 x 108, and 1.1 x 1011 M-1 respectively), and transporters, with 
1.2 being the most active transporter as well.7, 56  Subsequently, cholapods 1.1 and 1.2 
and various derivatives were evaluated for the binding of other anions such as bromide 
(Br-), iodide (I-), NO3-, acetate (AcO-), perchlorate (ClO4-), and ethyl sulfite (EtSO3-), and 
Cl- transport activity.  Binding constants in the range 103 to 1011 M-1 were reported, 57, 58  
and cholapod 1.3 (Ka (Et4N+Cl-) = 2.0 x 109 M-1) emerged as the new most effective Cl- 
transporter (kobs for 1.1, 1.2, and 1.3 is 0.039, 0.012, and 0.0030 s-1 respectively at 0.004 
mol% cholapod-to-lipid).59  It is interesting to note that cholapod 1.3, with four hydrogen 
bond donors compared to 1.2’s five donors, binds Cl- less tightly but transports the anion 
more effectively.  These results suggest that 1.2 might be approaching the optimum 
design for a Cl- receptor/transporter based on the steroidal scaffold.  This hypothesis is 
supported by results that showed that Cl- binding affinity decreased or remained 
unchanged in cholapods with six hydrogen bond donor groups, such as eicosyl (C20) 
ester cholapod, 1.4 (Ka (Et4N+Cl-) = 1.8 x 1011 M-1).58  Cholapod 1.4 is an analog of 1.2, 
and other results showed that the ester chain has no effect on transport activity.59  Thus 
the inference would be that a saturation limit is possible in the cholapod design such that 
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increasing anion binding affinity eventually leads to a decrease in anion transport 




























1.1: X = O




















 Although the cholapods are not anion-specific (as depicted by the high binding 
affinities for the anions listed above), they are powerful anion-selective transporters (i.e., 
they do not transport cations), rapidly transporting Cl- across lipid membranes via a Cl-
/NO3- anion exchange mechanism.59  Both lucigenin and chloride ion-selective assays 
were used to study the transport activities of the cholapods in liposomal bilayers. 
Cholapod 1.3 exchanges Cl- for NO3- with a half-life of 26 seconds at a 1:25 000 ratio of 
cholapod to lipid.59  Finally, the carrier mechanism was confirmed for the cholapods in 
two separate assays: one in which transport rates were measured in gel phase liposomes, 
and another in which membrane thickness was varied.  In gel phase liposomes, the rate of 
transport by an anion carrier decreases compared to rates in fluid phase liposomes.  
Similarly, increasing membrane thickness leads to a decrease in transport rate.  Under 
these two conditions, the rate of Cl- transport by the cholapods decreased, suggesting a 
mobile carrier mechanism. Overall, the cholapods represent the best characterized class 
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of anion transporters that act as carriers, and future structure-activity studies focusing on 
optimization for biological activity are planned by Davis and co-workers.  
 
1.6.1.2 Anion Transport by a Relay Mechanism.  A relay mechanism differs from a 
shuttle mechanism in that rather than a non-stop fluid movement of anions across the 
membrane, the anions are transported in stages across the membrane, just like in a relay 
race where the baton is passed along in stages from player to player.  Smith and 
coworkers recently reported a new Cl- transporter that does not function by the generic 
carrier/channel mechanism, but functions as a hybrid of both systems in what they called 
a relay transport mechanism.  The transporter was designed as a phospholipid derivative 
with an anion recognition unit (urea) attached at the end of one of the phospholipid acyl 



















Compound 1.5 functions as a Cl-/NO3- anion exchanger, as determined in a standard 
lucigenin assay. Basically, Cl- influx was observed in liposomes encapsulating the 
fluorescent dye lucigenin, and into which compound 1.5 had been pre-incorporated, when 
the intravesicular solution contained NaNO3.  However, in the presence of intravesicular 
Na2SO4, the rate of Cl- influx was reduced significantly.  This is consistent with an anion 
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exchange process; that is, Cl- influx can only occur with a corresponding counteranion 
efflux.  Sulfate anion is more hydrophilic and therefore not easily transported as Cl- or 
NO3- anions, hence the diminished influx of Cl- ions.  The relay mechanism was proven 
by a series of experiments: 1) When 1.5 was not pre-incorporated into the liposomal 
membrane, no Cl- transport activity was observed.  For Cl- transport to occur, molecules 
of 1.5 must reside in both layers of the membrane, since one molecule is too short to span 
the whole membrane.  Thus, without pre-incorporation, and within the experimental time-
frame, molecules of 1.5 could not equilibrate into both layers of the liposomal bilayer 
membrane.  This result provided initial evidence for a relay mechanism such as depicted 
in Figure 1.11, which requires that 1.5 reside in both layers of the bilayer membrane.  2) 
Correlation of Cl- transport rate (kobs; s-1) to the concentration of 1.5 ([1.5]n) gave n values 
of 2 and 4 suggesting that 1.5 forms aggregates of 2 or 4 in the membrane to achieve Cl- 
transport. The proposed relay mechanism for n = 2 is shown in Figure 1.11a, while for n 
= 4 is shown in Figure 1.11b. 3) Chloride transport activity by 1.5 decreased with bilayer 
thickness as observed for the steroidal carriers discussed above.  Chloride transport 
activity decreased when acyl carbon chain of bilayer phospholipids was increased from 
14 to 18, and no transport activity was observed when the carbon chain is above 18.  
Since compound 1.5 has an acyl chain length of 15, it can be inferred that it is long 
enough to span each leaflet of the bilayer according to the proposed relay mechanism in 
Figure 1.11. However, as chain length increased for the bilayer phospholipids, 1.5 is no 
longer long enough to span the bilayer creating a gap between the urea recognition motifs 
within each bilayer leaflet. The Cl- anion would have to ‘jump’ across this gap in order to 
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be transported to the other side of the membrane.  The energetic cost for crossing the gap 




Figure 1.11. Relay mechanism for: a) dimeric (n = 2), and b) tetrameric (n = 4) 
aggregates of transporter 1.5. Adapted from reference 60. 
 
1.6.2 Transporters that Function as Anion Channels. 
 There are more literature examples of synthetic anion (Cl-) transporters that 
function as channels than as carriers.53  Just as natural transport proteins occur as 
monomolecular or oligomeric structures (Figure 1.12),23, 30, 61 synthetic compounds that 
function as unimolecular or oligomeric anion channels have also been reported in the 
literature. The following discussion highlights an example each of a unimolecular or 





Channel Oligomeric Channels  
Figure 1.12. A depiction of ion channel motifs inserted into the bilayer membrane.  The 
unimolecular and possible oligomeric structures are shown.  The channels are depicted as 
blue cylinders, while the anion as a red sphere. 
 
1.6.2.1 A Synthetic Oligosaccharide-Based Unimolecular Anion Channel.  Tecilla 
and coworkers, very recently reported a new family of synthetic anion transporters called 
cyclic phosphate-linked oligosaccharides (CyPLOS).62, 63  CyPLOS was designed to 
incorporate the properties of small cyclodextrins and crown ethers. The Cyclic 
phosphate-linked disaccharides 1.6-1.8 (Chart 1.3) appended with tetraethylene glycol 
(TEG) chains were among the several analogs of CyPLOS studied for transmembrane ion 
transport. Compound 1.6 is anionic and cyclic, 1.7 is anionic and acyclic, while 1.8 is 
cyclic and neutral.  Initial membrane transport assays revealed that 1.6 was the most 
active followed by 1.7, then 1.8. The inference from this result is that the anionic nature 
of the ionophore is more important than its cyclic nature. Surprisingly, despite the 
presence of negative charges on the ionophore and its TEG tails, compound 1.6 displays 
anion rather than cation selectivity. The rate of anion transport by 1.6 is comparable to 
that of other cyclodextrin ionophores. In addition, correlation of transport rates to the 
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concentration of 1.6 suggests that it functions as a unimolecular channel. While the 
length of the TEG chains in CyPLOS 1.6 is too short to span the whole length of the 
bilayer, it is longer than one leaflet of the bilayer membranes used in the studies. This 
arrangement probably caused small defects in the membrane sufficient for ion transport, 
but not large enough for the release of a small molecule such as calcein.  Calcein is a 
fluorescent dye that self-quenches at concentrations greater than 50 mM in LUVs (or 100 
mM in SUVs), and is often used to detect membrane defects.36, 64  Calcein release assays 
were used to eliminate the possibility that 1.6 and analogs caused membrane defect. The 
proposed orientation of 1.6 and analogs in the membrane shown in Figure 1.13, is 
analogous to that proposed for another class of synthetic anion transporters (SATs) 
described by Gokel and coworkers.65  However, Gokel’s SATs form pores in the 
membranes through which anions flow, and have been well characterized.  Obviously, 
detailed studies are necessary to fully characterize CyPLOS 1.6, and elucidate its 






































































Figure 1.13.  Proposed orientation of CyPLOS 1.6 and analogs in the bilayer membrane. 
One molecule of 1.6 does not span the whole membrane, but extends into the second 
layer of the bilayer, causing a defect that allows the transport of ions but, but not small 
molecules. [Org. Biomol. Chem. 2009, 7, 1060-1063] – Reproduced by permission of The 
Royal Society of Chemistry.62 
 
1.6.2.2 Synthetic Oligomeric Anion-π Slides.  Matile and co-workers have reported a 
class of synthetic anion channels based on the π-acidic, shape-persistent oligo-(p-
phenylene)-N,N-naphthalenediimide (O-NDI) scaffold.  These O-NDI channels function 
as anion-π slides (Figure 1.14), and transport anions across the bilayer using anion-π 
interactions.66, 67  Anion-π interactions are defined as favorable, non-covalent interactions 
between an anion and a π-acidic (or electron deficient) aromatic ring.  Anion-π 
interactions are not known in biological systems, and have only started gaining attention 
in supramolecular chemistry, because they are counterintuitive in nature – anions and π-
systems are expected to repel each other.  However, the incidence of anion-π interactions 
has been growing,68, 69 and Matile has successfully incorporated them into the design of 





Figure 1.14.  Depiction of an O-NDI anion-π slide.  The anion interacts with the 
transporter through dipole interactions between the anion’s negative π-electron cloud 
(pink spheres) and the positive, π-acidic dipole of the electron deficient aromatic ring 
(blue squares). Reprinted with permission from J. Am. Chem. Soc. 2006, 128, 14788-


































































The concept of anion-π slides. The O-NDI anion-π slides developed by Matile offer an 
appealing, way to generate functional synthetic anion transporters that mimic the multi-
ion hopping mechanism by which channel proteins conduct ions through their pores.70, 71 
This multi-ion hopping mechanism involves the binding of multiple ions along multiple 
binding sites within the pore of the channel allowing ions to be pulled through the pore, 
such that as one ion exits into the cell interior, another anion in the binding site above it 
hops in to replace the discharged ion.  The process is repeated by the ions above until an 
anion from the extracellular milieu is pulled into the pore creating a cascading pumping 
effect. This multi-ion hopping technique ensures the release of bound anion on one side 
of the membrane in response to anion binding on the other side, and the process should 
be reversible under equilibrium conditions.  The concept of ion hopping in O-NDI anion-
π slides is depicted in Figure 1.15.   
 The existence of multi-ion hopping was proven by observation of anomalous 
mole fraction effects (AMFE).  AMFE refers to lower than expected activity found with a 
mixture of ions compared to pure ions.  The occurrence of AMFE indicates that the 
occupation of multiple sites in a channel is required to efficiently transport any selected 
ion.  Using the base-pulse assay with the pH-sensitive fluorescent dye HPTS, it was 
found that the O-NDI anion–π slides are excellent chloride transporters.67  AMFE studies 
of Cl-/I- mixtures demonstrated that the transport of chloride and iodide by O-NDI slides 
is competitive and that binding of more than one chloride is required to observe fast 
transport.  That is, AMFE for Cl-/I- mixtures provided experimental evidence for the 
occurrence of multi-ion hopping from anion–π binding site to anion–π binding site along 
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rigid O-NDI rods (see above; Figure 1.15). The existence of anion–π interactions was 
confirmed by high-level ab initio and DFT calculations.  AMFE studies also suggest that 
the O-NDI anion–π slides form at least dimeric structures in the membrane, since a 
minimum of two O-NDI molecules have to be in close proximity for AMFE to be 
observed.  Ab initio calculations supported this hypothesis that O-NDI rods exist as 
oligomeric structures in the bilayer membrane.67 
 
                   
Figure 1.15. The concept of anion-π slides. The electrostatic potential surface of an O-
NDI rod supports the possibility of multi-ion hopping along the anion-π sites S1-S6 (blue 
surfaces) as indicated in the qualitative energy diagram. S1-S6 represent potential anion 
binding sites that coincide with the O-NDI rod’s π-acidic, electron deficient sites. 
Binding of Cl- at site one (S1) results in electrostatic repulsion with the Cl- ion in binding 
site S2, leading to the hopping of S2 Cl- to binding site S3, and onward until the Cl- in S6 
is ejected on the other side of the membrane. [Chem. Eur. J. 2009, 15, 28-37] – Copyright 
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 Finally, anion-π slides with photosynthetic activities have been developed from 
the analogous oligo-perylenediimide (O-PDI) scaffold. The O-PDI anion-π slides 
transport chloride anions across the bilayer via a chloride/electron antiport (exchange) 
mechanism.72  Systems such as O-NDI and O-DPI anion-π slides exemplify elegant 
applications of synthetic anion transporters to understanding protein function and 
presenting potential for future application in diagnostics and optoelectronic materials.  
 
1.7 Summary of Transmembrane Anion Transport. 
 Membrane transport is important and fundamental to life, and when it is impaired, 
growth, reproduction and general well-being are in jeopardy.  Anions in particular are 
crucially involved in membrane transport processes, and so, natural anion transport 
proteins have been implicated in a myriad of human maladies.  The development of 
synthetic anion transporters that mimic natural proteins is of premium importance, as 
these synthetic compounds may; 1) provide us with a better understanding of ion 
transport processes, 2) lead to the discovery of potential therapeutics for ion channel 
diseases, and 3) generate materials for sensing and diagnostics. This chapter has 
described the concepts involved in transmembrane ion transport with specific focus on 
anion transport.  Examples of the types of interactions used by natural proteins to bind 
and transport their anionic substrates were presented with particular focus on electrostatic 
and hydrogen bonding interactions, the two most abundant types of interactions observed 
in these natural as well as synthetic systems.  Liposome-based techniques for detecting 
anion transport were discussed, as well as examples of synthetic anion transporters that 
act as carriers and channels.  The synthetic examples presented represent only a 
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conservative selection of systems that have been reported in the literature.  These 
examples showcase the commendable efforts that have been applied by scientists to the 
development of synthetic transporters.  These efforts however, often involve tedious and 
long synthetic steps to arrive at natural protein mimics.  The synthetic anion transporters 
described in Chapters 2-4 of this thesis are simple small molecules obtained in only a 
few synthetic steps (all ≤ 3), that mimic the gating (Chapter 2) and anion exchange 






Chapter 2: Membrane-Active Calixarenes for ‘Gated’ Transmembrane 
Chloride Transport 
The majority of this chapter has been published in reference 118: 
• Okunola, O. A.; Seganish, J. L.; Salimian, K. J.; Zavalij, P. Y.; Davis, J. T. 
“Membrane-active calixarenes: toward ‘gating’ transmembrane anion transport.” 
Tetrahedron 2007, 63, 10743-10750. Copyright 2007, with permission from 
Elsevier. 
Syntheses of compounds 2.1, 2.2a and 2.2b described in this chapter were performed by 
Ms. Jennifer L. Seganish and Mr. Kevan J. Salimian, former graduate and undergraduate 
students respectively, in the Davis group, while Dr. Peter Y. Zavalij resolved the crystal 
structures described.  
2.1 Introduction. 
 The goals of the research in this chapter are two-fold: 1) to investigate the 
chloride (Cl-) transport activities of some lipophilic calixarene amides, all fixed in the 
cone conformation; and 2) to develop calixarene-based Cl- transporters with tunable 
properties through sidechain modification.  These studies build on previous work in the 
group that showed that partial cone calix[4]arene tetrabutylamide paco-H 2.1 mediated 
transmembrane Cl- transport (Figure 2.1).6  One of the major findings in this chapter is 
the identification of the cone calixarene analog TAC-OH 2.3 which allows the tuning of 
Cl- transport by pH.  Before describing the new studies on the calixarene cone 
conformers (Chart 2.1 and Sections 2.5–2.8), I first provide a brief background about 
why we study Cl- transport, and some literature examples of synthetic Cl- transporters 
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whose activities are gated by external stimuli such as voltage, pH or light (Sections 2.2 
and 2.3).  I also present a discussion on the use of calixarenes as membrane-active ion 
transporters (Section 2.4).   





















cone-H (R = H) 2.2a











































2.2 Why Study Transmembrane Cl- Transport? 
 Chloride is a simple, inorganic anion that is spherical in shape and has a 
thermochemical radius r, of 1.72 Å.12  Chloride, as the conjugate base of a very strong 
acid (HCl; pKa = –8.0), is completely dissociated and highly solvated (hydration energy, 
∆Gh = 80.8 ± 1.4 kcal/mol) in solution.12  Along with bicarbonate (HCO3-) and 
phosphate, Cl- is one of the most abundant anions found in physiological environments.  
The transport of Cl- in biological systems is crucial to myriad biological processes such 
as signal transduction, regulation of cell volume, stabilization of resting membrane 
potential, fluid transport in the epithelia, to name a few.73  Chloride is transported across 
cellular membranes by a wide variety of natural anion transport proteins classified as 
anion exchangers (AE) or cation-dependent Cl- co-transporters.  Most chloride channels 
are also “gated” structures that function through recognition of stimuli such as voltage, 
volume, ligand, Ca2+-activation or cAMP-activation.73  Understanding relationships 
between the structure and function of channel proteins is crucial since maintaining the 
proper ion balance across cell membranes is essential to life.  Knowledge of channel 
structure is also important because impaired ion transport can cause disease.2, 3, 74, 75  For 
example, Best disease, a form of macular degeneration leading eventually to blindness, is 
caused by a malfunction of the Ca2+-activated Cl- channel bestrophin in the retinal 
pigment epithelium.76  Similarly cystic fibrosis, the life-shortening genetic disease, is 
caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) 
protein that facilitates transmembrane Cl- transport.77  Malfunction of the CFTR disrupts 
salt and water transport across epithelia, leading to the varied symptoms of the disease, 
such as salty sweat, severe lung disease, exocrine pancreatic failure, male infertility, and 
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intestinal blockage.78  The two-fold goals of understanding natural ion transport processes 
and discovering new therapeutics have driven the development of synthetic 
transmembrane ion transporters.29, 48, 79   
 
2.3 Synthetic Cl- Transporters. 
 Historically, most studies have focused on cation transporters.  However, there 
has been continuing progress in identifying “small molecules” that can transport Cl- 
anions across lipid membranes.  Recent, independent reviews by A.P. Davis, Sheppard 
and Smith,53 Gale,26 and Gokel50 provide excellent discussions of the emerging field of 
transmembrane Cl- transport.  Synthetic Cl- transporters include compounds that function 
as self-assembled channels80, 81 or as monomolecular carriers (Section 1.6).7   These 
compounds, which can alter transmembrane ion and pH gradients, may have potential 
applications as biochemical reagents and/or chemotherapeutic agents.82, 83  As such, 
efforts at developing synthetic Cl- transporters with tunable properties have also 
increased in recent times. Following is a discussion on some examples of such tunable Cl- 











2.6: X = OMe, Y = SO2Me










































































































2.8: R1 = H
 
 
2.3.1 Selected Examples of Synthetic Cl- Transporters with Tunable Properties. 
2.3.1.1 Voltage-Dependent Channels.  
Gokel.  Gokel and colleagues have reported studies on lipophilic peptides, generically 
called synthetic anion transporters (SATs), which aggregate to form Cl--conducting 
channels.  The original peptide, 2.5 (Chart 2.2), consists of four parts: 1) a lipophilic tail 
consisting of two octadecyl (C18H37) chains attached at the N-terminus, 2) a heptapeptide 
sequence (GGGPGGG) inspired by a conserved motif in the putative ion pathway of the 
ClC family of Cl- transporters, 3) a benzyl group at the C-terminus, and 4) a diglycolic 
acid linker connecting the heptapeptide and hydrocarbon tails.84, 85  In liposomal 
membranes, SAT 2.5 displayed an ion permeability order of Cl- ≈ NO3- > SO42- >> K+, 
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with a Cl- vs. K+ selectivity of > 10,16a and is proposed to form dimeric structures that 
insert into one leaflet of the bilayer membrane to achieve Cl- transport (Figure 2.2a).65, 86, 
87  SAT 2.5 exhibited voltage-dependent Cl- transport between –3 and +10 mV.  A 
correlation of channel open time to membrane potential (in mV) showed that open time is 
strongly dependent on transmembrane voltage (Figure 2.2b).  The average conductance 
measured for SAT 2.5 was 1.3 nS (S = Siemens) which corresponds to an estimated 6–7 
Å pore size.88-90  SAT 2.5 promoted Cl- transport in mouse trachea epithelial cells 
providing promise for future application in correcting deficiencies in Cl- transport, such 
as observed in cystic fibrosis.91  
 
 
Figure 2.2. a) Proposed dimeric assembly of synthetic anion transporter 2.5 for forming a 
Cl- channel in one leaflet of the phospholipid bilayer. [New J. Chem. 2005, 29, 291-305] 
– Reproduced by permission of The Royal Society of Chemistry (RSC) for the Centre 
National de la Recherche Scientifique (CNRS) and the RSC.65 b) Single-channel 
characteristics of SAT 2.5 in planar phospholipid bilayer a strong dependence of channel 
open times on membrane potential (mV), fraction of open channels increasing with 
increase in potential. Reprinted with permission from J. Am. Chem. Soc. 2002, 124, 1848-





Matile.  Another class of self-assembled Cl- channels based on rigid, peptide-substituted 
p-octiphenyl rods have been reported by Matile and coworkers.  The peptide sidechains 
of rigid rods 2.692 and 2.793 (Chart 2.2) are composed of sequences of alternating polar 
and non-polar amino acid residues.  This ensures that upon self-assembly, the channel 
formed has a polar interior for ion conduction, and a non-polar exterior to aid membrane 
insertion.  That is, the interior of the channel formed by rod 2.6 is lined by lysine (Lys) 
residues, while that of 2.7 is lined by arginine (Arg) and histidine (His) residues.  The 
leucine (Leu) residues line the exterior of both channels.  The channels thus formed are 
stabilized by intermolecular hydrogen bond interactions between the β-sheets formed by 
the short peptide sidechains of 2.6 and 2.7 (Figure 2.3a).  The incorporation of Lys into 
the structure of rigid rod 2.6 afforded selectivity for Cl- over K+ (permeability ratios PCl-
/PK+ ~ 3).92  Rod 2.6 was designated a push-pull rod due to the asymmetric substitution 
with at its terminals: the methoxy electron-donating (push) group at one end, and the 
electron-withdrawing sulfonyl (pull) group at the other.  Such an asymmetric design 
resulted in the Cl- transport activity of rigid rod 2.6 being voltage-dependent.  In contrast 
to the gradual increase in Cl- transport activity observed for Gokel’s SAT 2.5, activity 
with rigid rod 2.6 increased exponentially with increase in membrane potential (Figure 
2.3b), and it was suggested that 2.6 forms both α- and β-barrel-type channels.  The α-
barrel channels were short-lived and were thus proposed to form at low potentials.  The 
β-barrel channels on the other hand were more stable and long-lived, and thus proposed 
to be the structures formed at high membrane potentials.   
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Figure 2.3. a) Representation of the putative β-barrel structure formed by Matile’s rigid 
rods 2.6 and 2.7 in the membrane. The arrows extending from the octiphenyl backbone 
represent β-sheets formed by interdigitating peptide sequences. [Org. Biomol. Chem. 
2003, 1, 1226-1231] – Reproduced by permission of The Royal Society of Chemistry.93  
b) Single-channel characteristics of push-pull rod 2.6 in EYPC planar bilayer membranes 
showing representative traces between 50-150 mV. c) A plot of Po (open probability) vs. 
V (membrane potential) with an exponential fit. [Chem. Eur. J. 2003, 9, 223-232] – 
Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.92  
 
2.3.1.2 pH-Dependent Transporters. 
Matile.  The ion selectivity of octiphenyl rod 2.7 (Chart 2.2) was pH-sensitive due to the 
presence of the Arg and His residues.  At pH = 6, the pores formed by 2.7 were slightly 
cation-selective (PCl-/PK+ ~ 0.5), while at pH = 4, (presumably after the histidines are 
protonated), the pores became anion-selective (PCl-/PK+ ~ 3.8).93  Additionally, the 
addition of an anionic guest such as HPTS resulted in partial blockage of the anion-
selective (KD ≈ 30 µM) channel formed by rigid rod 2.7.   
 
a) b) c) 
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Gin.  A unimolecular amino-cyclodextrin (ACD) ion channel (2.8; Chart 2.2) that is 
selective for anions over cations at neutral pH has been described by Gin.  Channel 2.8 
discriminates among halide anions according to the order I- > Br- > Cl-.94  The lipophilic 
pentabutylene glygol chains allow the channel to span the length of the phospholipid 
bilayer.  ACD 2.8 was confirmed to function as a unimolecular channel through a linear 
correlation between the rates of ion transport and the concentration of the channel.  The 
anion selectivity of 2.8 was attributed to the portal amino groups.  Likewise the tuning of 
anion transport rates by pH.  Anion transport rate increased with increasing pH.  The 
rationale for this behavior of 2.8 is that at low pH (< 6.0), the amino groups are 
protonated, electrostatic (charge-charge) attraction with the anion is therefore very strong, 
leading to reduced anion transport rate.  On the other hand, at high pH (> 7.0), the portal 
amines are neutral leading to weaker charge-dipole interactions that favor anion 










































Figure 2.4. A balance of Coulombic interactions between the ions and the ammonium 
groups lining the channel opening direct the increase in anion transport with rising pH 
values by ACD 2.8. The cyclodextrin cavity is depicted as a concave cylinder, while 
ammonium groups and anions as blue and red spheres respectively. [ChemBioChem 
2007, 8, 1834-1840] – Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced 
with permission.95 
 
Davis.  J.T. Davis, Gale, and Quesada have reported simple isophthalamides of the 
generic structure 2.9 (Chart 2.2), which function as efficient transmembrane transporters 
of Cl- when R is a hydroxyl (OH) group.96  Particularly, Cl- transport rates decreased with 
increasing pH when R is a hydroxyl group.  Analogs of 2.9 have also been studied for 
bicarbonate transport and those studies will be described in detail in Chapter 4. 
 
2.3.1.3 A Light-Gated Unimolecular Channel.  Gin further modified ACD 2.8 with a 
photoswitchable azobenzene group to afford CD 2.10 (Chart 2.2), whose anion transport 
activity is light-gated.97  In the “closed” (trans) form of CD channel 2.10, anion transport 
rate is reduced, whereas transport rates increased in the “open” (cis) form (Figure 2.5).  
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Modulation of transport was attributed to the binding of the azobenzene moiety within 
the cyclodextrin cavity in the trans form, blocking the channel entrance from anion 
passage.  On the other hand, the cis azobenzene affords an open pore to allow anion 
translocation (Figure 2.5).  The order of anion selectivity observed with cyclodextrin 2.8 
(see above) was retained in the cis form of 2.10.  However, Cl- transport was slightly 
more efficient when the rates of anion transport by the two isomers were compared 
(Table 2.1).  Gin did observe some cation transport in the trans isomer, presumably due 














Figure 2.5. Depiction of the ion-transport gating mechanism in azobenzene ACD 2.10.  
The trans azobenzene isomer binds within the cavity of the cyclodextrin blocking 
passage of anions. Exposure of the system to light results in isomerization to the cis 
isomer, which affords an open channel for the passage of anions. Adapted with 






Table 2.1. Comparison of anion transport rates by light-gated cyclodextrin 2.10.† 
Rate of anion transport, kobs (s-1) 
Anion ktrans kcis kcis/ktrans 
Cl- 0.0073 0.018 2.5 
Br- 0.032 0.052 1.6 
I- 0.044 0.055 1.2 
† Adapted with permission from Org. Lett. 2008, 10, 3693-3696.  Copyright 2008 American Chemical 
Society.97 
 
 The examples presented illustrate how simple modifications can lead to 
transporters with tunable properties. The ligand, pH and voltage-gated examples are 
particularly attractive as these are some of the same stimuli by which anion transport is 
gated in natural transport proteins.  The lipophilic calixarenes discussed later in this 
chapter also use simple structural modifications and changes in pH to gate Cl- transport.  
 
2.3.2 Calixarene-Based Synthetic Cl- Transporters. 
 Some of our group’s contributions in the anion transport field have used the 
calix[4]arene scaffold.5, 6, 98, 99 Calixarenes are macrocycles with a broad range of 
applications in supramolecular chemistry.100, 101  They are available in a variety of sizes, 
readily synthesized, and functionalized both on the phenolic OH groups (lower rim) and 
on the aromatic nuclei (para position/upper rim).  Calixarenes are easily pre-organized 
into a variety of conformations.  Their pre-organized structure has made them attractive 
building blocks and molecular scaffolds in the development of receptors for anions, 
especially the calix[4]arene framework.102, 103  Calix[4]arenes functionalized at the lower 
rims can exist in one of four different conformations viz: cone, partial cone (paco), 1,3-
alternate and 1,2-alternate (Figure 2.6). The conformational flexibility of functionalized 
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calix[4]arenes provides a means to spatially arrange functional groups so as to achieve 























Figure 2.6. The four different conformations of calix[4]arenes: a) cone, b) partial cone, 
c) 1,3-alternate, d) 1,2-alternate. 
 
 A review by Cragg and Iqbal nicely describes previous studies that have used 
calixarene-type macrocycle as transmembrane cation transporters, as channels or as 
mobile carriers. 104  Kobuke and colleagues,105-107 and Gokel, de Mendoza and co-
workers,108 have described formation of synthetic cation channels using lipophilic 
calixarenes.  
 Recently, Carreira and coworkers discovered a calixarene-amphotericin conjugate 
that forms K+ selective channels.109  Various calixarenes also function as mobile cation 
carriers.  Thus, Beer and colleagues have described resorcin[4]arene-crown analogs that 
are efficient transmembrane carriers of K+.110  Jin has also shown that a calix[4]arene-
crown-5 analog selectively transports K+ across planar bilayers.111  Izzo and colleagues 
have recently described calix[4]arene-cholic acid conjugates that can move both H+ and 
K+ cations across synthetic liposomes.112, 113 
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 While calixarenes are known to bind anions in solution,102, 103 their use as 
membrane-active anion transporters is relatively new.5, 6, 98, 99  Izzo, Tecilla, de Riccardis 
and coworkers recently reported cationic calix[4]arenes in the 1,3-alternate conformation 
that function as anion selective ionophores.113  In the J.T. Davis group, studies by Kotch 
on calixarene-nucleoside conjugates,114, 115 designed as ion pair transporters, led to the 
discovery that a tetrabutylamide calix[4]arene fixed in the 1,3-alt conformation (2.11) 
forms ion channels that move Cl- across phospholipid membranes.98  Presumably, the NH 
protons on the calixarene’s secondary amides hydrogen bond to Cl- and help its 
translocation across the membrane.116, 117  X-ray structures confirmed that this 1,3-alt 
calixarene self-assembled into channel-like motifs held together by hydrogen bonds to 
bridging Cl- anions.98  Voltage clamp experiments in planar lipid bilayers confirmed that 
this 1,3-alt calixarene tetra-amide formed discrete ion channels.  Subsequently, Seganish 
investigated the structure and Cl- ion transport activity of a related isomer, the partial 
cone calix[4]arene tetrabutylamide paco-H 2.1 (Figure 2.1).6  The studies led to the 
proposal that Cl- transport mediated by paco-H 2.1 was controlled by both ligand self-
association and side-chain conformation.   Both solution and solid state (Figure 2.7) 
studies revealed that the amide sidechain of the inverted arene group of paco-H 2.1 does 
not participate in anion coordination, and presumably anion transport.  I therefore set out 
to investigate how changing the orientation of this inverted side chain (that is, having it 
point in the same direction as the other three sidechains), or removing it would influence 




















Figure 2.7. Solid-state structure of paco-H 2.1 showing: a) the single molecule view, and 
b,c) the packing side and top views respectively.  The NH proton of the inverted side 
chain is buried in a pocket formed by the neighboring arenes.  In the crystal packing of 
paco-H 2.1, individual calixarene units are connected by intermolecular hydrogen bonds 
involving only the three downward-pointing n-butylamide chains. The inverted arene NH 
proton is not involved in the hydrogen-bond array.  Arrows point to the NH amide 
protons on the inverted arene of paco-H 2.1. [Angew. Chem., Int. Ed. 2006, 45, 3334-





 In the following discussion, I report the comparative Cl- transport activity for four 
calixarene amides all fixed in the cone conformation.  I present significant findings 
regarding the use of these calixarenes as transmembrane Cl- transporters: 1) the cone 
conformer cone-H 2.2a (R = H), like its 1,3-alt and paco isomers, transports Cl- across 
liposomal membranes; 2) the conformation of the calixarene scaffold (paco-H 2.1 vs. 
cone-H 2.2a) is important for modulating Cl- transport rates; 3) the substitution pattern on 
the calixarene’s upper rim is crucial for Cl- transport function; and 4) at least one of the 
four arms of the calixarene can be left unmodified without loss of function, enabling the 
development of a pH-sensitive anion transporter (TAC-OH 2.3).118  This last finding is 
timely given the interest in gating the activity of synthetic ion transporters by using 
external stimuli.119-122  There is also an interesting parallel between this “small molecule” 
and the ClC chloride transporter protein, as it has been proposed that anion transport by 
ClC is gated by charge-charge repulsions between Cl- and negatively-charged glutamate 
residues within the anion channel.31 
 
2.4 Rationale for studying calixarenes 2.1-2.4. 
 The compounds that we studied are shown in Scheme 2.1.  We previously 
reported that paco-H 2.1 transports Cl- across liposomal membranes.6  Herein, we use 
paco-H 2.1 as a standard for comparing the Cl- transport activity of the cone calixarenes 
2.2-2.4. Compounds 2.2a (cone-H) and 2.2b (cone-tBu) are fixed in the cone 
conformation and feature four n-butyl secondary amides on their lower rim.  They differ 
in the substitution pattern on their upper rims.  In the previous work with paco-H 2.1 we 
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found that substitution of the calixarene’s upper rim with t-butyl groups led to loss of Cl- 
transport activity.6  In this study we set out to determine if this same phenomenon held 
true for the cone conformers 2.2a (R = H) and 2.2b (R = tBu).  The other two analogs, 
phenol 2.3 (TAC-OH) and ester 2.4 (TAC-OEster), were made so that we could determine 
the functional effect of either removing or replacing a single n-butyl amide on the 
macrocycle’s lower rim.  Replacement of a secondary amide with another functional 
group (as in 2.4) without complete loss of activity might provide the opportunity for 
appending other anion-sensitive groups to the calixarene.  This might allow development 
of new Cl- sensors and transporters.  We also reasoned that deprotonation of the phenolic 
proton on TAC-OH 2.3 might enable formation of a pH-sensitive switch for gating Cl- 














cone-H (R = H) 2.2a












































2.5 Synthesis and Characterization of Calixarenes 2.2-2.4.  
 The synthesis of compounds 2.1-2.4 was straightforward. Compounds 2.1, 2.2a 
and 2.2b were synthesized by Ms. Seganish and Mr. Salimian, while the tri-amido 
calixarenes (TAC) 2.3 and 2.4, their precursor and alkylating agents were synthesized by 
the author.  Calixarenes 2.1 and 2.2b (R = tBu) were prepared using published methods.6, 
123, 124  As shown in Scheme 2.2, cone-H 2.2a was synthesized from the corresponding 
tetra-ester 2.12125 via i) hydrolysis to the tetra-acid 2.13; ii) acid chloride activation; and 
iii) amide bond formation.  The tris-N-butylamido phenol analog TAC-OH 2.3 was 
prepared from calix[4]arene 2.14,126, 127 by direct alkylation with 2-bromo-N-
butylacetamide 2.15 (Scheme 2.3).  The desired trisubstituted derivative TAC-OH 2.3 
was separated from other alkylation products by chromatography.  Further alkylation of 



































Scheme 2.2. Synthesis of cone-H 2.2a. a) KOH aq., MeOH, THF, rt; b) 1. SOCl2, 






























Scheme 2.3. Synthesis of calixarenes 2.3 and 2.4. a) AlCl3, PhOH, PhCH3, rt; b) 
BrCH2CONHBu 2.15, Ba(OH)2, BaO, DMF, 40 oC; c) BrCH2CO2Bu 2.16, Cs2CO3, 
DMF, 70 oC. 
 
 All characterization of compounds 2.2a, 2.2b, 2.3 and 2.4 by 1H- and 13C-NMR 
spectroscopy and by electrospray ionization – mass spectrometric (ESI-MS) analysis 
were carried out by the author.  The 1H NMR spectra of the new compounds 2.2a, 2.3 
and 2.4 indicated that each calixarene analog existed as a cone conformer in solution, as 
shown by their characteristic AB coupling patterns for the bridging –CH2– groups.  For 
example, calixarenes that are tetra-substituted at their lower rim and fixed in the cone 
conformation usually display one pair of doublets between δ 3.2 and 4.5 ppm for the 
diasterotopic ArCH2Ar protons.128, 129  This was the case for both 2.2a and 2.2b. The cone 
conformation for the trisubstituted TAC-OH 2.3 was also consistent with the 1H NMR 
data, which showed two sets of doublets with identical integration corresponding to two 
different AB systems (Figure 2.8).  One AB system for four ArCH2Ar protons consists of 
doublets at δ 4.27 and 3.35 ppm with coupling constant J = 13.5 Hz.  The second AB 
system for the other four ArCH2Ar protons in TAC-OH 2.3 consists of doublets at δ 4.19 
and 3.43 ppm with J = 14.4 Hz. TAC-OH 2.3 displays two pairs of doublets because of 
the asymmetry arising from tri-substitution at its lower rim.130  The cone conformation 
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for TAC-OEster 2.4 was confirmed by the presence of a pair of doublets corresponding to 
a single AB system.  The AB system for the ArCH2Ar protons in 2.4 consists of the 
doublets at δ 4.44 and 3.26 ppm with J = 14.0 Hz.  The asymmetry of calixarenes 2.3 and 
2.4 in contrast to the symmetry of 2.2a and 2.2b was further established by the amide NH 
proton resonances.  The tetra-amides 2.2a and 2.2b have only one signal for their amide 
NH protons, while tri-amides 2.3 and 2.4 displayed two separate signals for the central 
and terminal amide NH protons. 
 
 
Figure 2.8. A portion of the 1H NMR of TAC-OH 2.3 showing the two different AB 
systems. Two sets of doublets (a and b) corresponding to the two AB systems for the 
ArCH2Ar proton signal of TAC-OH 2.3. Another set of doublet (c) corresponds to the AB 
system for the ArOCH2 signal of the two outer amide side chains and a singlet (d) 













 In addition to spectroscopic analysis, cone-H 2.2a, TAC-OH 2.3, and TAC-OEster 
2.4 were characterized as cone conformers by single-crystal X-ray crystallography.  
Crystals for cone-H 2.2a were obtained by Ms. Seganish, while those for tri-amides 2.3 
and 2.4 were obtained by the author.  Figure 2.9 shows the X-ray crystal structures for 
the tetra-amide cone-H 2.2a and the tri-amide TAC-OEster 2.4. In the solid-state, both 
compounds adopt the well-known “pinched-cone” conformation with C2V symmetry.131  
Both compounds also feature two intramolecular hydrogen bonds between two amide NH 
groups and neighboring carbonyl oxygens.  This conformation, if maintained in solution, 
would leave the additional amide NH protons in cone-H 2.2a (two free NH groups) and 
TAC-OEster 2.4 (one free NH group) available for hydrogen bonding to Cl- anion. 
 
 
cone-H 2.2a TAC-OEster 2.4  
Figure 2.9. X–ray crystal structures of cone-H 2.2a (left) and TAC-OEster 2.4 (right) 
showing the “pinched-cone” conformations for both compounds. Intramolecular H-bonds 
between secondary amide NH protons and neighboring carbonyls are indicated by the 
dotted lines. The butyl side-chains are removed for clarity. Arrows point to the “free” 




 The crystal structure of TAC-OH 2.3 also showed the compound as adopting the 
cone conformation (Figure 2.10).  Here the intramolecular hydrogen bond pattern is 
different from those observed in the structures of 2.2a and 2.4 where, at least two of the 
amide NH protons in each compound are involved in hydrogen bonding interactions, and 
each hydrogen-bonded NH proton is involved in one hydrogen bonding interaction only.  
With TAC-OH 2.3, the NH proton of the “central” amide side chain is involved in two 
intramolecular hydrogen bonding interactions: one with the ether oxygen of an adjacent 
arene ring; and the second hydrogen bonding interaction with the phenolic oxygen of the 
opposite arene ring (Figure 2.10a).  A view of the structure from another direction shows 
that the “central” amide side chain points toward the center of the cavity of the calixarene 
with the NH proton tilted towards the ether oxygen of the adjacent arene ring (Figure 
2.10b).  Thus, the hydrogen bond between the NH proton and the ether oxygen is slightly 
stronger (2.28 Å) than the bond with the phenolic oxygen (2.36 Å).  The NH protons of 
the two “terminal” amide side chains do not participate in any hydrogen bonding 
interactions, leaving two “free” NH protons for complexation with Cl- ions, provided the 





 a) b) 
 
Figure 2.10. a) Crystal structure of TAC-OH 2.3 showing the two intramolecular 
hydrogen bonds between the “central” amide NH proton and the ether and phenolic 
oxygens of the neighboring arene rings.  b) Top view of the structure of TAC-OH 2.3 
showing the “central” amide side chain pointing into the cavity of the calixarene.  The 
arrows show the amide NH protons for the “central” (blue arrow) and the two “terminal” 
(black arrows) amide side chains. 
 
2.6 NMR Titration Study Shows Cl- Binding to TAC-OH 2.3. 
 Compounds 2.2-2.4, which contain either three or four secondary amide NH 
groups on their lower rim, all bind Cl- weakly in non-polar organic solvents. Thus, 
titration of solutions of these calixarenes with tetrabutylammonium chloride (TBACl) in 
CD2Cl2 typically showed a downfield shift of the secondary amide NH protons and, 
assuming a 1:1 binding stoichiometry, gave binding constants on the order of Ka = 10-30 
M-1. For example, representative NMR titration data for the interaction of Cl- with TAC-
OH 2.3 is shown in Figure 2.11. Upon addition of TBACl to a solution of TAC-OH 2.3 
in CD2Cl2 we observed downfield shifts for the two “terminal” amide NH protons (∆δ = 
0.40 ppm, labeled in blue), and for the “central” amide NH proton (∆δ = 0.14 ppm, 
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labeled in red). The association constant for binding TBACl by TAC-OH 2.3 was 
determined to be Ka = 24 ± 5.1 M-1 (based on changes in the chemical shift of the 
“terminal” NH protons) in CD2Cl2,† which is similar to the value that we previously 
obtained for binding of Cl- by the secondary amide NH groups in paco-H 2.1 (Ka = 28.7 ± 
17 M-1).6  Changes were also observed in the chemical shift of the phenolic OH protons 
suggesting that the complexation of Cl- in solution involves all four hydrogen bond donor 
groups of TAC-OH 2.3.‡  
 
 
Figure 2.11. 1H NMR stack plot showing titration of TAC-OH 2.3 with TBACl. Blue 
lines (–) mark the changes in chemical shift for the two “terminal” NH protons, while the 
red lines (–) mark the changes in chemical shift for the “central” NH proton. 
 
2.7 Transmembrane Cl- Transport by Calixarenes 2.2-2.4. 
 The liposomal assays described herein were performed by the author.  
Compounds 2.1–2.4 were tested for Cl- transport activity using liposome assays similar to 
                                                 
† The NMR association constant for TAC-OH 2.3 was determined assuming a 1:1 binding stoichiometry using the 
program ‘Associate 1.6’ from the F.N. Diederich group at ETH, Zurich. 
‡ Identical Ka values were determined for all four hydrogen bond donor groups of TAC-OH 2.3: Ka (2 “terminal” NH) = 













those previously reported by our group.5, 99  Liposomes loaded with the Cl- sensitive dye, 
lucigenin, were subjected to a Cl- gradient in the extravesicular solution.  Lucigenin’s 
fluorescence is specifically quenched upon binding Cl- ions.38, 56  In a typical experiment 
(in 100 mM NaNO3/10 mM sodium phosphate buffer (pH 6.4)) I incubated calixarenes 
2.1-2.4 (2 mol% ligand-to-lipid) with egg-yolk phosphatidylcholine (EYPC) liposomes 
containing lucigenin and 100 mM NaNO3/10 mM sodium phosphate buffer (pH 6.4).  I 
then introduced Cl- to the extravesicular buffer by adding an aliquot of a NaCl solution in 
10 mM sodium phosphate (pH 6.4).  The resulting Cl- concentration gradient across the 
lipid membrane was relieved by ligand-mediated transmembrane transport of Cl- into the 
liposomes, resulting in the quenching of lucigenin’s fluorescence. A cartoon 
representation of the liposome assay sequence is shown in Figure 2.12.  The 
intravesicular Cl- ([Cl-]i) anion concentration was calculated from the dye’s measured 
fluorescence using the Stern–Volmer constant (Ksv) determined under the assay 
conditions according to Equation 2.1 where fo is the normalized fluorescence in the 
absence of Cl-, and f is the normalized fluorescence in the presence of Cl-.  Ksv is itself 
calculated from the slope of a calibration curve plotting fo/f versus added chloride 
concentration [Cl-] (Equation 2.2 and Section 6.2.2). 
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Figure 2.12.  Cartoon representation of liposome assays.  Lucigenin-encapsulated EYPC 
liposomes are subjected to a Cl- gradient, which is relieved in the presence of active 
calixarene-based Cl- transporters. The quenching of lucigenin’s (a Cl--sensitive dye) 
fluorescence indicates the presence of intravesicular Cl- ions. Electroneutrality is 
maintained by efflux of NO3- anions (or symport of Na+ cations with Cl-).  
 
2.7.1 Calixarene Conformation Attenuates Cl- Transport Rate. 
 The data in Figure 2.13 clearly shows that both paco-H 2.1 and cone-H 2.2a 
isomers transport Cl- across the EYPC liposomes.  It appears that the paco-H 2.1 
conformer is about twice as efficient as the cone isomer 2.2a when administered at the 
same concentration (2 mol% ligand-to-lipid ratio).  Despite its lower activity relative to 
paco-H 2.1 the calixarene cone-H 2.2a is still an active transmembrane Cl- transporter.  
This result encouraged us to continue our studies on the related cone analogs cone-tBu 




















Figure 2.13. Influence of calixarene conformation on Cl- transport. Chloride transport 
across EYPC liposomes containing lucigenin in a 100 mM NaNO3/10 mM sodium 
phosphate buffer (pH 6.4) solution. The Cl- concentration was determined from 
lucigenin’s fluorescence. Compounds 2.1 and 2.2a were added to give a 2 mol% ligand-
to-lipid ratio. At t = 15 s, NaCl was added to give an external Cl- concentration of 24 
mM. Lucigenin fluorescence was converted to Cl- concentration using the Stern–Volmer 
constant determined under the assay conditions. Each trace is an average of three trials. 
 
2.7.2 Upper-Rim Substitution Pattern is Crucial for Cl- Transport. 
 To investigate the influence of upper-rim substitution on Cl- transport activity, the 
t-butyl substituted analog cone-tBu 2.2b was also tested in this lucigenin assay.  As 
shown in Figure 2.14, cone-tBu 2.2b, unlike its analog cone-H 2.2a, was essentially 
inactive towards transmembrane Cl- transport under these standard liposomal assay 
conditions.  This result is consistent with our previous studies wherein we found that 
substitution of a paco calixarene with t-Bu groups resulted in complete loss of anion 
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transport function.6, 99  A possible explanation for the complete loss of transport function 
is that the bulky tert-butyl group induces ligand conformations that do not allow 
favorable interactions with the anionic guest.6, 99  Thus, it is clear again from these assays 
that the substitution pattern on the upper rim of the calixarene tetra-amide is absolutely 


















Figure 2.14. Influence of upper rim substitution on Cl- transport. Chloride transport 
across EYPC liposomes containing lucigenin in a 100 mM NaNO3/10 mM sodium 
phosphate buffer (pH 6.4). The Cl- concentration was determined from lucigenin’s 
fluorescence. Compounds 2.2a and 2.2b were added to give a 2 mol% ligand-to-lipid 
ratio. At t = 15 s, NaCl was added to give an external Cl- concentration of 24 mM. 
Lucigenin fluorescence was converted to Cl- concentration using the Stern–Volmer 




2.7.3 Influence of Lower-Rim Modification on Transport: Chloride Transport by 
Phenol 2.3 and Ester 2.4. 
 The transmembrane Cl- transport activity by trisubstituted amide calixarenes, 
phenol 2.3 and ester 2.4, was also assessed using the standard lucigenin assay.  As shown 
in Figure 2.15, the tris-N-butylamido phenol TAC-OH 2.3 transports Cl- ions across 
EYPC liposomal membranes at pH 6.4 even more efficiently than does the tetra-amide 
cone-H 2.2a.  This result, indicating that replacement of one of the secondary amide side-
chains with an acidic OH group could be tolerated, prompted us to study TAC-OH 2.3 as 
a pH sensitive transporter (see the following section).  The data in Figure 2.15 also 
shows that the ester 2.4 is clearly less efficient as a Cl- transporter than the tetra-amide 
cone-H 2.2a.  However, while substitution of one amide side-chain with an ester resulted 
in pronounced reduction in Cl- flux across the membrane, there was still some transport 
activity remaining for TAC-OEster 2.4 above the background.  Similar results were 
obtained with an ether analog in which the ester side-chain was replaced with an n-butyl 
chain (2.19).  The butyl ether analog displayed slightly more efficient Cl- transport 
activity than TAC-OEster 2.4 (see Section 6.2.2).  Thus, substitution on the calixarene 
cone’s lower rim with an ester or ether side-chain may eventually be useful for the 
development of Cl- anion sensors through the attachment of anion-sensitive reporter 
groups.  Since the active phenol analog TAC-OH 2.3 displayed good Cl- transport 
activity, we decided to look at its transport properties as a means for developing a 
compound whose transmembrane transport activity can be switched on and off by 





















Figure 2.15. Influence of lower rim functionalization on Cl- transport. Chloride transport 
across EYPC liposomes containing lucigenin in a 100 mM NaNO3/10 mM sodium 
phosphate buffer (pH 6.4). The Cl- concentration was determined from lucigenin’s 
fluorescence. Compounds 2.2a, 2.3 and 2.4 were added to give a 2 mol % ligand-to-lipid 
ratio. At t = 15 s, NaCl was added to give an external Cl- concentration of 24 mM. 
Lucigenin fluorescence was converted to Cl- concentration using the Stern–Volmer 
constant determined under the assay conditions. The traces shown are the average of 
three trials.  
 
2.7.4 Modulation of Transmembrane Cl- Transport by Changing pH. 
 We reasoned that the phenolic OH on the unsubstituted arene of TAC-OH 2.3 
afforded the potential to develop a pH-tunable Cl- transporter.  For example, a tri-
methylated calix[4]arene with a single free phenol has a pKa = 12.5.132  Deprotonation of 
the OH group on TAC-OH 2.3 should introduce unfavorable electrostatic interactions 
between the calixarene and any bound Cl- ions.  Such electrostatic repulsions should 
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inhibit anion binding and consequently influence the efficacy of TAC-OH 2.3 as an anion 
transporter.  On the other hand, transmembrane Cl- transport by cone-H 2.2a should not 
be as sensitive to pH since 2.2a does not have sufficiently acidic protons to be 
significantly deprotonated in the pH 7–10 range.  The transport function of TAC-OH 2.3 
and cone-H 2.2a were, therefore, monitored as a function of extravesicular pH using 
EYPC liposomes loaded with the Cl- dye, lucigenin (Figure 2.16).  
 As shown in Figure 2.16a, the rate of Cl- transport mediated by TAC-OH 2.3 
clearly decreased as the extravesicular solution became more basic.  In sharp contrast, the 
Cl- transport rate by cone-H 2.2a stayed constant over the same pH range between 6.4 
and 9 (Figure 2.16b).  The data are consistent with a negative charge in TAC-OH 2.3 
acting to inhibit transmembrane transport of the Cl- anion, by limiting anion binding and 
or partitioning of the calixarene into the liposomal membrane.  Control experiments with 





































































Figure 2.16. Transmembrane Cl- transport as a function of pH: a) with TAC-OH 2.3; and 
b) with cone-H 2.2a. Experiments were done using EYPC liposomes with lucigenin (1 
mM) in a 100 mM NaNO3/10 mM sodium phosphate buffer at various pH (6.4, 7.4, 8.0, 
9.0). Compounds 2.2a and 2.3 were added to give a 2 mol % ligand-to-lipid ratio. At t = 
15 s, NaCl solution was added to give an external Cl- concentration of 24 mM. Lucigenin 
fluorescence was converted to Cl- concentration using the Stern–Volmer constant 







 The primary aim for designing and studying synthetic anion transporters is to 
develop systems that mimic natural protein properties and activities.  Efforts to achieve 
this aim have been the main focus of synthetic transporters recently described in the 
literature, and the results presented in this chapter.  Some of our efforts to achieve this 
goal of mimicking the function of Cl- transport proteins have involved the use of 
lipophilic calixarene derivatives.  In a recent review on the use of calixarenes to effect 
transmembrane ion transport, Cragg and Iqbal suggested that charge-charge interactions 
might be used as a strategy for gating transport.104  The studies reported in this chapter, 
and in other related research from our group,96 clearly demonstrate that electrostatic 
repulsion can be used to turn on and off transmembrane transport of Cl- anion.  This 
regulatory mechanism, observed with “small molecule” transporters such as TAC-OH 
2.3, is also related to the proposal that the self-assembled ClC protein channel makes use 
of negatively charged Glu residues to gate Cl- transport.30, 31  The ease of synthesis (≤ 3 
steps), and the low concentration range (µM) at which the lipophilic calixarenes 
discussed transport Cl- make them attractive candidates for developing therapies for Cl--
transport-related deficiencies such as cystic fibrosis.   
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Chapter 3: A Nitrate–Selective Transmembrane Transporter 
 
Some of this chapter has been published in references 175 and 183: 
• Okunola, O.A.; Santacroce, P.V.; Davis, J.T. “Natural and synthetic receptors for 
nitrate anion.” Supramolecular Chem. 2008, 20, 169-190.  
• Santacroce, P. V.; Okunola, O. A.; Zavalij, P. Y.; Davis, J. T. “A transmembrane 
anion transporter selective for nitrate over chloride.” Chem. Commun. 2006, 
3246-3248 (DOI: 10.1039/b607221f). Reproduced by permission of The Royal 
Society of Chemistry. 
Some of the experimental work described in this chapter was performed by Dr. Paul V. 
Santacroce, a former post-doctoral associate in the Davis group. 
3.1 Introduction. 
 The goal of the research in this chapter was to carry out structure-function studies 
on the influence of a rigid scaffold (in comparison to the calixarene scaffold – Chapter 
2) on transmembrane Cl- transport.  Calixarene 2.1 self-assembled into transport-active 
aggregates through the formation of hydrogen-bonded networks (Figure 2.8).  These 
hydrogen-bonded networks were proposed to contribute to a channel-like transport 
activity.  However, both solution and solid state studies revealed that paco-H 2.1 
transported anions using three of its four amide sidechains.6  Other studies in the Davis 
group,5 as well as those described in Chapter 2118 confirmed that efficient Cl- transport 
could be achieved with aromatic scaffolds substituted with only three amide sidechains.  
Thus, triphenoxymethane (TPM) tripods 3.1 and 3.2 (Chart 3.1) were designed to be 
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rigid analogs of the calixarene transporters that might transport anions by a carrier 
mechanism.  During our studies on the TPM tripods, we discovered that tris (5-nitro-2-
butylamidomethoxyphenyl) methane (nitro tripod) 3.1 selectively transports nitrate anion 
(NO3-), rather than Cl-, across phospholipid vesicles. While many neutral receptors 
bind133-136 and transport59, 137 nitrate anion, nitro tripod 3.1 is, to the best of our 
knowledge, the only compound reported in literature that shows such selectivity for the 
transmembrane transport of NO3- over Cl-.133, 138  Nitrate is an environmentally important 
anion for plants and animals,139, 140 but it has not been targeted as a guest for synthetic 
receptors and transmembrane anion transporters as much as other oxyanions and halides.  
Therefore, compounds that selectively transport NO3- across membranes may find some 
key applications.  As an introduction to the chemistry of nitrate I discuss the role of NO3- 
in human health, its physical properties, and theoretical binding motifs for NO3- (Section 
3.2).  Theoretical studies suggested that the careful arrangement of urea (a non-natural 
anion recognition motif) groups around NO3- anion may be the most effective way to 
design NO3--selective receptors.  Thus, I present two independent examples in which the 
use of urea receptors for binding NO3- yielded desired and unexpected results in Section 
3.3.  Lastly, I discuss our contribution to the development of NO3- receptors and 
transporters using amide-functionalized calixarene and triphenoxymethane scaffolds 





































nitro tripod 3.1 tBu-tripod 3.2paco-H 2.1  
 
3.2 The Chemistry and Biochemistry of the Nitrate Anion. 
3.2.1 Nitrate and Human Health. 
 Although nitrate is probably benign, it can be reduced to nitrite (NO2-), which is 
then converted to nitric oxides (NOx).140-142  Nitric oxide species react with thiols, amines 
and amides to form carcinogenic N-nitroso compounds (NOC) (Scheme 3.1).140-142  
Nitric oxide (NO) and NO2- also react with hemoglobin to form methemoglobin (Scheme 
3.1).  Methemoglobin impairs blood’s oxygen-carrying capacity and causes 
methemoglobinemia.141  Other health concerns associated with NO3- metabolism include 
diabetes, thyroid disorders, respiratory infections and congenital malformations.140-142  
The formation of NOx may sometimes be beneficial.142  Potential health benefits from 
endogenous NO3-/NO2- include: 1) gastric protection, 2) oral/dental protection, 3) blood 





    NO3-         +           2e-          +        2H+                            NO2-          +         H2O
  Nitrate                                                                             Nitrite
Nitrite Acidification:
    NO2-         +          H+                             HNO2 (pKa = 3.2)
  Nitrite                                                   Nitrous acid
    2HNO2                                     N2O3              +              H2O
Nitrous acid                       Dinitrogen trioxide 
    N2O3                                        NO                  +             NO2
Dinitrogen trioxide                Nitric oxide                   Nitrogen dioxide
Formation of N-nitroso compounds (Nitrosation):
    N2O3                                        NO+                  +           NO2-
Dinitrogen trioxide             Nitrosonium ion                    Nitrite
    NO+             +               RSH                             RSNO               +                H+ 
Nitrosonium ion         Reduced thiol                 Nitroso thiol  
    NO+             +               RR'NH                         RR'NNO           +                H+
Nitosonium ion           Secondary amin(d)e        N-nitrosamin(d)e         
Formation of Methemoglobin:
    NO/NO2-           +              Hb2+O2                       NO3-              +                Hb3+
Nitric oxide/Nitrite          Oxyhemoglobin             Nitrate                      Methemoglobin
 
Scheme 3.1 Reactive NOx intermediates obtained from nitrate metabolism.140-142 
 
3.2.2 Physical Properties of Nitrate. 
 Nitrate has D3h symmetry with equivalent N─O bonds (Scheme 3.2).143, 144  A 
survey of NO3- in the Cambridge Structural Database (CSD) conducted by Velders and 
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Feil revealed 338 discrete structures.145  From the 338 structures, the average N─O bond 
length was 1.231 ± 0.025 Å and mean ONO angle was 119.98 ± 2.15º.  The N─O bond 
lengthened as NO3- interacted with Lewis acids or H-bond donors.  Hase reported the 
average bond order for nitrate as 1.278.146  This value varies, however, depending on the 
method used to determine the bond order.147  Charge density on individual atoms also 












Scheme 3.2. Equivalent distribution of charges on nitrate’s oxygen atoms.  
 
 Nitrate is the conjugate base of nitric acid (pKa ≈ –1.3).  Aside from being a 
strong acid, nitric acid is also a strong oxidant that can oxidize relatively inactive metals 
like copper and silver, metals not oxidized by stronger acids like HCl (pKa ≈ –8.0).  
Nitric acid is mostly dissociated in water to give NO3- and hydronium ions.  Nitrate ions 
have an extensive hydration shell in aqueous solutions and form water-soluble salts with 
most cations.149  Because of its heavy solvation and weak basicity, NO3- is weakly 
coordinative and it is difficult to form robust hydrogen bonds with ligands.12, 27, 116, 117, 150-
152  Thus, developing NO3-–selective receptors that use hydrogen bonds is a challenge.  
Synthetic receptors that use amines,153 amides,135 pyrroles,154, 155 ureas,156-158 and 
guanidinium cations,152 have been tested for NO3- binding.  In addition to traditional 
hydrogen bond donors, receptors employing aryl C-H groups and anion─π interactions 
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have been described.159-162  The unifying trait among these receptors is that they usually 
show little selectivity for NO3-.  
 
3.2.3 Theoretical Binding Motifs for Nitrate. 
 Arranging hydrogen bond donors (D─H) on organic scaffolds is one method to 
make anion receptors.135, 152-158  Successful anion coordination by such receptors is due to 
the directionality of hydrogen bonds.  One can exploit directionality by designing 
receptors with cavities that differentiate between anions with different shapes.161, 163, 164  
Certain features are necessary for optimal hydrogen bonds between donors and acceptor 
atom.25, 164, 165  These features, using NO3- as the acceptor of interest, include: 1) an 
optimal distance, d, between donor, D─H, and acceptor that gives the strongest H•••O 
interaction; 2) a linear D─H•••O bond, with D─H dipole pointing at the acceptor; and 3) 
optimal arrangement of donors around nitrate oxygens.25, 163, 164 The optimal distance, d, 
depends on the type of hydrogen bond donor, the oxyanion, anion coordination, and 
solvent.161, 163, 164  
 In a survey of NO3- complexes, Hay and coworkers reached conclusions 
concerning the design of NO3-–selective receptors using hydrogen bonds.163, 164, 166  
Hydrogen bonds were classified as: strong when 1.2 ≤ d ≥ 1.5 Å; moderate when 1.5 ≤ d 
≥ 2.2 Å; and weak when 2.2 ≤ d ≥ 3.2 Å.  A bimodal distribution of H•••O distances was 
observed, with maxima at 1.9 and 2.7 Å (Figure 3.1).  Most hydrogen bonds were weak, 
with d ≥ 2.2 Å.  For moderate strength bonds (d < 2.2 Å), most contacts involved donors 
(D─H) where D = O or N, whereas above 2.3 Å (weak hydrogen bonds) most contacts 





Figure 3.1.  Distribution of H•••O distances found in the CSD for H atoms within 3 Å of 
a NO3- oxygen atom. Reprinted with permission from J. Am. Chem. Soc. 2004, 126, 
7925-7934.  Copyright 2004 American Chemical Society.164 
 
Hay also provided evidence for hydrogen bond directionality.163, 164  Calculations 
revealed donor hydrogens point toward oxygens of NO3- with a near linear D─H•••O 
angle (Figure 3.2a).  Also, oxygen acceptors prefer that donor hydrogens lie in the plane 
to form bent H•••O─N angle (~120º; Figure 3.2b).  Finally, a planar H•••O─N─O 
dihedral angle at 0º and/or 180º is preferred (Figure 3.2c).163, 164  Electrostatic potential 
surfaces showed energy minima for placement of hydrogen bonds in six equivalent 
positions around NO3-.  This motif corresponded to the expected locations of oxygen’s 
lone pairs of electrons (Figure 3.3).  The inference is that an ideal NO3- receptor should 
have six donor D─H groups that converge at the anion’s binding site.164  In this motif, 
two protons share an edge of a triangle defined by NO3- oxygens (Figure 3.3b).  Hay’s 
analysis of the CSD revealed, however, that only half of the six binding sites are 
occupied and these enable two binding modes; one motif where each of three oxygen 
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atoms are coordinated to one H (Figure 3.4a), and another where two nitrate oxygens 
coordinate to three H atoms (Figure 3.4b) [30].  Examination of the CSD showed that 
both motifs were common in solid-state structures.164, 167-172  The explanation for use of 
only three out of the six possible sites is attributed to sterics.  In a fully hydrogen bonded 
complex, two protons bound to adjacent oxygens would be just ~1.86 Å apart.  Such 
close contact would cause repulsive Coulombic and van der Waals interactions,164, 173 
calculated to be 16.8 kcal/mol.164 
 
b) 
H•••O─N angle, ºD─H•••O angle, º H•••O─N─O 
dihedral angle, º 
c) a) 
 
Figure 3.2.  Comparison of experimental distributions of geometric parameters with 
potential energy surfaces calculations, using a MeOH–NO3- complex as an example: a) 
linear D─H•••O angle, b) bent H•••O─N angle, and c) planar H•••O─N─O dihedral 
angle. Reprinted with permission from J. Am. Chem. Soc. 2004, 126, 7925-7934.  







Figure 3.3.  a) Contour map of the electrostatic potential surface of NO3- showing the 
location of the six energy minima (arrows) around NO3-.  The minima also correspond to 
the location of the oxygen atom lone pairs.  b) Potential binding motif for the formation 
of six hydrogen bonds with NO3-. O, red; N, blue; H, light grey. Reprinted with 






Figure 3.4.  a) The symmetric binding motif for placing three H atoms about NO3- using 
all three oxygen atoms.  b) The asymmetric motif using only two oxygen atoms with one 
of the oxygen atoms involved in a bifurcated hydrogen bond to two H atoms. Reprinted 
with permission from J. Am. Chem. Soc. 2004, 126, 7925-7934.  Copyright 2004 




 Although C─H donors interact weakly with NO3-, these contacts help stabilize 
anion-receptor complexes.160, 161  Nitrate forms two hydrogen-bond motifs with aryl 
C─H.  Nitrate can coordinate to one C─H with two oxygens or two oxygens can bind 
adjacent C─H groups (Figure 3.5).  Hay compared binding energies of NO3-–water and 
NO3-–benzene complexes.  The NO3-•••H─Ar interaction is indeed significant, as ∆E for 
NO3-•••H─Ar motifs were -7.50 and -9.26 kcal/mol compared to the -16.03 kcal/mol for 
the NO3-•••H─OH motif (Figure 3.5).  
 Hay’s recommendation for overcoming crowding in nitrate receptors is to 
incorporate diprotic donors into the scaffold.  Urea and guanidinium groups can contact 
two adjacent binding sites on the anion simultaneously.161, 164, 174  He also recommended 









∆E = -16.03 kcal/mol 
C6H6─NO3- Complex 1 
∆E = -7.50 kcal/mol 
C6H6─NO3- Complex 2 




Figure 3.5.  Structures and ∆E values obtained after geometry optimization for NO3- 
complexes with water (a) and benzene (b and c).  The binding motif of NO3- with Ar─H 
groups, where two of its oxygen atoms are coordinated to one Ar─H is represented in b; 
c represents the binding motif where two oxygen atoms bind adjacent Ar─H groups. 
Reprinted with permission from J. Am. Chem. Soc. 2005, 127, 8282-8283.  Copyright 
2005 American Chemical Society.161 
 
3.3 Synthetic Receptors for Nitrate. 
 Synthetic receptors incorporating neutral and/or charged groups have been 
designed for nitrate.  A detailed discussion of such receptors, especially those for which 
crystal structures are available, has been presented in a recent review written by the 
author.175   
 In summarizing his theoretical data on the design of selective receptors for 
oxoanions such as NO3-, Hay recommended employing receptors that incorporate diprotic 
donors, such as urea and guanidinium, into the scaffold.  This is because urea and 
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guanidinium can contact two adjacent binding sites on the anion and thus overcome 
unfavorable steric crowding as observed with monoprotic donors.164, 174  While urea is a 
non-natural anion recognition motif, the guanidinium moiety is frequently used in Nature 
to coordinate anions because it can form strong ion-pairs with (oxy)anions, as well as 
provide directional hydrogen bonding interactions.  In biological systems, the 
guanidinium moiety is present as the side chain of the amino acid arginine and has a high 
pKa value (~12–13).176, 177  This high pKa allows the guanidinium cation to remain 
protonated over a wide pH range.  In synthetic systems, use of the guanidinium moiety 
for nitrate recognition has been limited, even though it is widely used for the recognition 
of carboxylate and phosphate oxyanions.178  Similarly, crystal structures of urea-based 
receptors bound to NO3- are scarce.   
 The following is a discussion of the independent attempts by de Mendoza152 and 
Böhmer179 to develop NO3--binding macrocycles by incorporating urea and guanidinium 
motifs into their design.  The efforts led to mixed results suggesting that rational design 
alone is not enough for obtaining functional anion-specific receptors as we also 
experienced in our studies with nitro tripod 3.1. 
 
3.3.1 Urea-Based Receptors. 
De Mendoza. Following Hay’s recommendations that incorporating guanidinium and 
urea functions into the same receptor should provide ideal complementarity to an 
oxyanion,164 de Mendoza and coworkers developed macrocycles 3.3-3.5 as a new class of 
guanidine-urea receptors for NO3- (Figure 3.6 and Table 3.1).152  The nitrate binding 
ability of receptors 3.3-3.5 was assessed by 1H NMR and isothermal titration calorimetry 
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(ITC) titrations in CD3CN.  ITC titration allows the determination of binding constants 
and thermodynamic parameters at concentrations lower than those used for NMR 
titration, thereby avoiding the problem of receptor precipitation encountered with NMR 
titrations.  ITC binding isotherms suggested formation of 1:1 host-guest complexes and 
the Ka values were in good agreement with 1H NMR data (Table 3.1). Binding isotherms 
also revealed that NO3- binding by receptor 3.3 was mainly governed by entropic factors, 
whereas for receptors 3.4 and 3.5, both enthalpic and entropic factors play a significant 
role in NO3- binding.  The explanation for these differences is that the cavity of 
macrocycle 3.3 is too small for optimal anion inclusion, such that hydrogen bonding 
interactions between the receptor and NO3- are weaker.   
 De Mendoza’s hypothesis was supported by solid-state evidence, as can be seen 
in the crystal structures of the nitrate complexes of macrocycles 3.3-3.5 (Figure 3.6).  
The structure of the [3.3+•NO3-] complex is distorted, with one urea twisted away from 
the cavity, thus reducing the number of hydrogen bond contacts with NO3- to only three.  
In contrast, the crystal structures of hosts 3.4 and 3.5 show that: 1) NO3- fits into the 
cavities of receptors 3.4 ([3.4+•NO3-] in Figure 3.6) and 3.5 ([3.5+•NO3-] in Figure 3.6) 
and makes contact with all six NH donor groups from the urea and guanidinium moieties, 
and 2) each oxygen atom of NO3- forms two hydrogen bonds with the host, such that its 
lone pairs are shared with single NH donors from different functions (ureas and 
guanidinium) in the preferred motif shown in Figure 3.7a.152  The nitrate complexes of 
macrocycles 3.4 and 3.5 are rare examples of six-coordinate NO3- complexes 117 and 
represent the ideal for NO3- coordination as revealed by Hay’s theoretical studies.164  
Figure 3.7b shows another possible, but less preferred six-coordinate binding of NO3-, in 
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which each of the oxygen atoms of nitrate ion forms bifurcated hydrogen bonds with the 




















3.3 n = 4
3.4 n = 5
3.5 n = 6
 
Figure 3.6.  Macrocycles 3.3-3.5 and the crystal structures of their NO3- complexes: 
[3.3+•NO3-], [3.4+•NO3-], and [3.5+•NO3-]. [New J. Chem. 2007, 31, 736-740] – 
Reproduced by permission of The Royal Society of Chemistry (RSC) for the Centre 







Table 3.1.  Association constants (Ka; in M-1) and thermodynamic parameters for the 
binding of hosts 3.3-3.5 with tetrabutylammonium nitrate.† 
 3.3 3.4 3.5 
Ka(x103)a 9.94 - -c - -c 
Ka(x103)b 7.26 15.2 73.7 
∆Hd -1.07 -3.02 -3.48 
∆Sd 14.2 9.16 10.8 
∆Gd -5.37 -5.79 -6.75 
a Determined by 1H NMR titrations in CD3CN at 298 K.  b Determined by ITC titrations in CH3CN at 303 
K.  c Not determined because of in situ-crystallization.  d ∆H and ∆G in kcal mol-1, ∆S in cal mol-1 K-1. 
†[New J. Chem. 2007, 31, 736-740] – Adapted by permission of The Royal Society of Chemistry (RSC) for 







































Figure 3.7.  a) The preferred six-coordinate binding motif for NO3- inclusion in 
macrocycles 3.3-3.5.  Each oxygen atom of NO3- hydrogen bonds to one NH donor each 
from the urea and guanidinium functions.  b) The other possible binding motif for NO3- 
inclusion.  This motif in which each oxygen atom’s lone pair is hydrogen bonded to NH 
donors of the same function is not preferred. [New J. Chem. 2007, 31, 736-740] – 
Reproduced by permission of The Royal Society of Chemistry (RSC) for the Centre 




 The success of receptors such as 3.3-3.5 poses the temptation to assume that the 
suitable cyclic arrangement of three urea groups would, without question, lead to anion 
receptors for the planar NO3- anion.  However, this is not always the case as the linker 
holding the urea groups together plays an important role in the spatial orientation of the 
recognition motifs, even as observed with macrocycle 3.3 as compared to 3.4 and 3.5.  
Therefore, the problem of identifying the appropriate spacer to hold the three urea groups 
in the optimum position for nitrate coordination still needs to be addressed.  
 
Böhmer. A recent report by Böhmer and coworkers provides further evidence that design 
does not always translate to function.179  In a bid to address the “appropriate spacer” 
question, Böhmer and coworkers selected the 4,5-substituted xanthene skeleton (based on 
molecular modeling studies) as a spacer between the urea functions (Scheme 3.3).  The 
reasoning is that the repulsion between the xanthene and urea oxygens should favor the 
orientation of the urea NH protons toward the center of the macrocycle.  They also 
considered the more flexible diphenyl ether derivative (D unit) for contrast with the 
“rigidity” afforded by the xanthene (X unit) moiety (Scheme 3.6).  Synthesis of the tri-
urea macrocycles based on X and D units yielded four compounds: 3.6 (XXX), 3.7 
(XXD), 3.8 (XDD), and 3.9 (DDD) (Scheme 3.4).  Crystal structures were obtained for 
macrocycles 3.7, 3.8, and the Cl- complex of 3.9 (Figure 3.8).  Interestingly, the spherical 
Cl- anion in the 3.9•Cl- complex is bound in the manner projected for the trigonal planar 
NO3-.  Attempts to co-crystallize 3.9 with NO3- failed.   
 Anion complexation studies on tri-ureas 3.6-3.9 by UV and NMR spectroscopy in 
acetonitrile revealed that the originally proposed 3.6 showed the weakest affinity for 
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spherical anions such as chloride, and even weaker affinity for the target NO3- anion.  
Analysis of crystallographic data, along with molecular dynamics (MD) calculations 
revealed that the macrocycles formed strong intramolecular hydrogen bonds even with 
the rigid xanthene linker.  MD simulations in chloroform and the more polar acetonitrile 
showed that stronger solvation in acetonitrile pre-organized the macrocyles better for 
anion complexation, through the disruption of intramolecular hydrogen bonds.  However, 
to bind to the anion, desolvation to obtain free macrocyclic host has to occur first.  Thus, 
the weak affinity of hosts 3.6-3.9 for NO3- was ascribed to the rate-limiting nature of the 
desolvation step.  While it is difficult in this case to fully rationalize why the receptor 
design for NO3- failed, it might be important to note that the design template for tri-ureas 
3.6-3.9 is based on the rare and less favored six-coordinate geometry for NO3- described 



















































Scheme 3.3. Design of cyclic tri-ureas with rigid xanthene spacers as potential receptors 
for NO3- anion. [Org. Biomol. Chem. 2008, 6, 1004-1014] – Reproduced by permission of 








































































Scheme 3.4. The four cyclic tri-ureas 3.6-3.9 obtained based on different combinations of 
the xanthene (X) and diphenyl ether (D) spacers. Adapted from reference 179.  
 
 
Figure 3.8. Crystal structure of the Cl- complex of tri-urea 3.9 (3.9•Cl-) showing the Cl- 
anion and urea groups of the macrocycle in space filling representation. [Org. Biomol. 
Chem. 2008, 6, 1004-1014] – Reproduced by permission of The Royal Society of 
Chemistry.179 
  
 While rational design plays a crucial role in the identification of functional anion 
receptors,180 studies such as described above illustrate the fact that rational design alone 
does not always suffice.  The good news is that even when rational design does not lead 
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to expected results, it can serve as a reservoir for the serendipitous discovery of 
scientifically significant information.  Whereas the design of macrocyle 3.6 as a NO3- 
receptor did not generate the expected result, Böhmer and coworkers discovered a cyclic 
hexa-urea (XXDXXD), with high affinity for Cl- anions.181  They found that the hexa-
urea was formed preferentially over 3.7 when at least two equivalents of Cl- ions were 
present in the reaction mixture.  At the time of their discovery, such templating effect, by 
two spherical anions, in the synthesis of large flexible macrocycles was unprecedented. 
The discussion in the following section outlines our own serendipitous identification of 
nitro tripod 3.1 as a transmembrane anion transporter that is selective for NO3- over Cl- 
anion.  The original intent for 3.1 was to study it as a rigidified tripodal analog of paco-H 
2.1 for transmembrane Cl- transport. 
 
3.4 Synthetic Transporters for Nitrate Anion. 
 The ultimate goal in the design of synthetic anion receptors is function and 
application, such as transmembrane transport.  To act as a transmembrane transporter, a 
ligand must bind the anion and move it across a phospholipid membrane.  However, 
binding should be such that after moving the ligand across the barrier the receptor 
releases the ligand under appropriate conditions.  In this case, the ideal is to identify a 
NO3- receptor that is capable of binding and selectively transporting this anion across 
bilayer membranes.  Designing anion transporters that show selectivity for NO3- over Cl- 
remains a challenging endeavor, as even natural Cl- channel proteins conduct NO3- as 
well as other anions.73, 182  Similarly, synthetic transmembrane transporters that are 
selective for nitrate anion only are rare as most synthetic transmembrane Cl- transporters 
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also transport NO3- anions.7, 60, 72, 137  For example, Berezin and J.T. Davis recently 
reported a series of catechol-based anion transporters, bis-catechol 3.10-3.13, which 
transported NO3- and other anions across liposomal membrane.  Bis-catechol 3.11 was 
the most active analog with a Hofmeister ion permeability sequence of ClO4- > I- > NO3- 
> Br- > Cl-.27  While compound 3.11 conducted NO3- ions faster than Cl- and Br- ions, 
and displayed an anion selectivity trend similar to that of the CFTR Cl- channel182 (Table 
3.2), it is not selective for NO3- anion only.  The need to identify selective transmembrane 
nitrate transporters is therefore great considering the anions significant role in human 
health (Section 3.2.1).  As at the time of writing, only one selective transmembrane NO3- 
transporter has been reported in the literature (Scifinder survey): nitro tripod 3.1, a NO3- 
transporter developed in our lab.183  In the following section, I describe our design and 










3.10     R = CH3
3.11     R = (CH2)4CH3
3.12     R = CH2C(CH3)3







Table 3.2.  Anion transport rates (kAnion), turnover numbers (n), and differences in 
activation energy (∆∆G‡) for transmembrane anion transport by bis-catechol 3.11 with 








kcal • mol-1 
∆∆G‡CFTR* 
kcal • mol-1 
Cl- 1.29 ± 0.01 44 0 0 
Br- 4.40 ± 0.07 150 0.69 0.12 
NO3- 11.3 ± 0.10 384 1.27 0.21 
I- 36.2 ± 0.80 1230 1.94 0.41 
ClO4- 69.5 ± 1.9 2400 2.32 N/A 
*The last column lists differences in activation energy for anion permeation relative to Cl- in the CFTR 
channel (∆∆G‡CFTR values from reference 182). †Adapted with permission from J. Am. Chem. Soc. 2009, 
131, 2458-2459.  Copyright 2009 American Chemical Society.137 
 
3.4.1 Rationale for Anion Receptor 3.1. 
 The studies described here are part of a publication reporting the identification of 
the NO3--selective transmembrane transporter based on the triphenoxymethane (TPM) 
moiety. 183  I performed the synthesis of the TPM derivatives 3.1 and 3.2, and the NMR 
binding studies on 3.1 and 3.2, whereas membrane transport assays were performed by 
Dr. Paul Santacroce, a former post-doctoral associate in the Davis group.  
 It was previously demonstrated, by the Davis group, that amide functionalized 
calix[4]arenes and acyclic oligophenoxyacetamides transport Cl- across phospholipid 
membranes.5, 6, 98  The most effective of these Cl- transporters was the partial cone 
calix[4]arene (paco-H 2.1),6 and an acyclic trimer of phenoxyacetamide.5  To explore 
how the geometry of ligands with three hydrogen-bond amide NH donors influence anion 
binding and transport, we turned to C3-symmetric receptors based on the 
triphenoxymethane (TPM) core.  TPM derivatives have been reported by Scott to bind 
metal cations.184-186  In addition, Böhmer’s group recently showed that TPM analogs 
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outfitted with urea groups form hydrogen-bonded dimers in solution.187  The promising 
molecular recognition properties of these TPM compounds led us to prepare nitro tripod 
3.1 and tris (3,5-di-tert-buty-2-butylamidomethoxyphenyl) methane 3.2. We reasoned 
that TPM derivatives 3.1 and 3.2, like calixarene 2.1, might transport anions across 
phospholipid membranes.  The para-alkoxy substitution patterns of the TPM derivatives 
3.1 and 3.2 confer different electronic properties to each compound. The effect of such 
substitution should be apparent in their anion binding and transport properties. As shown 
below, the nitro tripod 3.1 binds both NO3– and Cl– ions but selectively transports NO3-. 
On the other hand, the t-butyl tripod 3.2 neither binds nor transports any of the anions 
studied. 
 
3.4.2 Synthesis and Characterization of Triphenoxymethane Derivatives. 
 Amide functionalized phenols and alcohols are usually synthesized via the four 
step route of alkylation, ester hydrolysis, acid chloride formation, and amidation. To 
avoid such tedious synthetic manipulations, TPMs 3.1 and 3.2 were synthesized from the 
known triphenols in a one-step alkylation reaction. Acid-catalyzed condensation of 5-
nitrosalicylaldehyde and p-nitrophenol gave the known triphenol 3.14,187 which was 
alkylated with 2-bromo-N-butylacetamide, 2.15, to give nitro tripod 3.1 in 36% yield 
(Scheme 3.5). Similarly, acid-catalyzed condensation of 3,5-di-tert-butyl-2-
hydroxybenzaldehyde and 2,4-di-tert-butylphenol gave the known tris-tBu-phenol 
3.15.184, 185 tBu-phenol 3.15 was alkylated with 2.15 to give t-butyl tripod 3.2 in 21% 
yield (Scheme 3.6).  The identity of both 3.1 and 3.2 was confirmed by ESI-MS and 
NMR (1H and 13C) spectroscopy.  Due to the symmetry of both compounds, only one 
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signal that integrated to three protons was observed for the NH protons at δ 5.86 and 6.82 
ppm for tripods 3.1 and 3.2, respectively (Figure 3.9).  The chemical shifts of the amide 
protons of these two compounds already suggest that they probably adopt different 
conformations in solution. The NH protons of 3.1 appear upfield compared to those of t-
butyl tripod 3.2, suggesting that the NH protons of nitro tripod 3.1 are probably in a 
shielded conformation, while those of 3.2 are more solvent-exposed, hence the larger 
chemical shift value for the NH proton of 3.2. 
 X-ray crystal analysis of nitro tripod 3.1 (Dr. Santacroce and Dr. Peter Zavalij) 
revealed a structure in which the three amide chains point in the same direction, creating 
a potential anion binding pocket (Figure 3.10). The pocket is created via an arrangement 




















































































































Figure 3.9. Portions of the 1H NMR spectra (in CD2Cl2) of: a) nitro tripod 3.1, and b) t-
butyl tripod 3.2 showing the NH (*) proton.   
 
 
Figure 3.10. Depiction of the X-ray crystal structure of nitro tripod 3.1. The n-butyl side 
chains have been removed for clarity.  All three amide side chains point in the same 
direction, providing a potential anion binding pocket. Two of the NH groups are 





3.4.3 Anion Binding Properties of Triphenoxymethane Derivatives. 
 Exploration of the anion binding properties of nitro tripod 3.1 and t-butyl tripod 
3.2 by 1H NMR titration with tetrabutylammonium chloride (TBACl) and TBANO3 in 
CD2Cl2 solutions revealed differences between TPM 3.1 and 3.2.  Upon the addition of 
the TBACl and TBANO3 salts, no changes were observed in the chemical shift of the NH 
protons of t-butyl tripod 3.2, indicating that the interactions of 3.2 with Cl– and NO3– are 
weak.  On the other hand, nitro tripod 3.1 coordinated to Cl– and NO3– ions in CD2Cl2 as 
evidenced by significant downfield shifts for the NH protons (∆δ = 2.32 ppm for Cl– and 
1.37 ppm for NO3–; Figure 3.11).  The bridgehead CH protons near the anion binding site 
also experienced a significant downfield shift in the presence of the anions.  The 
chemical shift changes for the NH and CH protons of nitro tripod 3.1 imply that the Cl– 
and NO3– anions are preferentially coordinated within the binding pocket formed by the 
amide side chains.  The association constants (Ka) for the binding of nitro tripod 3.1 with 









Figure 3.11. Summary of binding data for nitro tripod 3.1 with TBA salts. (a) 1H NMR 
titration stack plot of nitro tripod 3.1 vs. TBANO3. (* – NH protons) (b) 1H NMR 
titration curves for nitro tripod 3.1 binding to NO3- and Cl- showing change in chemical 
shift (∆δ) of amide (NH) protons of 3.1 vs. equivalents of anions added. (Gold trace – 
NH/Cl-; blue trace – NH/NO3-) 
 
Table 3.3. Chemical shift changes and binding constants (Ka) for the association of nitro 
tripod 3.1 with Cl- and NO3- ions in CD2Cl2.  




NH = 2.32 
CH = 0.52 
 
NH = 816 ± 108 
CH = 828 ± 158 
 
NO3- NH = 1.37 
CH = 0.21 
NH = 325 ± 113 
CH = 328 ± 95 
 
 
 Together, the X-ray and NMR data for nitro tripod 3.1 confirmed our proposal 
that the TPM scaffold can be used as an anion receptor.  Compared to other simple 
amide-based anion receptors such as the bis-benzamide 3.16 (Ka < 10 M-1 in CDCl3) or 
the tren-based tris-acetamide 3.17 (Ka = 307 M-1 in CDCl3),188. nitro tripod 3.1 binds Cl– 



















values for 3.1 are also larger than those for the related calixarene systems previously 
developed in the Davis group as Cl– transporters (Ka = 20-30 M-1 in CDCl3).6  Thus, pre-
organization of the three amide side chains does enhance the binding interaction between 
the receptor and the anions.  We, therefore, decided to investigate the membrane transport 
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3.4.4 Chloride Transport Activity of Triphenoxymethane Derivatives. 
 Since the tripods were originally designed as Cl- transporters, the anion 
transporting properties of nitro tripod 3.1 and t-butyl tripod 3.2 (in comparison with those 
of paco-H 2.1, a known Cl- transporter)6 were examined in egg yolk phosphatidylcholine 
(EYPC) large unilamelar vesicles (LUVs), using the base pulse, and lucigenin (Cl-
sensitive dye) assays.189  The data from the different liposome assays revealed that t-butyl 
tripod 3.2 was inactive towards the transmembrane transport of Cl- and NO3- ions.  Nitro 
tripod 3.1, on the other hand, was selective for the transmembrane transport of NO3- over 
Cl-.  
 Tripods 3.1 and 3.2 were tested for Cl- or NO3- transport across EYPC vesicles.  
In these experiments we compared the transport properties of 3.1 and 3.2 with those for 
paco-H 2.1, a known Cl- transporter.6  We first used the classical “base pulse” assay to 
compare transmembrane transport properties for tripods 3.1 and 3.2, and paco-H 2.1.37, 98  
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In this assay, activity is measured by monitoring pH changes inside a liposome 
containing HPTS, a pH-sensitive dye (Section 1.5.1).  Addition of NaOH creates a pH 
gradient across the membrane. If a compound mediates transmembrane ion transport (via 
either cation influx or anion efflux), then the intravesicular pH increases as monitored by 
HPTS fluorescence.  If the compound cannot transport ions there is no change in HPTS 
fluorescence (Figure 1.8).  The standard, paco-H 2.1,6 changed HPTS fluorescence in 
solutions containing either NaCl or NaNO3 as expected.  However, tripods 3.1 and 3.2 (at 
2 mol% ligand-to-lipid ratio) had little ability to transport Cl- (Figure 3.12).  This finding 
was confirmed in experiments that used a chloride dye, lucigenin,38, 56 to monitor 
intravesicular Cl- concentration (Figure 3.13).  The ability of nitro tripod 3.1 to bind but 
not transport Cl- ions indicates that having at least three amide side chains on the scaffold 
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Figure 3.12. Base-pulse experiments. Chloride containing EYPC liposomes (pH 6.4) in 
Cl- solution (pH 7.4).  At t = 0 s, a DMSO solution of 3.1, 3.2 or paco-H 2.1 was added 
and the intravesicular pH was determined by monitoring changes in HPTS fluorescence 
ratios. At t = 470 s, Triton-X detergent was added to lyse the liposomes to obtain 
maximum change in HPTS fluorescence ratio. Intravesicular pH increased in the presence 




























Figure 3.13. Cl- transport assay utilizing encapsulated lucigenin to monitor chloride 
transport by compounds 3.1, 3.2 and paco-H 2.1.  At t = 0 s, a DMSO solution of 3.1, 3.2 
or paco-H 2.1 was added, while a NaCl pulse was added at t = 15 s and quenching of 
lucigenin fluorescence monitored. Triton-X detergent was added to lyse the liposomes to 
obtain maximum lucigenin fluorescence quenching at t = 450, 470, 510 and 530 s for 2.1, 
3.1, DMSO blank, and 3.2 respectively.  Cl- influx is observed only in the presence of 
paco-H 2.1 (red trace).   
 
3.4.5 NO3- Transport Activity of Triphenoxymethane Derivatives. 
 We decided to explore the ability of the tripods to transport other anions, 
especially NO3-, since we had evidence for NO3- coordination by nitro tripod 3.1 in 
solution (Figure 3.11 and Table 3.3).  We reasoned that nitro tripod 3.1 might be binding 
the hydrophilic Cl- ion (∆Gh = −80.78 ± 1.43 kcal/mol)12 too tightly such that anion 
release becomes the rate-limiting step for the transport process.  However, the more 
lipophilic nitrate (∆Gh = −75.05 ± 1.43 kcal/mol)12 binds less tightly to tripod 3.1 (Figure 
3.11 and Table 3.3), we, therefore, reasoned that the release of NO3- may not be rate-
limiting as hypothesized for Cl-.  Thus, we proposed that nitro tripod 3.1 may function as 
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a NO3- transporter.  The data confirmed our reasoning as paco-H 2.1 and nitro tripod 3.1 
both transported NO3- ions in the base-pulse assay, while t-butyl tripod 3.2 did not 
(Figure 3.14).  For t-butyl tripod 3.2, we concluded that the t-butyl substituent probably 
generate unfavorable steric interactions that hindered or prevented anion binding and 
transport.6, 99  Figure 3.14 shows that nitro tripod 3.1 transports NO3- anions across 
EYPC membranes, as effectively as paco-H 2.1. The t-butyl tripod 3.2, on the other hand, 
is not a NO3- transporter, as there was little change in intravesicular pH upon addition of 
3.2. These base pulse experiments provided the first indication that nitro tripod 3.1 might 














   
   
   














Figure 3.14. Base-pulse experiments. Nitrate containing EYPC liposomes (pH 6.4) in 
NO3– solution (pH 7.4).  At t = 0 s, a DMSO solution of 3.1, 3.2 or paco-H 2.1 was added 
and the intravesicular pH was determined by monitoring changes in HPTS fluorescence 
ratios. At t = 470 s, Triton-X detergent was added to lyse the liposomes to obtain 
maximum change in HPTS fluorescence ratio. Intravesicular pH increased in the presence 




3.4.5.1 Nitrate Reductase Assay Confirms NO3- Transport by Tripod 3.1.  We 
confirmed that nitro tripod 3.1 transports NO3- across phospholipid membranes through 
an assay that uses nitrate reductase to monitor the release of NO3- from EYPC vesicles.190  
Nitrate reductase uses the NADPH cofactor to reduce nitrate to nitrite.  NADPH has a 
characteristic absorbance band at 340 nm, whereas the oxidized cofactor NADP+ does not 
absorb in this region.  Release of NO3- from vesicles was followed by changes in the 
NADPH absorbance at 340 nm.  Furthermore, the enzymatically generated nitrite anion, 
NO2-, was trapped to give diazo dye 3.18 in the Griess reaction (Figure 3.15a).190 This 
dye absorbs at 543 nm.  Thus, a decrease in NADPH absorbance at 340 nm and a 
concomitant increase in the 543 nm absorbance for 3.18 allowed us to monitor NO3– 
release from phospholipid vesicles. 
 EYPC liposomes (100 nm) filled with 100 mM NaNO3 – 10 mM Na phosphate 
(pH 7.2) were eluted from a Sephadex G-10 column using a solution of 100 mM NaCl – 
10 mM sodium phosphate (pH 7.2). Gel filtration was done to replace the bulk of the 
extravesicular NO3- with Cl-.  The resulting EYPC liposome suspension (100 µL) was 
diluted into 1.9 mL of a 100 mM NaCl – 10 mM sodium phosphate (pH 7.2) solution 
containing 0.3 units of nitrate reductase and 5 mM NADPH.  Solutions of either tripod 
3.1 or 3.2 in DMSO (2 mol% ligand-to-lipid ratio) were added to the EYPC suspensions 
and the resulting mixture was incubated for 3 hours to ensure complete reduction of 
nitrate to nitrite. Subsequently, Griess reaction of the enzymatically generated NO2- was 


































Diazo dye, 3.18 NADPH 
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Figure 3.15.  Enzyme-coupled assay confirms transmembrane NO3- transport by nitro 
tripod 3.1.  a) Tripod 3.1 transports NO3- out of EYPC vesicles suspended in NaCl 
solution. Nitrate reductase reduces extravesicular NO3-to NO2-. The resulting NO2- is then 
trapped to give diazo dye 3.18. b) UV spectrum of EYPC LUV suspension after addition 
of 3.1, 3.2 or DMSO blank. The arrow indicates a decrease in NADPH absorbance at 340 
nm in presence of 3.1. c) UV spectrum of 3.18 after Griess reaction of enzymatically 
produced NO2-.  Arrow indicates increase in absorbance for diazo dye 3.18 in the 
presence of nitro tripod 3.1.  
 
 The UV spectra in Figure 3.15b show significant consumption of NADPH in the 
presence of the NO3--loaded liposomes and nitro tripod 3.1.  In contrast, when t-butyl 
tripod 3.2 was added to the same NO3--loaded liposomes there was little change in 
NADPH absorbance. As shown in Figure 3.15c, the 543 nm absorbance for diazo 3.18 
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formed in the Griess reaction confirmed that significantly more nitrate was released from 
EYPC liposomes in the presence of nitro tripod 3.1, as compared to t-butyl tripod 3.2. 
These two assays, based on nitrate reduction and subsequent trapping of the 
extravesicular nitrite, confirm that nitro tripod 3.2 transports NO3- across EYPC vesicles. 
 There are no clear-cut explanations for the inconsistencies in the anion binding 
and transporting properties of tripod 3.1.  Our hypothesis is that anion release is the rate 
limiting step for Cl- transport, since it is the same receptor, nitro tripod 3.1 that 
preferentially transports NO3- ions, which it binds less efficiently than Cl-.  Other factors 
that could be affecting the Cl- transport ability of 3.1 are: 1) variations in the kinetics of 
anion binding at the membrane/aqueous interfaces; or 2) variations in mobility of the 
tripod-anion complex within the membrane.59  The former factor appears to be dominant, 
since some Cl- transport activity would have been observed for nitro tripod 3.1 if mobility 
of the tripod-anion complex within the membrane were the dominant effect.  In addition, 
the association events observed in the binding studies do not accurately reflect the 
scenario in the membrane transport studies as the chemical environments are different.  
The former events occurred in non-polar environments, while the latter in polar 
environments.     
 
3.4.6 Selective NO3- Transport by Nitro Tripod 3.1. 
 The data in Figures 3.12-3.15 suggested that nitro tripod 3.1 might control 
selective release of nitrate from phospholipid vesicles.  As such, we utilized the 
significant NO3-/Cl- transmembrane transport selectivity shown by nitro tripod 3.1 to alter 
the pH within phospholipid vesicles experiencing a NO3-/Cl- gradient.  Thus, EYPC 
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liposomes containing the pH sensitive HPTS dye in 100 mM NaNO3, 10 mM sodium 
phosphate buffer (pH 6.4) were suspended in a solution of 100 mM NaCl, 10 mM sodium 
phosphate buffer (pH 6.4).  Then, DMSO solutions of either tripod 3.1 or 3.2, or paco-H 
2.1 were added to the EYPC suspension.  As shown in Figure 3.16 addition of nitro 
tripod 3.1 resulted in a rapid increase in the intravesicular pH (∆pH = 0.7), whereas 
addition of t-butyl tripod 3.2 or paco-H 2.1 caused little change in internal pH. The 
constant pH in a system experiencing a significant transmembrane NO3-/Cl- gradient 
indicates that paco-H 2.1, which can transport Cl- and NO3- (Figures 3.12-3.14 and 
reference 6), operates via a NO3-/Cl- anion exchange process. The nitro tripod 3.1, on the 
other hand, readily moves NO3- out of the liposome along the NO3-/Cl- gradient, but is 
unable to compensate by transporting Cl- from the extravesicular buffer into the 
liposome.  To maintain electroneutrality nitro tripod 3.1 facilitates H+/NO3- co-transport 
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Figure 3.16. Change in intravesicular pH through selective NO3- transport. a) A plot of 
intravesicular pH vs. time in experiments where NO3--loaded EYPC liposomes (pH 6.4) 
suspended in a NaCl solution (pH 6.4) were treated with compounds 3.1, 3.2 and paco-H 
2.1. At t = 30 s, a DMSO solution of 3.1, 3.2 or paco-H 2.1 was added and the 
intravesicular pH was determined by monitoring changes in HPTS fluorescence ratios. At 
t = 470 s, Triton-X detergent was added to lyse the liposomes to obtain maximum change 
in HPTS fluorescence ratio. Intravesicular pH increased in the presence of nitro tripod 3.1 
only. b) Cartoon depiction of the mechanism of ion transport by 2.1 and 3.1. Paco-H 2.1 
functions as a NO3-/Cl- anion exchanger (top) whereas nitro tripod 3.1 functions as a 






 Nitro tripod 3.1 selectively transports NO3- across liposomal membranes in what 
is effectively an H+/NO3- co-transport process.  This is, to our knowledge, the first report 
of a synthetic compound with such a marked selectivity for transport of NO3– over Cl–.138  
While NO3– uptake and metabolism is of high agricultural, environmental and medical 
importance,140 the mechanism of transport by certain members of the nitrate permease 
enzyme family is still uncertain.139  Synthetic transmembrane NO3– transporters such as 
nitro tripod 3.1 could be potential enzyme mimics for studying and understanding such 
mechanisms.  Indeed nitro tripod 3.1 might serve as a good model for mimicking the 
natural H+/NO3– co-transporters, the NNP protein family, for which no crystal structures 
yet exist.  Nitro tripod 3.1 could also be used to induce pH changes in cells that are 
experiencing a NO3–/Cl– gradient or for the selective release of NO3– from vesicles.191   
The structural requirements that transform an anion receptor into an anion transporter are 
still not well understood.  Whereas nitro tripod 3.1 is a receptor for both NO3– and Cl– 
ions, it selectively transports NO3– ions across liposomal membranes.  The nitro tripod 
3.1 results indicate that pre-organizing the molecular scaffold to generate a better defined 
anion binding pocket enhances the activity of the scaffold as an anion receptor.  
However, the results also indicate that the presence of three amide side chains pointing in 
the same direction is essential but not sufficient for Cl– transport.  Thus, while 
calculations are useful for predicting putative binding motifs and receptor designs, the 
value of serendipitous discoveries such as with nitro tripod 3.1, should not be discounted.  
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Chapter 4: Small Molecules That Facilitate the Transmembrane 
Exchange of Bicarbonate and Chloride Anions 
The majority of this chapter has been published in reference 192: 
• Davis, J. T.; Gale, P. A.; Okunola, O. A.; Prados, P.; Iglesias-Sánchez, J. C.; 
Torroba, T.; Quesada, R. “Using "small" molecules to facilitate exchange of 
bicarbonate and chloride anions across liposomal membranes.” Nature Chem. 
2009, 1, 138-144.  
Some of the experimental work described in this chapter was performed by Dr. Roberto 
Quesada, a collaborator from the University of Burgos, Spain. 
4.1 Introduction. 
 The goals of the research in this chapter are two-fold: 1) identification of discrete 
organic compounds that transport bicarbonate (HCO3-) anion across bilayer membranes; 
and 2) development of a technique to assay for the transmembrane transport of HCO3-.  
These goals were achieved as will be described in this chapter.  Before describing the 
results for this chapter (Sections 4.6-4.8), I first present a discussion on the chemistry and 
biochemistry of HCO3-, highlighting its importance to human health, and the challenges 
associated with its complexation and transmembrane transport by non-protein systems 
(Sections 4.2 and 4.3).  We elucidated the HCO3- transporters described in this chapter 
(Chart 4.1) to be Cl-/HCO3- exchangers, I therefore present a brief discussion on the 
natural Cl-/HCO3- exchanger (AE) proteins  (Section 4.4).  Detection of HCO3- transport 
across bilayer membranes is a challenging process mainly due to the labile nature of the 
anion.  Identification of bicarbonate-specific indicators is therefore important.  I 
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summarize briefly, a few selected literature examples of synthetic receptors with 
fluorescent properties that have been identified as receptors for bicarbonate in Section 
4.5.  The studies I present in Sections 4.6-4.8, describe the first focused study on the 
transmembrane transport of HCO3- ions across phospholipid membranes by small 
molecule, non-protein receptors.  Transmembrane HCO3- transport was monitored 
qualitatively using ion-selective electrode, and 13C NMR spectroscopic techniques, as 
described in Section 4.8.192  These studies also describe initial efforts by the J.T. Davis 
group (in collaboration with the Gale group at the University of Southampton, United 
Kingdom) toward a well developed program on the transmembrane transport of HCO3- 




























4.2 The Chemistry and Biochemistry of Bicarbonate Anion. 
 Bicarbonate is a simple, organic anion with a trigonal planar geometry (Figure 
4.1).  It is smaller (thermochemical radius, r = 1.56 Å), more hydrophilic (Gibbs 
hydration energy, ∆Gh = −92.73 ± 1.43 kcal/mol), and more basic (pKa [conjugate acid] = 
6.4) compared to Cl- (r =1.72 Å; ∆Gh = −80.78 ± 1.43 kcal/mol; pKa = −8.0) or NO3- (r = 
1.96 Å; ∆Gh = −75.05 ± 1.43 kcal/mol; pKa = −1.3) anions.12, 193  
 
 
Figure 4.1. The trigonal planar bicarbonate (HCO3-) anion. 
 
 One of the most important chemical and biochemical properties of HCO3- anion is 
that it is the conjugate base of carbonic acid (H2CO3) as well as the conjugate acid of 
carbonate (CO32-) anion. Thus, conditions for studies on the complexation of HCO3- with 
receptors need to be regulated carefully to ascertain that binding and not deprotonation 
(acid-base reaction) is what is being observed.  The amphoteric nature of HCO3- makes it 
a candidate for a buffer.  Bicarbonate is central to the carbon dioxide (CO2)/HCO3- buffer 
system – the most important physiological pH buffering system that helps maintain 
cellular and whole-body pH.194  The pKa of the conversion of HCO3- to CO2 is 6.4 
(Scheme 4.1), which is close to physiological pH (~ 7.2-7.4).  Thus, under physiological 
conditions, both HCO3- and CO2 are present in significant amounts (approximately 95:5 
HCO3-/CO2 ratio), making HCO3- a labile substrate.195  Whereas dissolved gaseous CO2 
is generally thought to diffuse relatively easily across cell membranes, the charged HCO3- 
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anion is basically membrane impermeable.194  Transport proteins are therefore required to 
facilitate the movement of HCO3- anion across membranes.   
 
CO2 (gas) (Membrane Permeant)
                                         
CO2 (dissolved) + H2O(l)                 H2CO3(aq)                HCO3-(aq) + H+(aq)               CO32-(aq) + 2H+(aq)
                                                                                      
*CA = carbonic anhydrases
*CA
pKa        6.4                                            10.3
 
Scheme 4.1. The equilibrium reactions of HCO3- showing the pKa values of bicarbonate’s 
conversion to CO2 or carbonate (CO32-) anion. Carbonic anhydrases (CA) enhance the 
rates of the CO2 hydration and HCO3- dehydration reactions by catalyzing the 
conversions.  Adapted from reference 4.  
 
4.3 Why Study Bicarbonate Transport? 
 Bicarbonate plays important roles in the regulation of physiological pH, as well as 
the respiratory mechanism of living organisms – two fundamental processes that are 
crucial to human existence and well-being.  Bicarbonate is also implicated in a substantial 
number of other biological processes, a few of which are listed in Table 4.1.  Defective 
transmembrane transport of HCO3- can lead to conditions such as cystic fibrosis, heart 
disease and infertility.4, 13, 196-198  The lack of structural data for bicarbonate transport 
proteins means that little is known regarding the anion binding sites that modulate their 
affinity and selectivity.4, 23, 196  In addition to its many crucial biological roles, 
understanding the fundamental chemistry of HCO3- is also important given the concerns 
about global warming and increased CO2 levels in the earth’s atmosphere.  A better 
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understanding of the molecular recognition and transmembrane transport of HCO3- is 
needed. Despite its importance, and that of its transmembrane transport, there is 
surprisingly little known about the selective coordination of bicarbonate by organic 
receptors.  Likewise, there have been no studies that focus attention on the use of "small" 
molecules to promote the efficient transport of bicarbonate anion across lipid 
membranes,7 in contradistinction to the growing body of work on transmembrane 
chloride transport.53, 113, 118, 199-201  The challenge of achieving bicarbonate transport was 
eloquently expressed by A. P. Davis, Sheppard and Smith in 2007: “Finally, there is the 
topic of transporters for anions other than Cl-. For example, an interesting target with 
potential utility is a synthetic transport system for bicarbonate.  A specific goal would be 
a mimic of chloride/bicarbonate exchangers that play important roles in red blood cells 
and epithelial tissues.  The design challenge here is to produce a transporter that can 
extract the very hydrophilic bicarbonate anion into the lipophilic interior of a bilayer 
membrane.”53   
 Another challenge in the transmembrane transport of bicarbonate is the lack of 
efficient assays that monitor the transport process directly.  There are no known ion-
sensitive dyes or ion-selective electrodes that are specific to bicarbonate.202  This is 
probably largely due to the labile nature of bicarbonate as a substrate.  Two methods, one 
using the chloride-selective electrode (indirect method) and the other using 13C NMR 
techniques (direct method), were used to monitor transmembrane bicarbonate transport in 





Table 4.1. Examples of bicarbonate’s importance to key biological processes. 
Major Role Target Function Ref. 
Enzyme Substrate Rubisco Photosynthesis 203 









 Acetyl-CoA Carboxylase Fatty Acid Biosynthesis 207 
    
Enzyme Co-factor Leucine Aminopeptidase Protein Metabolism 208 
 Plant Cyclopropane Oxidase Ethylene Biosynthesis 209 
    
Cellular Signal cAMP Synthase Sperm Activation 198, 210 
    
Homeostasis Anion Exchange Proteins HCO3- Transport 4, 211 
 Na+/HCO3- Co-transporters Pancreas and Kidney 212 
    
Health/Disease CFTR Cl-/HCO3- Channel Cystic Fibrosis 13 
 DNA Cis-Platin Complex Cancer Chemotherapy 4, 213 
 Carbonic Anhydrase Memory/Alzheimer’s Disease 214 
 Bone Markers Osteoporosis/Bone Resorption  215 
 Anion Exchange Proteins Epilepsy 4, 216 
 Anion Exchange Proteins Cardiovascular Health 4, 217 
 
4.4 Bicarbonate Transport Proteins – The Chloride/Bicarbonate Exchanger.  
 In humans and other higher animals, carbon dioxide (CO2) is produced as a 
metabolic waste product in all cellular function.  For continued viability, the cell needs to 
get rid of the CO2 load.  While CO2 can diffuse across membranes, it is poorly soluble in 
the aqueous medium of the blood.  To resolve this dilemma, CO2 released from respiring 
tissues diffuses through blood plasma into the red blood cell (erythrocyte), where it is 
converted into the soluble HCO3- through the activity of carbonic anhydrases (CAs).  
CAs are enzymes that catalyze the reversible interconversion of CO2 and HCO3- (Scheme 
4.1).218  The soluble HCO3- enters the blood plasma and is transported to the lungs, where 
it enters the erythrocyte and is converted to CO2, which is then exhaled.  The transport of 
HCO3- in and out of erythrocytes is facilitated by the chloride/bicarbonate exchanger, 
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also known as the anion exchanger (AE) protein.  In order to avoid charge build-up from 
the transport of HCO3- in one direction, AE proteins transport Cl- ions in the opposite 
direction (Figure 4.2).  One Cl- ion is exchanged for every one HCO3- transported, thus 
AE proteins act as electroneutral antiporters.  By facilitating the transport of HCO3- ions 
in and out of the red blood cell, AE proteins indirectly facilitate CO2 efflux from the 
body.  Considering their crucial role in respiration as described above, it is not surprising 
that AE proteins make up 50% of integral membrane proteins, and represent the most 














Figure 4.2. The role of anion exchange (AE) proteins in facilitating CO2 efflux from the 
body.  CO2 molecules that diffuse into the erythrocyte are hydrolyzed into HCO3- through 
the action of carbonic anhydrases (CA).  HCO3- is then transported as the soluble form of 
CO2 via a Cl- exchange transport mechanism by the AE protein. Adapted from Biochem. 





4.5 Synthetic Fluorescent Bicarbonate Receptors. 
 In spite of the wealth of information available on the solution properties of 
bicarbonate binding and transporting proteins (Section 4.4),4, 196  surprisingly little work 
has been done on the complexation of HCO3- by synthetic compounds containing 
hydrogen bond donors.  A search of the Cambridge Crystallographic Database (CCD)† 
for discrete bicarbonate results in only 46 structures with just 2 examples of the anion 
bound by ‘conventional’ acyclic hydrogen bond donating receptors.219, 220  Complexation 
of bicarbonate is a challenging goal, since it is a labile substrate.  Particularly challenging 
is achieving selectivity for HCO3- over more basic anions such as its conjugate base – 
carbonate, or phosphate.221, 222   
 Some synthetic receptors that have been reported in literature for HCO3- 
complexation are outlined in Chart 4.2.  The selected examples are particularly 
interesting because they also possess fluorescent properties and are soluble in polar 
media, making them adaptable for liposomal or cellular assays.    
 Hennrich and Resch-Genger have reported iminoylthioureas 4.5-4.8 (Chart 4.2) 
as fluorescent bicarbonate receptors.221  Upon addition of various anions in a 1000-fold 
excess, compounds 4.5-4.8 displayed strong fluorescence enhancements with carbonate 
(53-fold) and bicarbonate (39-fold) ions in methanol solutions.  Fluorescence 
enhancement was most prominent for receptors 4.5 and 4.7 which possess at least six and 
three hydrogen bond donors respectively. The enhancement obtained with receptors 4.6 
and 4.8 in the presence of CO32– and HCO3– was less significant because of the reduced 
number of hydrogen bond donors (four and two respectively).  The reduction in 
                                                 
† Cambridge Crystallographic Database, CCDC, Cambridge, UK; 5.29 ed. 2007. 
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fluorescence enhancement from receptor 4.5 to 4.8 was attributed to an increase in 
receptor rigidity.  The slightly more flexible receptors 4.5 and 4.7 are probably able to 
change conformation to allow favorable receptor-anion interactions, whereas the degree 
of freedom is reduced in the more rigid 4.6 and 4.8.  The greater enhancement observed 
with carbonate over bicarbonate further highlights the difficulty of achieving bicarbonate 
selectivity in the presence of more basic anions.  In addition, compounds 4.5-4.8 are 
significantly weak receptors considering the huge excess (1000-fold) of anion required to 





















































































































 Receptors 4.9-4.11 (Chart 4.2), developed by Gale and coworkers, also function 
as fluorescent HCO3– receptors with stability constants (Ks) greater than 104 M-1 in 
DMSO/H2O (99.5:0.5 v/v) solutions for all three receptors.223  Similar association 
constants were also obtained for acetate anions.  Chloride anions were however, bound 
less strongly (Ks = 102, 139, and 85 M-1 for 4.9, 4.10 and 4.11 respectively).  The large 
difference in the affinities of receptors 4.9-4.11 for Cl- and HCO3- anions may make them 
suitable candidates for uncoupled HCO3- transport across liposomal membranes.   
 Finally, Suzuki and co-workers have reported a γ-cyclodextrin-pyrene derivative 
4.12 (Chart 4.2), as a fluorescent receptor that is highly selective for detecting HCO3- in 
water.202  Compound 4.12 is the only receptor among those listed in Chart 4.2 to show 
pronounced selectivity for HCO3- in aqueous media.  Suzuki and co-workers suggested 
that at pH 7–9 an association dimer formed from monocationic γ-CD-pyrene 4.12 
(4.1222+) was the species that bound HCO3- in aqueous solution (Figure 4.2).  The 
receptor-anion complex formed between 4.1222+ and HCO3- emitted an anomalous pyrene 
fluorescence that was not observed for the other anions tested (NO3-, Cl-, ClO4-, AcO-, 
HPO42-, SO42-).  The anomalous fluorescence induced by HCO3- was attributed to the two 
pyrene units of the 4.1222+/HCO3- adopting a twisted conformation as depicted in Figure 
4.2.  The γ-CD-pyrene derivative is also relatively sensitive, being able to detect HCO3- 
at 1 mM concentration in water.  Compound 4.12 may therefore serve as a valuable 













Figure 4.3. The fluorescent cyclodextrin-pyrene dye 4.12 forms an association dimer that 
selectively binds HCO3- resulting in fluorescence enhancement.202 
 
4.6 Prodigiosin and Isophthalamides as Receptors for Bicarbonate.  
 Our initial efforts toward achieving transmembrane HCO3- transport focused on 
identifying simple, “small” molecules that can function both as receptors and transporters 
for HCO3- ion.  Our search led to the selection of natural product prodigiosin 4.1, and the 
synthetic amides 4.2-4.4 (Chart 4.1).  Prodigiosin 4.1 was selected because it is known 
to transport H+ and Cl- ions into cells.224  Isophthalamide 4.2 had also been shown to 
mediate Cl- transport across liposomal membranes.96  As discussed in the following 
sections, compounds 4.1-4.4 not only transport HCO3- ion, but also facilitate Cl-/HCO3- 
exchange across phospholipid membranes, thus mimicking the properties of natural 
proteins that act as Cl-/HCO3- exchangers.  
 
4.6.1 Prodigiosins. 
Prodigiosins are a family of naturally occurring red pigments produced by 
microorganisms such as Streptomyces and Serratia.225  The prodigiosins are bacterial 
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secondary metabolites that possess a characteristic pyrrolylpyrromethene skeleton with a 
B-ring C-4 methoxy group and different alkyl substituents arranged either in an acyclic or 
cyclic display (Scheme 4.2).  The prodigiosins have been shown to possess potent 
antimicrobial, antimalarial, anticancer, and immunosuppressive activities.226  Prodigiosin 
4.1,227 the parent member of the pigments was first isolated in pure form in the 1920s, but 
its full acyclic tripyrrole structure was only fully elucidated in the 1960s by partial228 and 
complete229 synthesis.  Prodigiosin 4.1 causes selective apoptosis of cancer cells226 and its 
synthetic analogue obatoclax (Scheme 4.2) is in clinical trials for the treatment of 
different types of cancer.230, 231  Prodigiosin 4.1 has also been shown to promote 
transmembrane Cl- transport via H+/Cl- symport,224, 232-234 or anion exchange 
mechanism.235, 236  Indeed, the antibiotic activity of prodigiosin-like compounds has been 
related to their activity as transmembrane Cl- carriers.233  Although the origin of the 
prodigiosins’ cytotoxic activity has yet to be unambiguously established, various 
structure-activity relationship (SAR) studies have established that the pyrrolic A-ring and 
the C-4 methoxy group are important for cytotoxic potency.237-239  Prodigiosins are 
weakly basic (apparent pKa ~ 7-8) due to the presence of the azafulvene moiety 
(highlighted box in Scheme 4.3), and it has been shown that they undergo rotamer 
interconversion to generate two geometrical isomers (α and β forms, Scheme 4.3) with 
widely different apparent pKa values (pKaα ~ 8.3, pKaβ ~ 5.4, 1:1 acetonitrile 
(CH3CN)/H2O).238, 240   The two rotamers can be distinguished by 1H NMR in 
chloroform-d (CDCl3) containing excess trifluoroacetic acid (CF3CO2H) or 
methanesulfonic acid (CH3SO3H), with the α/β ratio being 1/2 under these conditions.240   
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 Due to the presence of hydrogen bond donors and acceptors in prodigiosin 4.1, we 
reasoned that it might function as a receptor and a membrane transport agent for HCO3-.  
Indeed the modeling of a prodigiosin-bicarbonate complex suggests a complimentary fit 
between the host (4.1) and the guest (HCO3-) as depicted in Figure 4.4.  Our reasoning 
about prodigiosin 4.1 proved true as 4.1 turned out to be a good HCO3- receptor as well 






































Scheme 4.2. Prodigiosin 4.1 and some of its natural product, red pigment relatives as 
well as the synthetic analog – Obatoclax, which is in clinical trials for the treatment of 
different cancers.  The pyrrolylpyrromethene skeleton is highlighted in a red box, and 
relevant carbon positions labeled 2, 4, and 5 according to Chemical Abstracts (CA) Index 



































Scheme 4.3.  Rotamer interconversion of “free base” 4.1 and its protonated version 
4.1•H+ showing the α and β forms.  The azafulvene moiety is highlighted in a blue box. 
 
 
Figure 4.4.  Structure of the putative prodigiosin-bicarbonate complex (left), and a DFT 

















 Isophthalamides, a class of aromatic diamides had predominantly been studied as 
receptors for binding anionic biomolecules such as nucleotide bases, barbiturates, 
dicarboxylic acids, and peptides150 until Crabtree re-introduced them as effective 
receptors for halides in the late 1990s.241  Isophthalamides have convergent amide NH 
groups that can form hydrogen bonds with anions.241, 242  The isophthalamide moiety can 
adopt 3 possible conformations, viz: syn-syn, syn-anti, or anti-anti conformations 
(Scheme 4.4) with the syn-syn conformation being the most efficient for anion binding.241  
Thus, we also investigated the bicarbonate transport ability of N,N`alkyl-4,6-
dihydroxyisophthalamides 4.2-4.4 (Scheme 4.5), especially in comparison to prodigiosin 
4.1.  Compounds 4.2-4.4 were prepared by Dr. Roberto Quesada.  The transmembrane 
chloride transport activity of N,N`butyl-4,6-dihydroxyisophthalamide 4.2 was recently 
reported.96  In the case of 4.2, conformational control of the anion binding cleft by 
intramolecular hydrogen bonds between the 4,6-dihydroxy units and the neighboring 
amide carbonyls locks the compound in the syn-syn conformation, resulting in an 
improved anion affinity and in optimal activity for transmembrane transport of chloride 
anion.  For this study, the related isophthalamides 4.3 and 4.4, functionalized with 
different alkyl substituents were synthesized.  The rationale for 4.3 and 4.4 was that 
membrane activity might be attenuated by the identity of the lipophilic tails attached to 
the isophthalamide.  The studies showed that isophthalamides 4.2-4.4 also facilitate Cl-
/HCO3- exchange across phospholipid membranes, howbeit with reduced potency 

























syn-syn syn-anti anti-anti  














4.4: R =  
Scheme 4.5. The structures of compounds 4.2 – 4.4. 
 
4.7 Anion Complexation Properties of Receptors 4.1-4.4. 
4.7.1 Bicarbonate Complexation with Prodigiosin 4.1. 
 Prodigiosin and its analogues bind chloride in the solid-state and in solution.233, 238  
Furthermore, the use of chloride-selective dyes and electrodes revealed that prodigiosin 
4.1 transports Cl- anions across lipid membranes.233, 236  It was reported 50 years ago that 
prodigiosin reacts with carbonic acid to give a protonated adduct,243 however, there has 
been no direct evidence presented that prodigiosin 4.1 can bind bicarbonate.  Thus, the 
anion complexation properties of prodigiosin 4.1 with bicarbonate, chloride and nitrate 
anions were studied by 1H NMR titration methods in deuterated methylene chloride 
(CD2Cl2).  Starting with a 2.0 mM solution of prodigiosin, the anion was added as a 
solution of its tetraalkylammonium salt in increasing equivalent amounts.  NMR data was 
then collected immediately and 5 minutes after addition of the anion solution, to ensure 
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equilibration of the binding process before addition of the next anion aliquot.  The NMR 
studies showed that the three anions (HCO3-, Cl- and NO3-) binds to 4.1, causing shifts of 
proton resonances in prodigiosin 4.1 upon addition of the tetraalkylammonium salt.  The 
NMR signals in 4.1 that were most affected by anion addition were the H2 proton on the 
A-ring and the methyl group on the C-ring (Figure 4.5).  These are the carbon-bound 
protons that would be expected to be most influenced by anion binding, as they are 
closest to prodigiosin’s putative anion-binding cleft (Figure 4.4).†  The changes in these 
chemical shifts upon addition of tetraethylammonium bicarbonate (TEAHCO3) were 
greater than those for the same protons in 4.1 upon addition of tetrabutylammonium 
chloride or nitrate (Ka = 9.7 ± 1.4 and 8.9 ± 1.9 M-1; Figures 4.6-4.8), presumably 
reflecting the higher basicity of the bicarbonate anion.  A stability constant could not be 
calculated for the prodigiosin-bicarbonate complex because, in addition to changes in 
chemical shifts for 4.1, a second set of NMR peaks emerged during bicarbonate titration.  
This slow exchange process may be due to higher-order complex formation with 
bicarbonate or to an HCO3- triggered interconversion of rotamers (Scheme 4.3).240  
Experiments were repeated with the protonated form of prodigiosin as the 
methanesulfonate salt (4.1•H+ CH3SO3-; after addition of methanesulfonic acid).  Under 
the same experimental conditions, addition of bicarbonate resulted in deprotonation of 
4.1•H+ as evidenced by loss of the now visible pyrrole NH resonances in the 1H NMR 
spectrum (Figure 4.9), and a reversal of the solution’s color from the deep pink of 
protonated 4.1•H+ to the orange of free base 4.1 (Figure 4.10).  In contrast, addition of 
chloride causes a downfield shift (and not loss) of the pyrrole NH resonances of 4.1•H+ 
indicating hydrogen bond formation to the halide anion (Figure 4.11).  Additionally, the 
                                                 
† The pyrrole NH protons are not visible in the 1H NMR of prodigiosin in the free base form in CD2Cl2. 
 126 
 
deep pink color of protonated 4.1•H+ remains unchanged in the presence of 15 
equivalents of both Cl- and NO3- anions (Figure 4.10).  At pH 7.2 both protonated and 
free base forms of prodigiosin are present and it may be that any putative HCO3- transport 
process involves both forms.  Whilst a stability constant for bicarbonate complexation 
was not obtained, these NMR titrations demonstrated that the free base form of 
prodigiosin 4.1 binds bicarbonate in solution.  Electrospray mass spectrometry in 
negative mode on a solution mixture of prodigiosin 4.1, NaHCO3 and 
tetrabutylammonium chloride (TBACl) in methylene chloride revealed the presence of a 
bicarbonate adduct (Figure 4.12), providing more evidence for complex formation 






















Figure 4.8. 1H NMR titration curves for the binding of prodigiosin 4.1 with Cl- (left 
panel) and NO3- (right panel) based on the CH3 group of its C-ring.  The anions are 





Figure 4.9. 1H NMR titration of prodigiosin 4.1 + CH3SO3H with tetraethylammonium 



































Figure 4.10.  Visual evidence that prodigiosin 4.1 binds HCO3- as “free base”, while it 
binds Cl- and NO3- anions as the protonated form 4.1•H+ in CD2Cl2: A = 1.0 mM 4.1 
only; B = 1:1 4.1/CH3SO3H; C = B + 15.0 equivalents of TEAHCO3; D = B + 15.0 





Figure 4.11. 1H NMR titration of prodigiosin 4.1 + CH3SO3H with tetrabutylammonium 
chloride in CD2Cl2.  
A B C D E









Figure 4.12. Electrospray ionization mass spectrometry (negative mode; ESI-) of 
prodigiosin 4.1 showing m/z for a bicarbonate complex. Experiments conducted by the 
author. 
 
4.7.2 Anion Binding Properties of the Isophthalamides. 
 The anion binding studies described in this section were carried out by Dr. 
Roberto Quesada.  Understanding the anion binding properties of isophthalamides 4.2-4.4 
is crucial because of the presence of the hydroxyl groups which could easily be 
deprotonated by basic anions such as bicarbonate under the membrane transport assay 
conditions.  The anion binding properties of isophthalamide 4.2 (as a model for the 
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isophthalamides) was therefore investigated using NMR titration techniques.  Receptor 
4.2 shows good selectivity for chloride against nitrate in both acetonitrile-d3 and DMSO 
(Table 4.2).  The binding constants for the 4.2•Cl- complex was even lower in more 
competitive solvents such as in DMSO with increasing amounts of water (Figure 4.13).  
However, the observation of complexation events in such competitive media highlights 
the effectiveness of 4.2 as a chloride receptor.  Under similar conditions, titration of 4.2 
against tetraethylammonium bicarbonate in DMSO showed that deprotonation of the 
hydroxyl groups occurs, as such, no stability constant could be calculated.  Dr. Quesada 
also carried out experiments which demonstrated that the isophthalamides are not 
deprotonated in buffered solutions of bicarbonate under conditions similar to those used 
for the membrane transport experiments (data not shown). 
 
Table 4.2. Anion-binding constants (Ka) for receptor 4.2 determined by 1H NMR 









Ka (M–1) 5231 70.0 94.9 <10 
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Figure 4.13. Chemical shifts induced in the N-H group of receptor 4.2 by the addition of 
increasing amounts of TBACl in d6-DMSO containing increasing amounts of water. ‡ 
Error < 10%. Experiments conducted by Dr. Roberto Quesada. 
 
4.8 Transmembrane Bicarbonate Transport by Compounds 4.1-4.4.  
 The chloride-selective electrode assays described in Sections 4.8.1-4.8.3 were 
carried out by Dr. Roberto Quesada. They served as precedence for the 13C NMR 
experiments carried out by the author and described in Section 4.8.4. 
 
4.8.1 Prodigiosin 4.1 is a More Efficient Anion Transporter. 
Upon establishing bicarbonate binding by compounds 4.1-4.4, the transmembrane 
anion transport activity of the natural product 4.1 vs. the synthetic Cl- transporters 4.2-4.4 
was compared.  The transmembrane anion transport abilities of 4.1-4.4 were evaluated by 
monitoring chloride efflux from unilamellar POPC (1-palmitolyl-2-oleoyl-sn-glycero-3-
phosphocholine) vesicles using a chloride-selective electrode (an example of the ion-
 ∆δNH Ka(M-1)‡ 
d6-DMSO 0.79 70 
d6-DMSO + 2% H2O 0.74 64 
d6-DMSO + 5% H2O 0.66 46 
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selective electrodes described in Section 1.5.2) by Dr. Roberto Quesada.7  These studies 
were conducted using nitrate in the extravesicular solution.  Nitrate is more hydrophobic 
than bicarbonate and is frequently used to assess chloride transport efficiency.  Chloride-
loaded liposomes (in 5 mM sodium phosphate buffer; pH 7.2) were suspended in an 
extravesicular sodium nitrate solution. The transporters 4.1-4.4, dissolved in ~10 µL of 
DMSO, were then added to the extravesicular solution and chloride efflux was monitored 
over 300 s. At the end of the experiment the vesicles were lysed by the addition of 
detergent (polyoxyethylene-8 lauryl ether, C12E8) and the final value was normalized to 
equal complete chloride efflux. Prodigiosin 4.1 proved to be a potent chloride transporter 
using this assay. A 0.005% molar carrier to lipid concentration of prodigiosin 4.1 showed 
similar transport activity to the 0.1% molar carrier to lipid concentration for synthetic 
compounds 4.2-4.4 (Figure 4.14). These carrier loadings were capable of complete 
chloride efflux within 300 s, with the isopentyl-substituted isophthalamide 4.3 being the 















Figure 4.14.  Chloride efflux promoted upon addition of 4.1 (♦) (0.005 mol% carrier-to-
lipid ratio) and 4.2 (■), 4.3 (▲), 4.4 (●) (0.1 mol% carrier-to-lipid ratio) to unilamellar 
POPC vesicles loaded with 488 mM NaCl, 5 mM phosphate buffer (pH 7.2) dispersed in 
488 mM NaNO3, 5 mM phosphate buffer (pH 7.2).  At t = 300 s the vesicles were lysed 
by addition of detergent and the final reading at t = 375 s was considered to equal 100% 
chloride efflux.  Experiments conducted by Dr. Roberto Quesada. 
 
4.8.2 Transporters Mediate Transport Via and Anion Exchange Mechanism. 
 In the assay depicted in Figure 4.14, the anion transport activity can occur either 
via H+/Cl- or Na+/Cl- co-transport or by Cl-/NO3- exchange. To distinguish between these 
alternative mechanisms, we carried out the Cl- electrode transport assay while varying the 
anion in the external medium. If transport occurs by an anion exchange mechanism, 
changing the external anion should impact the transport rate, whilst a H+/Cl- or Na+/Cl- 
co-transport mechanism should not be affected by the external anion. As depicted in 
Figure 4.15, the transport assay was repeated by suspending the chloride-loaded vesicles 
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in a sulfate-containing external medium. As the sulfate dianion carries a higher charge 
and is significantly more hydrophilic than nitrate, transport activity by compounds 4.1-
4.4 should be reduced if an anion exchange mechanism is operative. Indeed, with sulfate 
as the external anion, no chloride efflux from the liposomes was detected upon addition 
of 4.1-4.4, supporting a Cl-/NO3- exchange (antiport) mechanism for mediating anion 
transport across the vesicle bilayer.  
 
SO42-
Cl- 4.1 - 4.4
 
Figure 4.15.  Lack of Cl- transport upon the addition of compounds 4.1 (♦) (0.04 mol% 
carrier-to-lipid ratio) and 4.2 (■), 4.3 (▲), 4.4 (●) (0.5 mol% carrier-to-lipid ratio) to 
unilamellar POPC vesicles containing 488 mM NaCl, 5 mM phosphate buffer (pH 7.2) 
and immersed in 166 mM Na2SO4, 5 mM phosphate buffer (pH 7.2) solution.  At 300 s 
the vesicles were lysed to obtain 100% chloride efflux at the final reading of t = 420 s. 




4.8.3 Transporters Facilitate Cl-/HCO3- Exchange Across Liposomal Membranes. 
 While both nitrate and bicarbonate have similar sizes and shapes, bicarbonate is 
significantly more hydrated than nitrate and, as stressed by A. P. Davis and coworkers,53 
it is more challenging to transport bicarbonate than nitrate across a lipid bilayer.244 
Prompted by the ability of prodigiosin 4.1 to bind bicarbonate and by the Cl-/NO3- anion 
exchange activity shown by 4.1-4.4, an experiment was designed to determine whether 
these compounds could facilitate transmembrane bicarbonate/chloride exchange. 
Chloride-loaded vesicles were suspended in a sulfate-containing medium. After 2 
minutes, a solution of bicarbonate was added and chloride efflux was monitored over an 
additional 5 minutes. At the end of the experiment the vesicles were lysed to calibrate the 
experimental data to 100% chloride release.  The results shown in Figure 4.16 confirmed 
that negligible chloride efflux was detected in the presence of sulfate as the external 
anion. Addition of bicarbonate to the extravesicular solution switched on chloride efflux 
in the presence of 4.1-4.4, indicating that these compounds enable chloride/bicarbonate 
antiport across liposomal membranes. As was observed for Cl-/NO3- exchange, 
prodigiosin 4.1 (at 0.04 % molar carrier to lipid) was more efficient than synthetic 



















Figure 4.16.  Chloride efflux promoted upon addition of 4.1 (♦) (0.04 mol% carrier-to-
lipid ratio) and 4.2 (■), 4.3 (▲), 4.4 (●) (1 mol% carrier-to-lipid ratio) to unilamellar 
POPC vesicles loaded with 451 mM NaCl, 20 mM phosphate buffer (pH 7.2) dispersed in 
150 mM Na2SO4, 20 mM phosphate buffer (pH 7.2).  At t = 120 s a solution of NaHCO3 
was added to give a 40 mM external concentration.  At t = 420 s the vesicles were lysed 
by addition of detergent and the final reading at t = 540 s was considered to equal 100% 
chloride efflux.  a) In the presence of the carrier compounds 4.1-4.4 chloride was not 
released from the vesicles when suspended in a sulfate solution.  b) Upon introduction of 
bicarbonate to the solution, chloride efflux began as one component of the 






Under the assay conditions described above, addition of bicarbonate induced 
small changes (~0.2 units) in the pH of the external medium.  Control experiments in the 
presence of compounds 4.1-4.4 were therefore carried out to eliminate the possibility that 
chloride efflux was driven by a pH gradient. Addition of NaOH to the external medium 
resulted in no significant chloride efflux.  Furthermore, addition of bicarbonate solutions 
to a suspension of vesicles in the absence of transporters 4.1-4.4 resulted in no chloride 
efflux. 
 
4.8.4 Direct Evidence for Transmembrane HCO3-/Cl- Exchange from NMR 
Spectroscopy. 
The NMR experiments described in this section were carried out by the author. 
The experiments depicted in Figure 4.16 provided strong, yet indirect, evidence that 
transporters 4.1-4.4 move bicarbonate across lipid membranes.  Thus to obtain direct 
evidence for transmembrane bicarbonate transport, 13C NMR spectroscopy was used to 
verify that transporters 4.1-4.4 facilitate transmembrane HCO3-/Cl- exchange.  
Experiments that use paramagnetic Mn2+ to bleach the 13C NMR signal for extravesicular 
H13CO3-, allowing for discrimination of extravesicular and intravesicular H13CO3- were 
developed.  The rationale for these paramagnetic NMR protocols were based on previous 
experiments that: 1) monitored transmembrane chloride transport in liposomes by 35Cl 
NMR,45, 46 and 2) showed that intracellular and extracellular H13CO3- could be 
distinguished in plant cells.245, 246  Figure 4.17 shows data from the first set of NMR 
experiments conducted to illustrate transporter-mediated HCO3-/Cl- exchange.  These 
NMR experiments were done under similar conditions as described for the Cl- electrode 
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experiments in Figure 4.16.  Thus, EYPC liposomes (5 µm) filled with 450 mM NaCl 
were suspended in a 150 mM sulfate solution and 50 mM H13CO3- was added to the 
NMR sample.  A sharp 13C NMR signal for extravesicular H13CO3- was observed at δ = 
161 ppm.  Upon addition of 0.5 mM Mn2+, this signal was broadened into the baseline as 
the paramagnetic cation interacted with extravesicular bicarbonate.  After addition of 
transporters (prodigiosin 4.1 in Figure 4.17a and isophthalamide 4.4 in Figure 4.17b), a 
sharp 13C NMR signal for H13CO3- (δ ~161 ppm) was restored.  This renewed 13C NMR 
signal must be caused by ligand-mediated transport of HCO3- into the liposome since the 
paramagnetic Mn2+ is impermeable to the phospholipid bilayer.  Importantly, the control 
experiment in which DMSO was added without transporter did not result in any 
restoration of 13C NMR signal (Figure 4.17c).  Compound 4.2 behaved similarly to 4.1 
and 4.4 when tested in this same assay. 

































Figure 4.17. Representation of titration sequence and 13C NMR data (a-c) for monitoring 
transmembrane transport of HCO3- into Cl--loaded EYPC liposomes by 4.1 and 4.4: i) a 
NaH13CO3 pulse (50 mM) was added to EYPC vesicles loaded with 450 mM NaCl, 20 
mM HEPES (pH 7.3) and dispersed in 150 mM Na2SO4, 20 mM HEPES (pH 7.3); ii) 
NMR spectra after addition of 0.5 mM Mn2+ (1:100 Mn2+/H13CO3- ratio); iii) NMR 
spectra after addition of transporter or DMSO (4.1 – 0.1 mol%, 4.4 – 1 mol% relative to 
lipid, or DMSO – 403 mol%).  Experiments conducted by the author. 
 
 Data from another NMR experiment designed to verify transporter-mediated 
HCO3-/Cl- exchange is shown in Figure 4.18.  In these experiments bicarbonate efflux 
from vesicles loaded with H13CO3- upon addition of transporters 4.1 or 4.4 was 
monitored.  Thus, EYPC vesicles filled with H13CO3- and suspended in Na2SO4 solution 
were aged overnight at 4 ºC.  Two 13C NMR signals separated by 1 ppm (δ ~162 and 
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~161 ppm) were observed, corresponding to separate signals for intravesicular and 
extravesicular H13CO3- (Figure 4.18a-c).  The observation of two separate signals for 
intravesicular and extravesicular H13CO3- was attributed to differences in the intra- and 
extravesicular chemical environment.  No leakage of H13CO3- from these vesicles 
occurred after addition of 50 mM NaCl.  A DMSO solution of the transporters was then 
added to give ligand-to-lipid ratios of 0.1 mol % for 4.1 or 1 mol % for 4.4.  These 
transporters promote Cl-/H13CO3- exchange, as confirmed by observation of only the 
NMR signal for extravesicular H13CO3- (Figure 4.18a/b).  After addition of 0.5 mM 
Mn2+ (1:100 Mn2+/ H13CO3-), this H13CO3- signal was broadened into the baseline, 
confirming that all of the intravesicular H13CO3- ions had been exchanged into the 
extravesicular milieu (Figure 4.18a/b).  A control experiment confirmed this 
interpretation (Figure 4.18c).  Thus, after addition of DMSO, the separate signals for 
intravesicular and extravesicular H13CO3- remained unchanged.  Addition of Mn2+ to this 
control sample erased the extravesicular H13CO3- signal, whereas the intravesicular 
H13CO3- signal remained intact since Mn2+ cannot cross the lipid membrane. 
 In order to rule out a Na+/HCO3- co-transport mechanism, another experiment 
similar to that depicted in Figure 4.18 but in which the order of addition of carrier and 
Cl- pulse were reversed was conducted.  No leakage of H13CO3- from these vesicles 
occurred after addition of a DMSO solution of the transporters.  Additionally, a shift in 
the bicarbonate signal only occurred after the addition of NaCl, thus establishing that 
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Figure 4.18. Representation of the titration sequence and NMR stack plots (a-c) for 
monitoring the transmembrane transport of HCO3- ions in H13CO3--loaded EYPC 
liposomes by 4.1 and 4.4. A 50 mM NaCl pulse was added to EYPC vesicles loaded with 
100 mM NaH13CO3, 20 mM HEPES buffer (pH 7.5) and dispersed in 75 mM Na2SO4, 20 
mM HEPES buffer (pH 7.3), and 13C-NMR data was acquired before (i) and after (ii) the 
Cl- pulse. NMR spectra were also collected after the addition of transporter or DMSO 
(4.1 – 0.1 mol%, 4.4 – 1 mol%, or DMSO – 870 mol% (10 µL) relative to lipid; iii), 
followed by addition of 0.5 mM Mn2+ (1:100 Mn2+/Cl- ratio; iv).  Experiments conducted 
by the author. 
 
 





 The studies in this chapter have led to the identification of “small” molecules that 
function as transmembrane bicarbonate carriers.  The ion selective electrode assays 
showed that both prodigiosin 4.1 and synthetic isophthalamides 4.2-4.4 facilitate the 
release of encapsulated chloride from POPC phospholipid liposomes in the presence of 
trigonal planar oxoanions such as nitrate and bicarbonate (Figures 4.14 and 4.16).  This 
efflux is produced via an exchange mechanism with external nitrate or bicarbonate 
anions.96, 236  Replacing nitrate with sulfate in the external medium resulted in no anion 
transport activity (Figures 4.15), as an anion exchange mechanism is not possible due to 
sulfate’s hydrophilicity.  An assay in which bicarbonate was added to the external sulfate 
medium showed that chloride transport mediated by 4.1-4.4 was restored, evidence that 
these compounds can extract the hydrophilic bicarbonate from aqueous solution into the 
interior of the phospholipid membrane, thus facilitating transmembrane HCO3-/Cl- 
exchange.  The 13C NMR assays provided direct evidence for transmembrane bicarbonate 
transport, as the intra- and extra-vesicular 13C-labelled bicarbonate populations could be 
distinguished (Figures 4.17 and 4.18). The NMR data, in combination with results from 
the Cl--selective electrode experiments, firmly establish that compounds 4.1-4.4 enable 
the transmembrane exchange of Cl-/HCO3- anions. 
 In conclusion, we have demonstrated that “small” molecules, including the natural 
product prodigiosin 4.1 and synthetic transporters 4.2-4.4, facilitate the 
chloride/bicarbonate exchange process that is typically mediated by membrane proteins 
(Section 4.4). This is the first report that prodigiosin 4.1 can catalyze 
chloride/bicarbonate antiport. This discovery may well present an alternative mechanism 
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by which prodigiosin 4.1 can influence biological systems. Furthermore, prodigiosin 4.1 
is more efficient at catalyzing Cl-/HCO3- exchange than are synthetic isophthalamides 
4.2-4.4, suggesting that the tripyrrole unit with its array of hydrogen bonding donor and 
acceptor groups may be an excellent motif on which to base the synthesis of potent 
bicarbonate receptors and transporters. Such synthetic bicarbonate/chloride antiporters 






Chapter 5: Future Directions 
 As discussed in Chapters 1 and 2, the majority of synthetic anion transporter 
examples reported in the literature are Cl- transporters, and the number continues to 
grow.26, 49, 50, 53  The earlier contributions from the Davis group toward anion transport 
chemistry have also been focused on Cl- transport.  In Chapter 2, I discussed our 
contributions to achieving transmembrane Cl- transport using lipophilic calixarenes fixed 
in the cone conformation.  TAC-OH 2.3 was identified as a compound whose Cl- 
transport activity is gated by pH.  The mechanism by which TAC-OH 2.3 gates Cl- 
transport (by electrostatic repulsion – Section 2.7.4) is similar to that described for the 
natural ClC chloride channel.  The natural ClC chloride channel gates the conduction of 
Cl- ions through its pore by the protonation and deprotonation of a glutamic acid residue 
at the entrance of its selectivity filter (Section 1.4.1.3).31  The studies described in 
Chapters 3 and 4 represent our initial efforts at venturing into a broader based study of 
the transmembrane transport of anions other than Cl- by synthetic molecules.   
Highlighted in Chapter 3 are the efforts that led to our discovery of nitro tripod 3.1, a 
receptor with affinity for both Cl- and NO3- anions, but which only transports NO3- ions 
by an H+/NO3- symport (or corresponding OH-/NO3- antiport) mechanism.  We are 
especially interested in developing synthetic receptors and transporters for the 
biologically important, but under-studied bicarbonate anion.  Despite the important role 
of bicarbonate in numerous biological processes, as well as the implication of its 
dysregulated transport across membranes in various diseases,4 little is known about 
synthetic receptors and transporters for the particular anion.  Thus, in Chapter 4, I 
described our initial efforts at identifying non-protein, small molecule receptors and 
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transporters for bicarbonate.  The transport of bicarbonate anion across liposomal 
membranes was achieved using the natural product prodigiosin 4.1 and synthetic 
isophthalamides 4.2-4.4.  Compounds 4.1-4.4 transport HCO3- via an anion exchange 
mechanism (Cl-/HCO3- antiport) much like Cl-/HCO3- anion exchanger proteins.1   
 While prodigiosin 4.1 is known to transport anions via a carrier mechanism,236 the 
mechanism of anion transport (carrier vs. channel mechanism) by synthetic transporters 
2.3, 3.1 and 4.2-4.4 have not been clearly elucidated.  Since these synthetic transporters 
are too small to span the bilayer membrane as unimolecular channels, it is necessary to 
determine whether they function as discrete entities (carriers) or as membrane-spanning 
aggregates (channels).  Elucidation of the anion transport mechanism (carrier vs. channel 
mechanism) may be achieved using various liposomal assays or the voltage clamp 
experiment.   
 As mentioned before, cystic fibrosis (CF) is caused by the dysregulation of both 
chloride and bicarbonate transport.  Since the ultimate goal for the design of synthetic 
anion transporters is their use as potential therapeutic agents, or as building blocks for 
potential therapeutics, transporters 2.3 and 4.1-4.4 may be useful as tools to study disease 
models.  Therefore, evaluation of transport activities in CF epithelial cells would be 
informative as to the therapeutic potential of these compounds.  Transport studies in cells 
would also allow comparison of the efficacy of compounds 2.3 and 4.1-4.4 with other 
small molecules known to restore the expression and function of CF mutants.   
 Compounds 4.1-4.4 are anion-selective, but not bicarbonate-specific, thus the 
need to identify new bicarbonate-specific receptors/transporters remains. The use of 
reversible, covalent binding of bicarbonate may allow such selectivity to be achieved.  
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Reversible, covalent binding of bicarbonate can be achieved by exploiting the reaction of 
trifluoroacetophenone (TFA) with carbonate and bicarbonate.247, 248 Carbonate anions 
react with the TFA moiety to give stable tetrahedral alkoxides.  Ahn and coworkers 
showed that an NH amide group, when located in the neighbouring α-position of a TFA 
unit, stabilizes the alkoxide intermediate via intramolecular H-bonding and shifts the 
equilibrium toward the tetrahedral TFA-anion adduct (Figure 5.1).249  TFA carriers 
should not interact with chloride anion, since Cl- is less basic and less nucleophilic than 
HCO3- anion.  Hence, TFA-based systems may allow the uncoupling of Cl-/HCO3- 
antiport processes by using a different carrier for each anion.  Compound 5.1 is proposed 
as a possible design for such TFA-based bicarbonate transporters using Smith’s 
phospholipid design (Chart 5.1).  The phospholipid design is particularly attractive for 
the ease of synthesis (receptor 5.1 can be obtained in 3-4 synthetic steps). 250  Comparison 
of 5.1 to a compound such as 5.2 should provide insight as to whether the phospholipid 
anchor group in 5.1 is necessary.  In addition, comparison of 5.1 to Smith’s original 
design (compound 1.5 in Section 1.6.1.2), which lacks the trifluoroacetophenone moiety 
may provide insight into the efficacy of the TFA unit for HCO3- recognition and 






















a) b)  
Figure 5.1. a) Covalent capture strategy for bicarbonate binding by a TFA-substituted 
phenylacetamide scaffold. b) The [TFA-HCO3]- adduct is stabilized by intramolecular 


























 Steroidal scaffolds may also be explored as organizing elements for the TFA 
anion recognition unit in phospholipid membranes.251  The steroidal design is especially 
attractive as both carrier-type and membrane-spanning transporters may be prepared. 59, 88, 
252  Cholic acid or 7-deoxycholic acid may be used to access carriers such as 5.3 and 5.4 
(Chart 5.2).  Deoxycholic acid may provide access to less sterically-crowded carriers. 
The influence of the anchoring group on membrane insertion and partition may also be 
studied with steroid-TFA adduct 5.5, an amide analog of 5.4.  The transport activities of 
proposed stabilized adducts 5.3-5.5 may be compared to that of known, non-stabilized 
5.6.251  Membrane-spanning steroid-TFA adducts such as 5.7 may also be studied for 
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transmembrane bicarbonate transport.  The steroid-TFA dimer may serve as a shuttle for 
HCO3- translocation across the membrane as depicted in Figure 5.2.  This dimer design 
may be a versatile way to achieve HCO3- transport as well as gain access to fluorescent 
sensors for the anion.  Compounds such as 5.7 may also be useful for probing the 
orientation of the steroid dimers in the bilayer membrane, a phenomenon that evades 
definitive characterization in some recently reported steroidal channels.88, 252  Finally, the 
anthracene-TFA adduct 5.8 recently reported by Ahn and coworkers, as a sensor for α-
amino carboxylates, may serve as a standard for quantifying the activity of fluorescent 










































































































































































Figure 5.2. Proposed transport of HCO3- by a cholate-TFA channel across the membrane. 
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Chapter 6: Experimental Procedures and References 
6.1 General Experimental. 
 All 1H NMR spectra were recorded on a Bruker DRX-400, a Bruker Avance 400 
instrument operating at 400.13 MHz, or a Bruker DRX-500 operating at 500.13 MHz, or 
on a Bruker DRX-600 operating at 600.13 MHz.  The 13C NMR spectra were recorded on 
a Bruker DRX-400 instrument operating at 100.52 MHz, or a Bruker DRX-500 
instrument operated at 125.77 MHz.  Chemical shifts are reported in ppm relative to the 
residual protonated solvent peak. Electrospray ionization (ESI) mass spectra were 
recorded on a JEOL AccuTOF-CS es-tof instrument with an Agilent 1100 HPLC 
interface. Deuterated solvents were purchased from Cambridge Isotope laboratories. 
Lucigenin and HTPS dyes were purchased from Molecular Probes. EYPC lipids, 
Nuclepore polycarbonate membranes and membrane supports were purchased from 
Avanti Polar Lipids. All other chemicals and solvents were purchased from Sigma, 
Aldrich, Fisher, Fluka, or Acros and used without further purification. EYPC fluorimetric 
assays were performed using a Hitachi F-4500 spectrophotometer with cuvette 
temperature maintained by a water bath circulator at 25 ºC (+/- 0.2 oC). The pH of 
solutions was monitored with a Fisher Scientific AR25 dual channel pH/ion meter. 
Chromatography was performed using 60-200 mesh silica purchased from Baker, or 
Sephadex G-25 purchased from Aldrich. Thin layer chromatography was performed on 
UniplateTM Silica Gel GF silica-coated glass plates and visualized with a UV lamp, or by 
staining with iodine or an aqueous solution of ceric ammonium molybdate (CAM). All 
solvents were dried and distilled following standard procedures.  Paco-H 2.16 and cone-
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tBu 2.2b123, 124 were prepared as previously reported from the corresponding partial cone 
or cone tetra-esters respectively, by: i) hydrolysis to the tetra-acid; ii) activation to the 
acid chloride; and iii) amide bond formation.  Both compounds were confirmed by 1H 
and 13C NMR.  Calixarene 2.14,126, 127 2-bromo-N-butylacetamide 2.15,254 n-butyl-2-
bromoacetate 2.16,255 tris-p-nitrophenol 3.14,187 and tris-tBu-phenol 3.15184 were 
prepared following published methods. All synthesis were carried out under an inert 
atmosphere (N2 gas).  Prodigiosin 4.1 was a gift from the Developmental Therapeutics 
Program at the National Cancer Institute, US National Institutes of Health, and confirmed 
by 1H and 13C NMR, and ESI-MS. X-ray crystal structures were obtained on a Bruker 
Smart1000 diffractometer with CCD area detector by Dr. Peter Y. Zavalij. 
 
6.2 Experimental Procedures for Chapter 2. 
6.2.1 Synthetic Procedures. 
25,26,27,28-tetrakis(2-butylamidomethoxy)calix[4]arene (cone-H 2.2a).  Cone 
25,26,27,28-tetrakis-(ethylacetylmethoxy)calix[4]arene 2.12 (275 mg, 0.36 mmol), 
prepared according to the literature,125 and 1 mL of 45 % aqueous KOH were stirred in 6 
mL of methanol/THF (1:1) at room temperature (rt) for 14 h. The solvent was evaporated 
under reduced pressure. The resulting solid was dissolved in a minimum amount of 
water, acidified with 6 N HCl and the water removed under reduced pressure. The 
material was dissolved in acetone, solid KCl was removed by filtration and acetone was 
then evaporated to give the tetra-acid as a white solid. The acid chloride was prepared by 
stirring a solution of the calixarene tetraacid 2.13 (565 mg, 0.85 mmol) in 20 mL of 
benzene with 5.1 mL of SOCl2. The reaction mixture was heated at reflux for 2.5 h and 
 153 
 
then concentrated under reduced pressure. The sticky brown solid was dried in vacuo for 
1 h and then dissolved in 20 mL of CH2Cl2. N-Butylamine (1.32 mL, 16 eq.) was added 
dropwise to the stirring solution at room temperature. Triethylamine (1.2 mL, 10 eq.) was 
then added dropwise and the reaction stirred under N2 for 12 h at rt. The solvent was 
evaporated and the resulting solid partitioned between CHCl3 and H2O. The organic layer 
was dried with sodium sulfate and evaporated. Pure 2.2a (332 mg, 44.5% yield from the 
tetra-ester) was obtained after silica gel chromatography with 3% MeOH–CH2Cl2. 1H 
NMR (400 MHz, CDCl3) δ: 7.34 (broad s, 4H, CONHCH2), 6.62–6.59 (m, 12H, ArH), 
4.50 (d, J = 13.9 Hz, 4H, ArCH2Ar), 4.43 (s, 8H, ArOCH2CO), 3.34 (q, J = 6.6 Hz, 8H, 
CONHCH2), 3.24 (d, J = 14.0 Hz, 4H, ArCH2Ar), 1.59–1.52 (m, 8H, NHCH2CH2), 1.37–
1.29 (m, 8H, NH(CH2)2CH2), 0.91 (t, J = 7.3 Hz, 12H, NH(CH2)3CH3). 13C NMR (100 
MHz, CDCl3) δ: 170.0, 156.3, 134.7, 129.3, 123.7, 74.5, 39.6, 32.0, 31.4, 20.6, 14.2. 
Mass calculated for C52H68N4O8: 876.504. Mass found (+)-ESI-MS: 877.513 (M + H+); 
899.477 (M + Na+).  
 
25,26,27,28-Tetrakis(hydroxy)calix[4]arene (2.14).126 A slurry of p-tert-
butylcalix[4]arene (1.03g, 1.59 mmol) and phenol (0.842 g, 8.94 mmol) in toluene (30 
mL) was stirred under N2 for 0.5 h. Then, AlCl3 (1.29 g, 9.69 mmol) was added and the 
reaction left to stir for 2 d at rt. The reaction was quenched with 0.2 N HCl (35 mL), the 
solvent removed in vacuo and MeOH (7 mL) added at which point a precipitate formed. 
The precipitate was filtered to yield crude 2.14, which crude was then purified by 
recrystallization (2% MeOH–CHCl3) to give pure 2.14 (0.337 g, 50%) as transparent 
crystals. M.p. 297-300 oC.  1H NMR (400 MHz, CDCl3) δ: 10.20 (s, 4H, ArOH), 7.06 (d, 
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J = 7.6 Hz, 8H, ArH), 6.73 (t, J = 7.6 Hz, 4H, ArH), 4.27 (s, 4H, ArCH2Ar), 3.55 (s, 4H, 
ArCH2Ar). 13C NMR (100 MHz, CDCl3) δ: 149.2, 129.3, 128.8, 122.7, 32.2. Mass 
calculated for C28H24O4: 424.167. Mass found (+)-ESI-MS: 425.229 (M + H+); 463.051 
(M + K+). 
 
25-Hydroxy-26,27,28-tris(2-butylamidomethoxy)calix[4]arene (TAC-OH 2.3).256 A 
solution of calixarene 2.14 (0.804 g, 1.89 mmol), Ba(OH)2 (1.79 g, 5.67 mmol) and BaO 
(1.69 g, 11.0 mmol) in DMF (15 mL) was stirred at 40 ºC for 1 h under N2 gas. A 
solution of 2-bromo-N-butylacetamide 2.15 (1.10 g, 5.67 mmol) in DMF (5 mL) was then 
added dropwise and the mixture stirred for 4 h. The mixture was diluted with CH2Cl2 (60 
mL), washed with 0.2 N HCl (3 x 30 mL) and H2O (3 x 30 mL), and dried over MgSO4. 
The solvent was removed in vacuo to give a yellow residue containing TAC-OH 2.3 and 
other impurities. TAC-OH 2.3 (0.376 g, 26%) was separated from the mixture by silica 
gel chromatography (1:1 EtOAc–Hexanes) as translucent colorless flakes. M.p. 121-123 
oC. 1H NMR (400 MHz, CDCl3) δ: 7.98 (t, J = 5.4 Hz, 1H, CONHCH2), 7.27 (d, J = 7.8 
Hz, 2H, ArH), 7.16 (d, J = 7.2 Hz, 2H, ArH), 7.13 (t, J = 7.8 Hz, 1H, ArH), 7.01 (t, J = 
5.8 Hz, 2H, CONHCH2), 6.88 (t, J = 7.5 Hz, 1H, ArH), 6.47 (d, J = 7.4 Hz, 2H, ArH), 
6.44 (td, J = 7.5, 1.8 Hz, 2H ArH), 6.35 (dd, J = 7.3, 1.8 Hz, 2H ArH), 4.39 (s, 2H, 
ArOCH2CO), 4.36 (d, J = 14.9 Hz, 2H, ArOCH2CO), 4.27 (d, J = 13.6 Hz, 2H, 
ArCH2Ar), 4.19 (d, J = 14.5 Hz, 2H, ArCH2Ar), 4.15 (d, J = 14.8 Hz, 2H, ArOCH2CO), 
3.75 (s, 1H, ArOH), 3.43 (d, J = 14.4 Hz, 2H, ArCH2Ar), 3.35 (d, J = 13.5 Hz, 2H, 
ArCH2Ar), 3.28–3.49 (m, 6H, NHCH2CH2), 1.49–1.64 (m, 6H, NHCH2CH2), 1.33–1.43 
(m, 4H, NH(CH2)2CH2), 1.24–1.33 (m, 2H, NH(CH2)2CH2), 0.93 (t, J = 7.3 Hz, 6H, 
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NH(CH2)3CH3), 0.75 (t, J = 7.3 Hz, 3H, NH(CH2)3CH3). 13C NMR (100 MHz, CDCl3) δ: 
169.1, 168.4, 155.1, 153.6, 152.5, 136.5, 132.9, 132.8, 131.4, 130.8, 129.4, 129.3, 128.7, 
125.4, 125.0, 121.2, 75.1, 74.7, 40.2, 39.6, 32.2, 31.6, 31.2, 30.6, 20.8, 20.6, 14.2, 14.0. 
Mass calculated for C46H57N3O7: 763.420. Mass found (+)-ESI-MS: 764.477 (M + H+); 
786.462 (M + Na+). 
 
25-(2-Butoxycarbonylmethoxy)-26,27,28-tris(2-butylamidomethoxy)calix[4]arene 
(TAC-Ester 2.4).257  A solution of TAC-OH 2.3 (0.100 g, 0.13 mmol), Cs2CO3 (0.43 g, 
1.32 mmol) in DMF (6 mL) was stirred at 70 ºC for 10 min under N2 gas. A solution of 
butyl-2-bromoacetate 2.16 (0.255 g, 1.31 mmol) in DMF (4 mL) was then added 
dropwise and the mixture stirred for 24 h. After 24 h, the reaction mixture was cooled to 
room temperature, and then quenched with 1.0 M HCl (10 mL). The aqueous mixture 
was extracted with CH2Cl2 (3 x 10 mL) and the resulting organic layer washed with 
distilled H2O (4 x 15 mL), dried over MgSO4 and the solvent was removed in vacuo. The 
residue was subsequently purified by silica gel chromatography (1:1 EtOAc–Hexanes) to 
give compound 2.4 as a white solid. Yield 45%; 1H NMR (400 MHz, CDCl3) δ: 7.91 (t, 
2H, CONHCH2), 6.88–6.77 (m, 7H, ArH; CONHCH2), 6.74 (t, J = 7.5 Hz, 2H, ArH), 
6.32 (d, J = 7.5 Hz, 4H, ArH), 4.77 (s, 2H, ArOCH2CO2), 4.59 (d, J = 14.0 Hz, 2H, 
ArOCH2CONH), 4.44 (d, J = 14.0 Hz, 4H, ArCH2Ar), 4.44 (s, 2H ArOCH2CONH), 4.31 
(d, J = 14.6 Hz, 2H, ArOCH2CONH), 4.13 (t, J = 6.8 Hz, 2H, CO2CH2), 3.45–3.34 (m, 
6H, NHCH2), 3.26 (dd, J = 14.0, 4.5 Hz, 4H, ArCH2Ar), 1.65–1.57 (m, 6H, NHCH2CH2), 
1.51–1.45 (m, 2H, CO2CH2CH2), 1.42–1.32 (m, 6H, NH(CH2)2CH2), 1.31–1.24 (m, 2H, 
CO2(CH2)2CH2), 0.93 (t, J = 7.4 Hz, 6H, NH(CH2)3CH3), 0.92 (t, J = 7.3 Hz, 3H, 
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NH(CH2)3CH3), 0.90 (t, J = 7.7 Hz, 3H, CO2(CH2)3CH3). 13C NMR (100 MHz, CDCl3) δ: 
171.6, 169.6, 169.5, 155.3, 135.5, 135.3, 133.8, 133.5, 129.9, 129.0, 128.7, 123.9, 123.6, 
123.5, 78.1, 74.6, 71.9, 65.4, 39.7, 39.5, 39.4, 32.3, 32.1, 31.4, 31.3, 31.0, 30.1, 20.7, 
20.5, 19.5, 14.3, 14.2, 14.1. Mass calculated for C52H67N3O9: 877.488. Mass found (+)-
ESI-MS: 878.507 (M + H+); 900.480 (M + Na+); 1014.549 (M + Ba2+). 
 
2-bromo-N-butylacetamide (2.15).254  To a solution of n-butylamine (2.28 g, 31.2 
mmol) in CH2Cl2 (20 mL) at -35 oC, bromoacetyl bromide (3.00g, 14.9 mmol) in CH2Cl2 
(10 mL) was added dropwise. The reaction mixture was allowed to stir for 1 h at -35 oC 
after which the cold-bath was removed and the mixture allowed to warm up to rt. The 
reaction was quenched with 0.2 N HCl (20 mL) and the organic layer washed with brine 
(20 mL) and dried over MgSO4. The solvent was removed in vacuo and the resulting 
crude product purified by column chromatography (2% MeOH–CH2Cl2) to yield 2.15 
(2.28 g, 79%) as white flakes. M.p. 32-34 ºC (lit. 30-33 ºC).258  1H NMR (400 MHz, 
CDCl3) δ: 6.50 (br s, 1H, CONHCH2), 3.92 (s, 2H, BrCH2CO), 3.32 (q, J = 5.9 Hz, 2H, 
NHCH2CH2CH2), 1.56 (m, 2H, CH2CH2CH2CH3), 1.40 (m, 2H, CH2CH2CH3), 0.97 (t, J 
= 7.3 Hz, 3H, CH2CH3). 13C NMR (100 MHz, CDCl3) δ: 165.6, 40.4, 31.7, 29.8, 20.4, 
14.1. Mass calculated for C6H12BrNO: 193.010. Mass found (+)-ESI-MS: 215.235 (M + 
Na+). 
 
Butyl-2-bromoacetate (2.16).255 Compound 2.16 was synthesized according to literature 
procedure with slight modifications.  Briefly, to a stirred solution of triethylamine (4.8 
mL, 3.47 g, 34.3 mmol), n-butanol (2.1 mL, 1.70 g, 22.9 mmol) and dichloromethane (30 
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mL) at -78 °C under a nitrogen atmosphere was added dropwise bromoacetyl bromide 
(2.0 mL, 4.62 g, 22.9 mmol). After stirring at -78 °C for 3 h the reaction mixture was 
allowed to warm up to rt.  A white precipitate that had formed was filtered off.  The 
organic layer was then washed with 0.2 N HCl (2 x 45 mL) and distilled water (2 x 50 
mL), and then dried over magnesium sulfate and filtered.  The excess solvent (CH2Cl2) 
was removed in vacuo to obtain a dark orange liquid.  The crude product (3.43 g, slight 
impurities by 1H NMR) was distilled under pressure to give 2.16 as a clear, colorless 
liquid in 39% yield (1.76 g, 118 mmol).  Distillate was collected under pressure at 61 ºC 
(literature b.p. is 78 ºC at 10 Torr259). 1H NMR (400 MHz, CDCl3) δ: 4.17 (t, J = 6.7 Hz, 
2H, COOCH2CH2), 3.82 (s, 2H, BrCH2CO), 1.64 (m, 2H, OCH2CH2CH2), 1.39 (m, 2H, 
OCH2CH2CH2CH3), 0.93 (t, 3H, J = 7.4 Hz, CH2CH2CH3). 13C NMR (100 MHz, CDCl3) 
δ: 167.3, 66.1, 30.4, 25.9, 18.9, 13.6.  
 
25-Butoxy-26,27,28-tris(2-butylamidomethoxy)calix[4]arene (TAC-OEther 2.17).257  
A solution of TAC-OH 2.3 (0.100 g, 0.131 mmol), and Cs2CO3 (0.43 g, 1.32 mmol) in 
DMF (6 mL) was stirred at 70 ºC for 10 min under N2. A solution of n-butyl bromide 
(141 µL, 0.179 g, 1.31 mmol) in DMF (4 mL) was then added dropwise and the mixture 
stirred for 24 h. After 24 h, the reaction mixture was cooled to room temperature, and 
then quenched with 1.0 M HCl (10 mL). The aqueous mixture was extracted with CH2Cl2 
(3 x 10 mL) and the resulting organic layer washed with distilled H2O (4 x 15 mL), dried 
over MgSO4, and the solvent was removed in vacuo. The residue was subsequently 
purified by silica gel chromatography (1:1 EtOAc–Hexanes) to give compound 2.17 as a 
transparent film in 17% yield . 1H NMR (400 MHz, CDCl3) δ: 7.70 (t, 1H, CONHCH2), 
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6.98 (t, J = 5.8 Hz, 2H, CONHCH2), 6.86 – 6.81 (m, 4H, ArH), 6.79 (t, J = 7.3 Hz, 2H, 
ArH), 6.46 (t, J = 7.7 Hz, 1H, ArH), 6.45 (t, J = 7.8 Hz, 1H, ArH), 6.35 (d, J = 7.5 Hz, 
2H, ArH), 6.30 (d, J = 7.6 Hz, 2H, ArH), 4.62 (d, J = 14.5 Hz, 2H, ArOCH2CO), 4.51 (d, 
J = 13.9 Hz, 2H, ArCH2Ar), 4.43 (d, J = 14.6 Hz, 2H, ArOCH2CO), 4.39 (s, 2H, 
ArOCH2CO), 4.38 (d, J = 13.9 Hz, 2H, ArCH2Ar), 3.88 (t, J = 7.7 Hz, 2H, ArOCH2CH2), 
3.39 (q, J = 7.2 Hz, 2H, CONHCH2), 3.33 (q, J = 7.3 Hz, 4H, CONHCH2), 3.26 (dd, J = 
14.0, 7.5 Hz, 4H, ArCH2Ar), 1.80–1.73 (m, 2H, ArOCH2CH2), 1.64–1.46 (m, 4H, 
NHCH2CH2; 2H, ArO(CH2)2CH2), 1.41–1.28 (m, 8H, NH(CH2)2CH2), 0.95 (t, J = 7.4 
Hz, 3H, ArO(CH2)3CH3), 0.93 (t, J = 7.4 Hz, 3H, NH(CH2)3CH3), 0.92 (t, J = 7.3 Hz, 6H, 
NH(CH2)3CH3). 13C NMR (100 MHz, CDCl3) δ: 169.9, 169.1, 157.1, 155.5, 155.1, 135.2, 
134.1, 133.6, 130.0, 129.6, 129.1, 128.7, 123.8, 123.4, 123.3, 76.0, 74.7, 74.3, 39.6, 32.3, 
32.3, 32.1, 31.8, 31.5, 30.1, 20.7, 20.6, 19.6 14.5, 14.3, 14.2. Mass calculated for 











6.2.2 Experimental Details. 
X-ray Crystallographical Data for TAC-OH 2.3.  Crystals were obtained by slow 
evaporation of a CD2Cl2 solution of TAC-OH 2.3, and the structure (Figure 6.1) was 
solved by Dr. Peter Y. Zavalij.  Table 6.1 shows crystal data and structure refinement 
parameters for TAC-OH 2.3.  Detailed crystallographic data and the structure report for 
UM1507 (TAC-OH 2.3) can be obtained from the Department of Chemistry and 
Biochemistry, University of Maryland, College Park, MD 20742. 
 
 
Figure 6.1. A view of TAC-OH 2.3 showing the anisotropic atomic displacement 
ellipsoids for non-hydrogen atoms at the 30% probability level. Hydrogen atoms are 









Table 6.1. Crystal data and structure refinement for TAC-OH 2.3.  
  Empirical formula C46H57N3O7 
  Formula weight 763.95 
  Temperature 220(2) K 
  Wavelength 0.71073 Å 
  Crystal size 0.55 × 0.31 × 0.04 mm3 
  Crystal habit colorless plate 
  Crystal system Monoclinic 
  Space group C2/c 
  Unit cell dimensions  a = 42.366(10) Å          α = 90° 
 b = 9.966(2) Å              β = 95.517(5)° 
 c = 18.799(4) Å            γ = 90° 
  Volume 7901(3) Å3 
  Z 8 
  Density, ρcalc 1.284 g/cm3 
  Absorption coefficient, µ 0.086 mm-1 
  F(000) 3280⎯e  
  Radiation source fine-focus sealed tube, MoKα 
  Generator power 50 kV, 40 mA  
  Detector distance 4.950 cm  
  Detector resolution 8.33 pixels/mm  
  Total frames 1012  
  Frame size 512 pixels  
  Frame width 0.3 ° 
  Exposure per frame 38 sec 
  Total measurement time 12.7 hours 
  Data collection method ω scans  
  θ range for data collection 2.30 to 22.50° 
  Index ranges -45 ≤  h ≤  45, -10 ≤  k ≤  10, -20 ≤  l ≤  18  
  Reflections collected 12468 
  Independent reflections 5131 
  Observed reflection, I>2σ(I) 1966 
  Coverage of independent reflections 99.2 % 
  Variation in check reflections 0 % 
  Max. and min. transmission 0.997 and 0.942 
  Function minimized Σw(Fo2 - Fc2)2  
  Data / restraints / parameters 5131 / 733 / 590 
  Goodness-of-fit on F2 1.070 
  ∆/σmax 0.000 
  Final R indices: R1,   I>2σ(I) 0.0970 
                             wR2, all data 0.2160 
                             Rint; Rsig 0.0512; 0.0854 
   Weighting scheme w = 1/[σ2(Fo2) + (0.02P)2 + 31.75P], 
 P = [max(Fo2 ,0) + 2Fo2]/3  
  Largest diff. peak and hole  0.270 and -0.254⎯e/Å3    







X-ray Crystallographical Data for TAC-OEster 2.4. Crystal data for TAC-OEster 2.4: 
C52H67N3O9, Mr 878.09, crystal dimensions 0.35 x 0.16 x 0.12 mm3, monoclinic, 
space group P21/c, a = 13.6215(18) Å, b = 19.208(2) Å, c = 19.424(3) Å, V= 4984.0(11) 
Å3, Z = 4, ρcalcd = 1.170 g/cm3, MoKα 0.071 mm-1. The structure refined to 
convergence [∆/σ ≤ 0.001] with R(F) = 5.53%, wR(F2) = 12.91%, GOF = 0.814 for all 
5,489 unique reflections. Crystallographic data for the structure of TAC-OEster 2.4 
reported in this thesis have been published,118 and deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication # CCDC-649436. Copies of 
the data can be obtained free of charge on application to CCDC, 12 Union Road, 
Cambridge CB21EZ, UK. E-mail: deposit@ccdc.cam.ac.uk. 
 
1H NMR Titrations for TAC-OH 2.3.  A stock solution of TAC-OH 2.3 (2.0 mM) in 
CD2Cl2 was prepared and divided into nine NMR tubes (300 µL solutions). Stock 
solutions of the anions (tetrabutylammonium chloride (TBACl) or tetrabutylammonium 
nitrate (TBANO3)) in two different concentrations labeled solution A (50 mM) and 
solution B (4 mM) were also prepared. Aliquots of anion stock solution were then added 
to each NMR tube in increasing volumes (in µL) as follows: of solution A – 0, 60, 120, 
and 240; and of solution B – 0, 15, 30, 75, 150, and 300. This provided final anion 
concentrations of: 0, 0.1, 0.2, 0.5, 1.0, 2.0, 5.0, 10.0 and 20.0 mM, and anion:2.3 ratios 
from 0 to 20 equivalents. The total solution volume was kept constant at 600 µL (pure 
solvent (CD2Cl2) was added to make up this volume where necessary) to afford a 
constant concentration of 1.0 mM for TAC-OH 2.3. Changes in the chemical shifts of the 
amide protons of TAC-OH 2.3 were then monitored by NMR (400 MHz, 25 ºC) and the 
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titration curves fit to the 1:1 binding model using the Associate 1.6 Copy software for 
bimolecular association constant determination by non-linear regression analysis of 
spectroscopic data. 
 
Preparation of EYPC Liposomes for Lucigenin Assays.  Large unilamellar vesicles 
(LUVs) were prepared using egg-yolk phosphatidylcholine (EYPC) lipid.  EYPC lipid 
(60 mg) was dissolved in 5 mL of chloroform/methanol. The resulting solution was 
evaporated under reduced pressure to give a thin film that was dried in vacuo overnight. 
The lipid film was then rehydrated with a phosphate buffer solution containing 1 mM 
lucigenin dye (10 mM sodium phosphate, pH 6.4; 100 mM NaNO3) to give a 60 mg/mL 
solution of lipid.  After 10 freeze/thaw cycles, the liposomes were extruded through a 100 
nm polycarbonate membrane at least 21 times at rt using a high-pressure mini-extruder 
(Avanti Lipids).  The resulting liposome solution was passed through a Sephadex (G-25) 
column to remove excess dye (eluant, sodium phosphate buffer, pH 6.4, 100 mM 
NaNO3). The isolated liposomes were diluted to give a concentration of 25 mM in EYPC, 
assuming 100% retention of lipid during the gel filtration process.  
 
Chloride Transport Assay in Liposomes.  In a typical experiment, 50 µL of the stock 
EYPC liposomes was diluted into 2 mL of 10 mM sodium phosphate (pH 6.4, 100 mM 
NaNO3) to give a solution that is 0.5 mM in lipid. Compounds 2.1–2.4 were added to 
give a 2:100 ligand-to-lipid ratio. To the cuvette containing the EYPC-transporter 
mixture was added 20 µL of 2.425 M NaCl solution through an injection port, after 15 s, 
to give an external Cl- concentration of 24 mM. Intravesicular Cl- concentration was 
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monitored as a function of lucigenin fluorescence. The fluorescence of lucigenin was 
monitored at 372 nm and emission at 503 nm for 300 s. The cuvettes were kept at 25 °C 
during the experiment with a constant water temperature bath. After 270 s, 40 µL of 10 % 
Triton-X detergent was added to lyse the liposomes. Experiments were done in triplicate 
and all traces reported are the average of the three trials. Lucigenin fluorescence was 
converted to chloride concentration using the Stern-Volmer constant determined under 
the assay conditions.189 The Stern-Volmer constant was determined by taking the slope of 
a plot of fo/f vs. chloride concentration, where fo is the normalized lucigenin fluorescence 
in the absence of Cl-, and f the normalized fluorescence in the presence of Cl-. A typical 
Stern-Volmer calibration curve is shown in Figure 6.2.  Figure 6.3 shows the rate of Cl- 
transport by TAC-OBu 2.10 compared to TAC-OAcBu 2.4. 
 













Figure 6.2. A standard fo/f vs. [Cl-] calibration curve for calculating Ksv – the Stern-
Volmer constant.  Ksv is taken as the slope of the calibration curve (142 mM-1 in this 















Figure 6.3. Comparison of the Cl- transport activity of a butyl ether calixarene analog, 
TAC-OEther 2.17, with that of TAC-OEster 2.4, and TAC-OH 2.3 as a standard.  
 
Chloride Transport Assay in Liposomes experiencing a pH Gradient.  For the 
experiments in which transmembrane Cl- transport was modulated by pH (Figure 2.16), 
the procedure was the same as described above, except that the pH of the extravesicular 
buffer was varied from 6.4-9.0. 
 
6.3 Experimental Procedures for Chapter 3. 
6.3.1 Synthetic Procedures. 
Tris(5-nitro-2-butylamidomethoxyphenyl)methane (3.1).  Nitro tripod 3.1 was 
prepared from the known tris-p-nitrophenol intermediate 3.14 (nitrophenol 3.14 was 
prepared by Dr. Santacroce).187 A solution of 3.14 (0.100 g, 0.23 mmol) and KOH (0.041 
g, 0.73 mmol) in acetone (15 mL) was stirred for 1 h at rt. Then, 2-bromo-N-
butylacetamide (2.15; 0.14 g, 0.73 mmol) dissolved in acetone (5 mL) was added and the 


















mL) was added to the reaction mixture. This solution was washed with water (15 mL) 
and the organic layer separated. The solvent was removed in vacuo and the resulting 
crude product purified by column chromatography (5% MeOH–CH2Cl2), to yield nitro 
tripod 3.1 (0.064 g, 36%) as a yellow powder. M.p. 190-191 ºC.  1H NMR (400 MHz, 
CDCl3) δ:  8.28 (dd, J = 9.2 Hz, 2.4 Hz, 3H, ArH), 7.66 (sd, J = 2.4 Hz, 3H, ArH), 7.01 
(d, J = 9.2 Hz, 3H, ArH), 6.52 (s, 1H, ArCHAr), 5.86 (t, J = 5.6 Hz, 3H, CONHCH2), 
4.52 (s, 6H, ArOCH2CO), 3.12 (q, J = 6.4 Hz, 6H, NHCH2CH2CH2), 1.30 (m, 6H, 
CH2CH2CH2CH3), 1.21 (m, 6H, CH2CH2CH3), 0.87 (t, J = 7.2 Hz, 9H, CH2CH3). 13C 
NMR (100 MHz, CDCl3) δ: 166.8, 159.7, 141.9, 130.2, 125.2, 124.4, 112.1, 67.5, 38.9, 
38.3, 31.1, 19.7, 13.2. Mass calculated for C37H46N6O12: 766.317. Mass found (+)-ESI-
MS: 767.427 m/z (M + H+). 
 
Tris(3,5-di-tert-butyl-2-hydroxyphenyl)methane (3.15).184 A solution of 2,4-di-tert-
butylphenol (5.34 g, 25.9 mmol) and 3,5-di-tert-butyl-2-hydroxybenzaldehyde (3.03 g, 
12.9 mmol) in methanol (40 mL) was strirred for 0.5 h at 0 ºC.  Then HCl gas was 
bubbled into the mixture for 2 h at 0 ºC to give a red colored solution with concomitant 
precipitate formation. The reaction mixture was then stirred for 2 d at rt.  The precipitate 
generated was filtered and washed with cold methanol to yield 3.15 (7.39 g, 91%) as an 
off-white powder.  M.p. 260 ºC (decomposed without melting). 1H NMR (400 MHz, 
CDCl3) δ: 7.27 (d, J = 2.4 Hz, 3H, ArH), 6.66 (d, J = 2.4 Hz, 3H, ArH), 5.58 (s, 1H, 
ArCHAr), 4.77 (s, 3H, ArOH), 1.36 (s, 27H, ArC(CH3)3), 1.13 (s, 27H, ArC(CH3)3). 13C 
NMR (100 MHz, CDCl3) δ: 151.2, 143.7, 137.6, 125.7, 124.0, 123.9, 43.0, 35.4, 34.7, 
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31.8, 31.6, 30.2. Mass calculated for C43H64O3: 628.485. Mass found (+)-ESI-MS: 
629.549 (M + H+). 
 
Tris(3,5-di-tert-butyl-2-butylamidomethoxyphenyl)methane (3.2). A solution of 3.15 
(0.525 g, 0.83 mmol) and NaH (0.065 g, 2.70 mmol) in THF (15 mL) was stirred for 2 h 
at rt. At this point, 2-bromo-N-butylacetamide (2.15; 0.504 g, 2.60 mmol) dissolved in 
THF (5 mL) was added and the reaction was allowed to reflux for 8 h. The reaction 
mixture was cooled to rt at which point a precipitate formed. The precipitate was filtered 
to yield crude t-butyl tripod 3.2. The resulting crude product was purified by column 
chromatography (3% MeOH–CH2Cl2), to yield 3.2 (0.174 g, 21%) as a white powder. 
M.p. 207-209 ºC. 1H NMR (400 MHz, CDCl3) δ: 7.22 (d, J = 2.4 Hz, 3H, ArH), 7.04 (d, 
J = 2.4 Hz, 3H, ArH), 6.82 (t, J = 5.8 Hz, 3H, CONHCH2), 6.25 (s, 1H, ArCHAr), 4.15 
(s, 6H, ArOCH2CO), 3.36 (q, J = 6.4 Hz, 6H, NHCH2CH2CH2), 1.56 (m, 6H, 
CH2CH2CH2CH3), 1.38 (m, 6H, CH2CH2CH3), 1.33 (s, 27H, ArC(CH3)3), 1.18 (s, 27H, 
ArC(CH3)3), 0.94 (t, J = 7.4 Hz, 9H, CH2CH3). 13C NMR (100 MHz, CDCl3) δ: 169.0, 
151.5, 146.5, 142.3, 137.0, 126.9, 123.6, 71.8, 39.3, 38.0, 35.8, 35.0, 32.1, 31.8, 31.7, 
20.5, 14.2. Mass calculated for C61H97N3O6: 967.738. Mass found (+)-ESI-MS: 968.804 
(M + H+); 990.793 (M + Na+). 
 
6.3.2 Experimental Details. 
1H NMR Titrations for Tripods 3.1 and 3.2.  Stock solutions of the nitro and t-butyl 
tripods, 3.1 and 3.2, (3.0 mM) in CD2Cl2 were prepared and divided into nine NMR tubes 
(300 µL solutions). Stock solutions of the anions (TBACl or TBANO3) in two different 
 167 
 
concentrations labeled solution A (100 mM) and solution B (4 mM) were also prepared. 
Aliquots of anion stock solution were then added to each NMR tube in increasing 
volumes (in µL) as follows: of solution A – 0, 30, 60, 120; and of solution B – 0, 15, 30, 
75, 150, and 300. This provided final anion concentrations of: 0, 0.1, 0.2, 0.5, 1.0, 2.0, 
5.0, 10.0 and 20.0 mM, and anion:tripod ratios from 0 to 13 equivalents. The total 
solution volume was kept constant at 600 µL (pure solvent (CD2Cl2) was added to make 
up this volume where necessary) to afford a constant concentration of 1.5 mM for the 
tripods. Changes in the chemical shifts of the amide (NH) and bridgehead (CH) 
hydrogens of the tripods were then monitored by NMR (400 MHz) and the titration 
curves fit to the 1:1 binding model using the Associate 1.6 Copy software for bimolecular 
association constant determination by non-linear regression analysis of spectroscopic 
data.  Figure 6.4 shows the titration curves for nitro tripod 3.1 with Cl- and NO3- anions. 
 
     
Figure 6.4. Titration curves for Cl- (left) and NO3- (right) binding by nitro tripod 3.1, 
showing the changes in the chemical shifts of the amide (NH, orange traces) and 
bridgehead (CH, blue traces) protons.  
 






















Preparation of EYPC Liposomes for Base-Pulse Assays.  LUVs were prepared using 
EYPC lipids. EYPC lipid (60 mg) was dissolved in 5 mL of chloroform/methanol. The 
resulting solution was evaporated under reduced pressure to give a thin film that was 
dried in vacuo overnight. The lipid film was then rehydrated with appropriate phosphate 
buffer solution (10 mM sodium phosphate, pH 6.4; 100mM NaX (X = Cl- or NO3-)) 
containing fluorescent HPTS dye (0.1 mM) to give a 60 mg/mL solution of lipid.  After 
10 freeze/thaw cycles, the liposomes were extruded through a 100 nm polycarbonate 
membrane at least 21 times at rt using a high pressure mini-extruder (Avanti Lipids).  The 
resulting liposome solution was passed through a Sephadex (G-25) column to remove 
excess dye (eluant, sodium phosphate buffer, pH 6.4, 100 mM NaX (X = Cl- or NO3-)). 
The isolated liposomes were diluted to give a concentration of 25 mM in EYPC, 
assuming 100% retention of lipid during the gel filtration process.  
 
Base-Pulse Liposome Transport Assays (Figures 3.12 and 3.14).  The base pulse 
assays with HPTS were carried out as previously reported.5, 98  In a typical experiment, 50 
µL of the stock EYPC liposomes was diluted into 2 mL of 10 mM sodium phosphate (pH 
6.4, 100 mM NaNO3) to give a solution that is 0.5 mM in lipid. Compounds 2.1, 3.1, and 
3.2 were added to give a 2:100 ligand-to-lipid ratio. To the cuvette containing the EYPC-
transporter mixture was added 20 µL of 0.5 M NaOH solution through an injection port, 
after 20 s, to give an external OH- concentration of 5 mM. Addition of the NaOH resulted 
in a pH increase of approximately 1 pH unit in the extravesicular buffer. The 
fluorescence of the intravesicular pH was monitored at excitation wavelength of 403 nm 
and 460 nm, and emission at 510 nm for 500 s. After 470 s, 40 µL of 10 % Triton-X 
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detergent was added to lyse the liposomes, and obtain maximum dye emission.  
Experiments were carried out in triplicate.  The final transport trace was obtained as a 
ratio of the emission intensities monitored at 460 and 403 nm. The [H+out] (extravesicular 
proton concentration) was assumed to remain constant over the course of the experiment, 
while [H+ins] (intravesicular proton concentration) values were calculated for each point 
from the HPTS emission intensities according to the calibration equation pH = 1.2038 x 
log (I0/I1) + 7.3353, where I0 is the emission intensity with excitation at 460 nm and I1 is 
emission intensity with excitation at 403 nm. The calibration was performed by 
measuring the HPTS emission intensities and the pH values of a 470 pM HPTS solution 
in 10 mM phosphate buffer containing 100 mM NaNO3 (Figure 6.5).  
 
 

















Figure 6.5. A calibration plot relating the emission intensity of HPTS (470 pM) to pH of 




Chloride Transport in Lucigenin-Containing EYPC Liposomes (Figure 3.13).  LUVs 
were prepared and assays conducted as described in Section 6.2.2.  
 
Nitrate Reductase assay (Figure 3.15).  LUVs were prepared as described above for 
base-pulse assays, with the exception that the lipid film was rehydrated with 1 mL of a 
solution of 10 mM sodium phosphate (pH = 7.2) containing 100 mM NaNO3 and no dye. 
Also, the liposome solution was passed through a Sephadex (G-25) column (eluant, 10 
mM sodium phosphate, pH 7.2, 100 mM NaCl) to remove the external NaNO3 ions.  In a 
typical experiment, 50 µL of the stock EYPC liposomes was diluted into 2 mL of 10 mM 
sodium phosphate (pH 7.2, 100 mM NaCl, 1.1 mM NADPH, 0.3 units of nitrate 
reductase) to give a solution that is 0.5 mM in lipid.  Tripods 3.1 and 3.2 were added to 
separate cuvettes in addition to a blank cuvette (lacking transporter) and the UV was 
monitored over time.  Once the NADPH UV-Vis spectrum stabilized, 60 µL of 
sulfanilamide (0.29 M in 2 N HCl) and 216 µL of N-(1-naphthyl)ethylenediamine (0.29 
M in 2 N HCl) were added to the cuvette.  The solution turned a red color in the presence 
of nitrite and remained clear in the absence of nitrite. The UV-Vis spectrum of the 
resulting solution was monitored at 543 nm. 
 
HPTS assay for selective NO3- transport (Figure 3.16).  LUVs were prepared and 
assays conducted as described above for base-pulse assays, with the exception that the 
intravesicular (10 mM sodium phosphate, pH 6.4; 100mM NaNO3) and extravesicular 
(10 mM sodium phosphate, pH 6.4; 100mM NaCl) phosphate buffers were different, and 
no base pulse (0.5 M NaOH) was added in the experiment.  Thus, the pH of the 
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intravesicular and extravesicular compartments is the same, that is, a concentration, and 
not a pH, gradient exists across the bilayer membrane.  Instead of the base pulse, 
compounds 2.1, 3.1 and 3.2 were added to the cuvette containing the anion-asymmetric 
liposome mixture through an injection port at t = 30 s to give a 2:100 ligand-to-lipid ratio.    
 
6.4 Experimental Procedures for Chapter 4. 
6.4.1 Experimental Details. 
1H NMR Titration for Prodigiosin 4.1.  A) Titrations with “free base” prodigiosin 4.1: 
A stock solution of the prodigiosin 4.1 (4.0 mM) was prepared in CD2Cl2 and divided 
into three NMR tubes (300 µL solutions).  Pure solvent (CD2Cl2; 300 µL) was added to 
make up the initial total volume up to 600 µL.   A 100 mM stock solutions of each anion 
(tetraethylammonium bicarbonate (TEAHCO3) or TBACl or TBANO3) was also 
prepared.  The titration was performed by incremental addition of 6.0 µL aliquots of the 
anion stock solution, giving an increment of 0.5 anion equivalents with each addition up 
to a total of 15.0 anion equivalents.  Thus, the total volume in the NMR tube ranged from 
600-780 µL, while the concentrations of prodigiosin and anion ranged from 2.0-1.54 and 
0.0-23.1 mM respectively.  At least two data acquisition sets were obtained for each 
addition of the 6.0 µL anion aliquot: first data set immediately after addition of anion 
aliquot, and another data set at least 5 minutes after the start of the first data acquisition.  
The pyrrole NH protons were not visible in the 1H NMR spectrum of prodigiosin in the 
free-base form in CD2Cl2.  Thus changes in the chemical shifts of the H2 proton on the 
A-ring and the methyl group on the C-ring of prodigiosin 4.1 (Scheme 4.2) were 
monitored by NMR (600 MHz), and the chemical shifts fit to a 1:1 binding model using 
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WinEQNMR (Version 1.20) software by Michael J. Hynes in the laboratory of Professor 
Philip Gale at the University of Southampton, Southampton, UK.  Titration curves for Cl- 
and NO3- binding based on methyl group on prodigiosin’s C-ring are shown in Figure 
4.7.  (B) Titrations with protonated prodigiosin 4.1:  1H NMR titrations with protonated 
prodigiosin were carried out as described above with the exception that a 1:1 solution of 
4.1-to-methanesulfonic acid in CD2Cl2 was used as the starting solution.  Aliquots of 
anions were then added in 1.0 equivalent increments.  Concentrations and final volumes 
are the same as described above except that the anion solution was added as 12.0 µL 
aliquots.  
 
Preparation of phospholipid vesicles for Cl- ion-selective electrode assays (Figures 
4.14-4.16).  Chloride ion-selective electrode assays were carried out by Dr. Roberto 
Quesada in the laboratory of Professor Philip Gale at the University of Southampton, 
Southampton, UK.  Experimental details for these assays can be found in the Nature 
chemistry publication.192    
 
Liposome preparation for 13C NMR assays.  Giant EYPC liposomes (5 µm) were 
prepared by evaporating a chloroform solution of EYPC (20 mg/mL) under reduced 
pressure, which resulted in a thin film that was dried in vacuo overnight.  The liposomes 
were then formed by rehydrating the lipid film with either 450 mM NaCl in 20 mM 
HEPES buffer, pH 7.3 (for the chloride-loaded liposomes described in Figure 4.17), or 
100 mM NaH13CO3 in 20 mM HEPES buffer, pH 7.5 (for the bicarbonate-loaded 
liposomes described in Figure 4.18).  Buffer solutions were prepared in a 9:1 H2O/D2O 
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mixture.  After five freeze–thaw cycles, the liposomes were extruded through a 5 µm 
Nuclepore polycarbonate membrane 41 times at room temperature using a high-pressure 
mini-extruder (Avanti).  For the chloride-loaded liposomes, the giant liposome 
suspension obtained after extrusion was used in the 13C NMR transport assays without 
further purification.  However, for the bicarbonate-loaded liposomes, the resulting giant 
liposome suspension was separated from extravesicular NaH13CO3 by size-exclusion 
chromatography (stationary phase: Sephadex G-25, mobile phase: 9:1 H2O/D2O, 20 mM 
HEPES, pH 7.3, 75 mM Na2SO4). The 30 mL suspension (NaH13CO3 inside, Na2SO4 
outside) collected was centrifuged (Eppendorf Centrifuge 5804R) at 10,000 revolutions 
per minute for 30 minutes followed by removal of the non-liposome-containing buffer. 
The recovered giant liposome suspension was then diluted with the 75 mM Na2SO4 
mobile phase buffer and used directly in the 13C-NMR transport assays. The stock 
concentrations obtained for the liposomes were 90.3 mM for the chloride-loaded 
liposomes (assuming 100% lipid retention after extrusion) and 66.6 mM for the 
bicarbonate-loaded liposomes (assuming 80% lipid retention after gel filtration), 
respectively. 
 
Bicarbonate transport in chloride-loaded liposomes monitored by 13C NMR (Figure 
4.17).  13C NMR spectra were recorded using a Bruker DRX500 spectrometer with a 5-
µm broad-band probe operating at 125.77 MHz, with chemical shifts reported in ppm.  
The instrument was locked on 9:1 H2O/D2O.  Experimental conditions were: acquisition 
time, 0.93 s; spectrum width, 35,211 Hz; 90º pulse width, 6.70 ms; relaxation delay, 0.2 
s; number of scans, 160; temperature, 27 ºC.  For each experiment, 230 mL of stock (90.3 
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mM) liposome solution was mixed with 340 mL of 150 mM Na2SO4 in 20 mM HEPES 
buffer, pH 7.3, in a 5 mm NMR tube to give a liposome suspension that contained NaCl 
inside and Na2SO4 outside.  A NaH13CO3 pulse was then added to the mixture to give 35 
mM and 50 mM final concentrations of liposome and H13CO3-, respectively.  The 13C 
NMR of the preceding liposome mixture (NaCl inside, Na2SO4 and NaH13CO3 outside) 
was then taken.  After data acquisition, a solution of MnCl2 was added to give a final 
Mn2+ concentration of 0.5 mM (1:100 Mn2+/H13CO3- ratio), and immediately followed by 
another set of data acquisition.  A final set of 13C NMR data was collected after the 
addition of a solution of the ligand (4.1, 4.2 or 4.4) or DMSO to the mixture.  
Isophthalamides 4.2 and 4.4 were added in a 1 mol% ligand-to-lipid ratio, and 
prodigiosin 4.1 was added in a 0.1 mol% ligand-to-lipid ratio.  For the DMSO control, 6 
mL of the solvent was added, which corresponded to a 403 mol% DMSO-to-lipid ratio.   
 
Bicarbonate transport in bicarbonate-loaded liposomes monitored by 13C NMR 
(Figure 4.18).  Instrument details are the same as those described above for the chloride-
loaded liposomes.  The instrument was locked on 9:1 H2O/D2O.  Experimental conditions 
were: acquisition time, 0.93 s; spectrum width, 35,211 Hz; 90º pulse width, 6.70 ms; 
relaxation delay, 0.2 s; number of scans, 196; temperature, 27 ºC.  For each experiment, 
an initial 13C NMR spectrum of 520 mL of the giant liposome solution was acquired.  
Then, a NaCl pulse resulting in final extravesicular concentrations of 58 mM and 50 mM 
for the giant liposomes and chloride, respectively, was added to the NMR tube.  The 13C 
NMR of this liposome mixture (NaH13CO3 inside, Na2SO4 and NaCl outside) was taken, 
followed by the addition of a solution of the ligand (4.1, 4.2 or 4.4) or DMSO.  Again, 
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isophthalamides 4.2 and 4.4 were added in a 1 mol% ligand-to-lipid ratio, while 
prodigiosin 4.1 was added in a 0.1 mol% ligand-to-lipid ratio.  For the DMSO control, 10 
mL of the solvent was added, which corresponded to an 870 mol% DMSO-to-lipid ratio. 
A 13C NMR spectrum of the ligand-containing cocktail was then acquired before and 
after the addition of a solution of MnCl2 (0.5 mM final Mn2+ concentration, which 
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